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The research described in this thesis was carried out as part of the EPSRC National Centre in 
Continuous Manufacturing and Crystallisation (CMAC), whose vision is to accelerate the adoption 
of continuous manufacturing processes for the production of high-value chemical products. Results 
focus upon the crystallisation of multi-component molecular complexes (MMCs), in particular co-
crystals, an important class of potential functional molecular materials. MMCs are commonly 
discovered through small scale batch solvent evaporation, a method that provides little control over 
the crystallisation process, often yields only small quantities of crystalline material which may not 
be phase pure and is not generally scalable. Methods have been developed to help translate traditional 
small scale batch co-crystallisation of MMCs to selective continuous co-crystallisation processes.  
The co-crystal system urea-barbituric acid (UBA) has three polymorphs, previously identified in the 
literature and was selected as a candidate for transfer to continuous crystallisation as its 
polymorphism offers a development challenge in being able to achieve selectivity of solid products 
through by various crystallisation processes. Chapter 4 describes small scale crystallisation studies 
of UBA using evaporation, cooling and mechano-crystallisation techniques, demonstrating that 
UBAI is the more prevalent polymorph. Solid state and solubility analysis of the isolated UBA 
polymorphs are detailed; these data provide information on the energetic relationship between the 
polymorphs highlighting the similarity in energy of UBAI and UBAIII, and the metastable nature of 
elusive UBAII. In addition the polymorphic nature of the barbituric acid starting material has been 
investigated with samples from different suppliers proving to consist of different polymorphs. As 
well as being important in designing subsequent crystallisation processes, results from these studies 
corroborate work previously reported in the literature  
Chapter 5 describes how these results have been used in development of continuous crystallisation 
experiments using Mixed-Suspension Mixed-Product Removal (MSMPR) with a cascade of three 
stirred tank reactors, while Chapter 6 investigates flow crystallisation of UBA using the Continuous 
Oscillatory Baffled Crystalliser (COBC) and the Kinetically Regulated Automated Input tubular 
flow Crystalliser (KRAIC). The KRAIC was designed and constructed as part of this research. The 
continuous crystallisation experiments presented in Chapters 5 and 6 demonstrate the selective 
continuous co-crystallisation of UBAI across all three continuous crystallisation platforms. 
In Chapter 7 a range of novel co-crystalline MMCs is presented, with structural determinations, using 
single crystal X-ray diffraction, coupled with characterisation of properties and crystallisation 
characteristics; these studies emphasise the physical property advantages of MMCs and in some 
cases their potential for future translation to continuous crystallisation. 
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1 Introduction I – Multi-Component Materials 
1.1 Crystal Engineering and Multi-component Crystallisation 
Crystal engineering is a modern branch of chemistry considered to have originated around 40 years 
ago and was first documented in 1971 when Schmidt published a paper on solid state photochemical 
properties of cinnamic acids, in which he coined the phrase “crystal engineering”1. Crystal 
engineering involves design and facilitation of the solid state organised self-assembly of molecules 
using non-covalent interactions, in order to form a crystalline solid that displays a desirable  
property2, 3.  
In contrast to chemical synthesis where emphasis is placed upon the reactivity of a molecular species 
and the ability to form new covalent bonds, crystal engineering focuses on the geometry and 
functionality of a molecule to give an indication of the propensity to form intermolecular interactions 
that influence the molecular packing within a crystal4.  
In the infancy of crystal engineering Schmidt predicted that future progress in the field would ‘be 
difficult if not impossible until we understand the intermolecular forces responsible for the stability 
of the crystalline lattice.’1 It is the desire to understand further these non-covalent intermolecular 
interactions that has driven the evolution of the crystal engineering field, which has swiftly evolved 
over the past 15 years5. 
A crystal engineering approach to the production of new molecular materials commonly involves 
studying the crystallisation of compounds related by a systematic variation in molecular structure. 
This enables variations in properties that appear upon analysis to be pinpointed to a specific detail 
in the crystal structure6. The choice of materials and their variation in crystal engineering is governed 
by an analysis of their likely intermolecular interactions, primarily the hydrogen bond but also with 
consideration of other possible significant intermolecular interactions.  
This systematic variation is also used to produce multi-component molecular materials. A target 
material is combined with one or more additional materials (co-formers) to crystallise together in the 
same crystal lattice through intermolecular interactions, altering the packing arrangement of the 
target material and potentially inducing a favourable change in physical properties. This proved 
useful when studying molecular complexes involving chloranilic acid (CA) which are known to be 
brightly coloured, either red, orange or purple7. The structures of molecular complexes combining 
CA with one of a family of picolinic acid based co-formers showed structures in which proton 
transfer had occurred between CA and the co-former, altering the protonation state of the CA.  
From the structures each of the three colours could be assigned to one of the three protonation states 
of chloranilic acid, as previously proposed by Molcanov et al.7 
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In co-crystallisation studies by Aakeroy et al.8 using hexamethylenbisacetamine (HBA), an API used 
for prevention of proliferation of lung cancer cells and as a treatment for leukaemia, HBA was 
crystallised with a variety of dicarboxylic acids with systematic variation in carbon chain lengths in 
an attempt to increase the aqueous solubility of the API. Complexes of the API and co-formers 
formed structures containing alternating chains of API and co-former. The co-crystal involving the 
shortest dicarboxylic acid, succinic acid, was found to improve aqueous solubility by a factor of 2.5. 
As the chain length increased, the aqueous solubility of the co-crystals produced was reduced, to the 
extent that their solubility was less than that of the API alone8. It is also possible to use co-
crystallisation as a templating method to access a particular polymorphic form of a single component 
API, as found recently with paracetamol form II9. 
 
1.2 Classification of Multi-component materials 
Multi-component molecular complexes (MMCs) can be classified into several sub groups, namely 
co-crystals, salts, solvates and hydrates, the nomenclature of which is highly debated6, 10, 11. However 
it is generally accepted that a salt is produced with a free acid and a basic salt former (or a free base 
and an acidic salt former) between which proton transfer occurs.  This results in a single crystal 
lattice comprised of two or more oppositely charged species where the crystal remains neutral 
overall. Salt formation is commonly used in the pharmaceutical and agrichemical industries as a 
convenient method to isolate synthetic products and/or to improve physicochemical properties12.  
Similarly to salts, co-crystals are formed by two or more different compounds held together in the 
same crystal lattice through intermolecular interactions. However, the molecular species within a co-
crystal remain neutral, i.e. as in molecular systems such as those studied here, there is no proton 
transfer. As for salts, co-crystals can be used in the industrial context as they can strongly influence 
physicochemical properties such as solubility, melting point and others, relevant to processing, 
delivery or bioavailability of materials. 
Salts and co-crystals are not inclusive of hydrates or solvates where the second component is a water 
molecule or solvent molecule introduced by the solvent of crystallisation. Solvates and hydrates are 
occasionally referred to in the literature as pseudo-polymorphs13, 14 or even classed as polymorphs 
by some authors, however in the context of this thesis they shall be termed solvates. Solvates and 
hydrates can be classified further into two subgroups – either as true solvates/hydrates where the 
solvent/water molecule is incorporated into the crystal lattice in a fully ordered manner through 
intermolecular interactions in a stoichiometric ratio, or as non-stoichiometric solvates/hydrates, i.e. 
those where water or solvent is trapped in pores or channels, often exhibiting disorder, and can be 
adsorbed or removed upon heating or with gas or solvent displacement15.  
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It is important to note that in this work a multi-component product will be referred to as a molecular 
complex, encompassing both molecular salts and neutral complexes under this term. The term co-
crystallisation is commonly accepted shorthand for multi-component crystallisation and the two can 
be used interchangeably10. 
 
 
Figure 1.1 Schematic highlighting polymorphism and different types of multi-component 
molecular complexes (MMCs) showing (a) the target material, (b) polymorph (c) hydrate, (d) 
hydrated co-crystal, (e) 1:1 co-crystal, (f) salt, (g) 1:1 co-crystal polymorph and (h) 3:1 co-crystal. 
 
1.3 Understanding Polymorphism in Crystalline Solids 
Crystalline solids, including many important pharmaceutical and other functional molecular 
materials, can exhibit polymorphism; this is a common phenomenon in which crystalline solids 
containing identical molecular species can adopt different packing arrangements forming different 
crystalline forms or phases known as polymorphs. The discovery of polymorphism, in 1832 by 
Wohler and von Liebig’s 16 study on benzamide, and its subsequent investigation, has been essential 
in many industries, not least in the pharmaceutical industry where polymorphism can affect 
physicochemical properties such as solubility, drug retention times and compression properties, not 
to mention implications in regulatory and patent documentation.17, 18 
Although not widely known outside of the academic community, most people will have personally 
encountered polymorphism in products they use daily. One obvious example of contrasting physical 
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properties are the carbon polymorphs (allotropes) – soft graphite found in pencil lead and hard 
diamond used in jewellery 19. Polymorphism is regularly found in any industry involved in the 
manufacture of crystalline products including washing detergents, pharmaceuticals, cosmetics and 
foodstuffs. 
The orientation and packing of the molecular species within each polymorph are strongly reliant 
upon the intermolecular interactions between these species and this gives rise to variation in the 
relative stability and physicochemical properties between polymorphs. In structures comprising 
flexible molecular species, polymorphs can be formed via alterations in conformation about a single 
bond due to differing intermolecular interactions; this is commonly referred to as conformational 
polymorphism2, 16, 20-22. In essence, polymorphism is to crystal structures what isomerism is to 
discrete molecules and can present itself in single component materials and MMCs alike. It has been 
proposed that all crystalline solids are polymorphic, but in certain systems the conditions under 
which their polymorphic forms are obtainable have yet to be identified or cannot be achieved23. 
Compounds that have been studied in detail appear to display a higher degree of polymorphism than 
lesser studied compounds, likely to be due to increased knowledge, greater resources expended on 
exploring crystallisation conditions under which different polymorphs may be found, and an 
increased amount of experimental data23, 24. 
One medicinal molecule that exhibits significant polymorphism is 5-methyl-2-
[(2nitrophenyl)amino]-3-thiophene carbonitrile, commonly known as ROY (for red-orange-yellow) 
(Figure 1.2).  
 
Figure 1.2 Molecular structure of ROY (conformational bond highlighted in red) 
This flexible molecule, discovered accidentally by researchers at Eli Lilly in the early 90s20, has ten 
known polymorphs to date, however that alone is not what caught the attention of crystal engineers. 
Each polymorph of ROY displays a different combination of crystal shape and colour ranging from 
red prisms to yellow needles, which is attributed to the conformational polymorphism of this 
molecule in the solid state. The alteration of torsion angles can affect the π-conjugation between the 
thiophene and phenyl rings which leads to a shift in the visible absorption spectra19. Earlier studies 
of coloured polymorphs were carried out on dimethyl-3,6-dichloro-2,5-dihydroxyterepthalate 
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(MCOHT) by Byrn et al. in 1972 25. This showed that MCOHT underwent a temperature induced 
transition between two different coloured polymorphs (Figure 1.3). 
 
Figure 1.3 shows dimethyl-3,6-dichloro-2,5-dihydroxyterepthalate (1) the two polymorphs; 
yellow (2) and white (3) and their reactive intermediate (4)25. 
 
1.4 Thermodynamics of Polymorphism  
As detailed in section 1.3 above, polymorphism is the phenomenon where the molecules of a material 
have the ability to crystallise in more than one arrangement to create different polymorphic phases 
which will have variation in thermodynamic stability due to the free energy of each form. In 
understanding the relative stabilities of polymorphs, and trying to control their formation, it is 
important to understand the underlying thermodynamics, while recognising that the formation of 
solid crystal forms is governed not only by thermodynamics but also by kinetics. 
 
Properties governed by thermodynamics, relevant to the potentially different physical properties seen 
in different solid forms of a material, include the following: 
 Melting points; 
 Desolvation of adsorbed and bound solvents; 
 Internal/structural energy, enthalpy, heat capacity, entropy, free energy, including surface 
free energy; 
 Thermodynamic activity, including phase transitions (heats of transitions including melting 
and crystallisation, glass transitions for amorphous materials, polymorphic transitions); 
 Vapour pressure; 
 Solubility and hygroscopicity; 
 Thermal expansion; 
 Stability under processing conditions (including under different environments); 
 Compatibility of materials (interactions between components). 
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All systems have an internal energy and it is possible to measure a change in the physical properties 
if they are accompanied by a change in this internal energy, by methods such as differential scanning 
calorimetry (DSC) (section 3.6). These changes can then be related to changes in the key 
thermodynamic parameters such as enthalpy and entropy. For example, transformation from a solid 
to a liquid (melting) results in a transfer of energy to the sample (endothermic process) in the form 
of heat. It is important to note that it is only possible to measure a difference in energy and not the 
absolute energy. 
 
Thermodynamic properties can be classed as either extensive, whereby the value is dependent upon 
the mass of the sample present, or intensive when a value is independent of mass. For example the 
amount of heat required to melt 10 g of sodium chloride (NaCl) is an extensive value but if this value 
were divided by mass to give heat/g of NaCl this value will be true for any mass of substance, which 
is intrinsic to that material and is an intensive property. The difference in these properties across two 
systems can determine whether energy will be exchanged between the two systems and if so in which 
direction it will be exchanged. Temperature, for example, is a measure of the intensity of heat in a 
system (system A) and relative to the temperature of another system (system B) this will indicate 
how much heat will flow between system A and system B and which system will be the heat donor 
and which will be the heat acceptor. This is directly related to the Second Law of Thermodynamics, 
which states that no process is possible whose sole result is the transfer of heat from a colder to a 
hotter body (in the Clausius formulation), and is the basis for the definition of the thermodynamic 
quantity of entropy. 
 
The First Law of Thermodynamics allows the energy differences to be quantified, as it states that 
“the total energy of a system and its surroundings must remain constant although it may be changed 
from one form to another”. Critically, the First Law refers to both system and surroundings – there 
can be local changes in the energy of the system itself, which can be measured in experiments such 
as DSC. 
 
The energy of a system is dependent upon the pressure, volume, temperature, mass and composition 
within that system, and since we measure differences in energy, we typically refer to quantities such 
as ΔE = EII - EI, which would be the change in energy when transforming from one state to another 
(in this case as state I goes to state II). 
 
Of the quantities that are commonly measured in looking at crystalline solid forms, their 
transformations and polymorphism, enthalpy is key.  Enthalpy, H, is defined as U + PV, where U is 
the internal energy, and this shows that enthalpy is dependent upon the pressure and volume of a 
system. The quantity governing chemical transitions is the Gibbs free energy G.   
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G is defined as U – TS + PV = H – TS, and for a chemical process assumed to be isothermal (constant 
T), this leads to the common thermodynamic expression G = H – TS. The value of G governs 
the thermodynamic spontaneity of chemical processes, the key condition for such spontaneity being 
that G < 0. However, since both H and S are dependent on temperature, and with T a primary 
parameter in the expression for G, it follows that variation of temperature is one factor that can be 
used to control which chemical (or physical) state will be the most stable (minimising G). The same 
is true for pressure, but here we focus only on the variation in temperature. 
 
As the temperature term is directly linked in this expression with entropy not enthalpy, then the term 
TS will increase more rapidly than H leading to a more negative value of G with increasing 
temperature. 
 
The free energy differs between polymorphs, the form with the lowest free energy being classed as 
the most thermodynamically stable, and due to the different thermodynamic characteristics of 
different solid forms, the relationship between the free energy and temperature also differs between 
polymorphs (Figure 1.4). This means that the free energy curves for different polymorphs (Forms I 
and II in the figure) may cross; at a given temperatures the two polymorphs may be isoenergetic in 
terms of free energy (shown by the point of interception in Figure 1.4), which would represent the 
phase transition temperature between the polymorphs. 
 
 
Figure 1.4 Schematic to highlight the variation in the relationship between free energy and 
temperature for different polymorphs 
It is important to note that thermodynamics is not concerned with the rate of polymorph 
transformation (kinetics), but only the relative energies and stabilities of the polymorphs. Using the 
carbon allotropes diamond and graphite as an example, diamond is thermodynamically less stable 
than graphite, however it is the extremely slow kinetics of the transformation that allow diamond to 
persist in a metastable state.  
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1.4.1 Solid-state Transitions Between Polymorphs: Enantiotropy and Monotropy 
Two polymorphs (termed A and B for this explanation) are defined as enantiotropic if the two phases 
can undergo a fully reversible solid state phase transition i.e. below the melting points of A and B 
there is a transition point (Ttransition)  at which the Gibbs free energies of A and B are equal (Figure 
1.5, right). When T < Ttransition, GA < GB and thus polymorph A is more thermodynamically favourable 
however when T > Ttransition, GB < GA and so the stability is reversed with polymorph B now the most 
thermodynamically stable24, 26. 
 
On the other hand if polymorphs A and B are defined as monotropic they are related through an 
irreversible solid state phase transition where under all temperature conditions one form (A, for 
example) would remain the most thermodynamically stable and form B would always convert to 
form A, never the reverse (Figure 1.5, left). 
 
 
Figure 1.5 Plot showing relationship between energy and temperature for polymorph A (blue) 
and B (red) with a monotropic relationship and an enantiotropic relationship (where GA, GB and 
Gliq represent the free energy of polymorphs A and B and the liquid phase, TmA and TmB are the 
melting points of A and B and Tt is the temperature of the phase transition from A to B)  
The stability ranges for a particular form (as a function of pressure, temperature and other variables 
such as composition) form the basis for the construction of phase diagrams, a key tool in using 
thermodynamics to guide studies of polymorphism and solid form control. Phase diagrams have not 
been determined during this work, and will not be discussed further here. 
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1.5 The Importance of Solid Form Control 
Pharmaceutical manufacture and processing is heavily focused upon the control of the physical 
properties of the product (Table 1.1), including polymorphism. Physical properties can not only 
affect drug bioavailability and how the active pharmaceutical ingredient (API) interacts with the 
target in the body, but it also affects the manufacturing process itself27. Control is achieved by 
monitoring the physical properties using process analytical technologies (PAT) and tailoring the 
crystallisation conditions by using alternative solvents and additives, adjusting temperature and 
supersaturation or by changing the method of crystallisation altogether.    
 
Table 1.1. Control of physical properties during manufacturing and potential effects on 
manufacturing, processing and the final product.  
Physical property Secondary effects 
Crystal size  Bulk powder flow 
 Rate of dissolution 
 Filtration  
Crystal size distribution 
(CSD) 
 Bulk powder flow 
 Filtration 
 Consistency of downstream processing 
Crystal morphology  Bulk powder flow 
 Agglomeration 
 Ease of downstream processing 
 Rate of dissolution 
Surface properties 
Polymorphic form  Bioavailability 
 Solubility 





It is important that polymorphs of the API and associated excipients can be isolated and controlled. 
This is achieved by using different crystallisation conditions, crystallisation techniques and/or 
additives. There is only one thermodynamically stable polymorph of a material; while there may be 
many metastable polymorphs, over time metastable forms will convert back to the most 
thermodynamically stable form. In order to prevent unwanted polymorphic conversion it is 
preferential to use the most thermodynamically stable form unless particular desired properties are 
exhibited in other less stable forms alone. Transformation can also occur in the presence of water or 
water vapour to form hydrates or can be in contact with solvent vapours in manufacturing processes 
to form undesirable solvates. 
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Control of the solid form is vital in drug delivery methods. For example, mannitol is used as a drug 
carrier molecule for APIs administered to the lungs using a dry powder inhaler (DPI). The efficiency 
of the API-carrier formulation is reliant upon the physical properties of not just the API but also the 
mannitol carrier crystals. Crystal size, morphology and properties of the crystal surface are 
influential on the success of mannitol as a drug carrier. Fine particles are required to reach lower 
areas of the lungs and the elongated rod morphology is useful in aiding deposition in the lungs. These 
properties are influenced by the crystallisation conditions in production, particularly the degree of 
supersaturation of the crystallisation solution 28.  
 
Tableting of an API is also influenced by the solid form of the material; an example of this is the 
commonly used analgesic paracetamol. The most common polymorphic form of paracetamol is form 
I, however studies have shown that the more elusive polymorph, form II, is more readily compressed 
into tablet form due to its slip-layered structure especially in comparison to the interlocked concertina 
structure of form I (Figure 1.6) 9.  
 
Figure 1.6  The interlocked concertina structure of paracetamol form I and the slip-layered structure of 
paracetamol form II9.  
Problems have been encountered in some cases due to a lack of polymorphic control. Norvir®, a 
brand of the protease inhibitor ritonavir, a part of an AIDS treatment preparation, was produced 
successfully for two years, prior to a new thermodynamically stable polymorph emerging in the 
manufacturing process. The presence of this more thermodynamically favourable form meant that 
the original polymorph could no longer be produced and the thermodynamically stable polymorph 
had reduced solubility and bioavailability in comparison. Re-formulation of the drug was required 
and in the interim the drug had to be removed from the market reducing profit to the manufacturer 
and, more importantly, reducing the availability of an important AIDS treatment24, 27.  
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1.6 Functional Materials; Optimisation of Solid State Properties of Molecular 
Materials 
Functional crystalline materials have a wide variety of applications, from food additives to 
explosives, each reliant on a specialist function that has been heavily influenced by its crystal 
structure (Table 1.2). Some applications have been discussed in more detail below.  
 
Pharmaceuticals and Agrochemicals 
An important property of many crystalline products is their aqueous solubility. In pharmaceuticals 
this is important in enabling an API to dissolve readily when administered orally and to ensure 
efficient and consistent uptake into the body. Similarly, the active agrochemical ingredient (AAI) in 
agrochemical products is usually hydrophilic and delivered to the crop in an aqueous solution, though 
in some cases it may be important to form a lipophilic crystal to enable the AAI or API to bind to 
animal tissues. Many APIs and AAIs initially have poor aqueous solubility, but through 
crystallisation with co-formers to form salts and co-crystal it is possible to increase their solubility 
(see section 7.5 for an example)29, 30.  
 
Energetic materials 
Energetic materials including explosives and propellants are used as components in fireworks, 
munitions and for demolition. It is important to regulate the sensitivity of these materials to ensure 
that detonation occurs in a controlled manner and only when required. Polymer binders are often 
used to enclose crystals of the energetic material acting as a shock absorber, alternatively sensitivity 
can be reduced through co-crystallisation to alter the crystal structure of the material. Studies have 
produced 1:1 co-crystals of hexanitrohexaazaisowurtzitane (CL-20) and trinitrotoluene (TNT) which 
exhibits a reduction in sensitivity in comparison to its constituents whilst maintaining the same 
explosive intensity31.    
 
Pigments and Dyes 
The colour of crystalline solids can be tuned by altering conjugation of systems and adjusting 
π-π stacking arrangements the crystal structure through polymorphism and co-crystallisation. This 
can induce intense colour in crystalline materials which proves particularly useful in pigment and 
dye manufacture. An example of this is a molecular complex formed between 4-cyanopyridine and 
squaric acid, both off-white in colour, which involves a 4-cyanopyridinium cation and a singly 
deprotonated squaric acid mono-anion and is red in colour. The colour is believed to be caused by a 




In recent years metal organic frameworks (MOFs) have emerged as an important area of materials 
chemistry due to their porous nature which provides potential for gas storage, especially carbon 
dioxide and hydrogen gases. MOFs lend themselves to this function due to their stability and high 
surface area and their functionality can be readily modified through crystallisation to tailor them to 
adsorb particular molecules33.  
 
Table 1.2 Properties that can be controlled in functional materials. 
Property type Property 
Examples of application 
domains 
Chemical Chemical and photochemical 






Kinetic Stability, kinetics of solid state 




Fast moving consumer goods 
Physical and 
Thermodynamic 
Thermal and electrical 
conductivity, Melting point, 
thermal stability, heat capacity, 
solubility, hygroscopicity, free 
energy and chemical potential, 




Fast moving consumer goods 
Dyes and pigments 
Spectroscopic Rotational, vibrational and 
electronic properties and 
spectral features in nuclear 
magnetic resonance. 
Dyes and pigments 
Optically active materials 





Fast moving consumer goods 
Explosives 
Surface Crystal morphology, surface 





Fast moving consumer goods 
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1.7 Intermolecular Interactions 
As stated previously, intermolecular interactions are fundamental to formation of molecular 
crystalline solids whether they contain only a single molecule type or are multi-component molecular 
complexes. The interactions to be described in this section can also occur between non-bonded atoms 
within the same molecule, termed intramolecular interactions. Intramolecular interactions are not as 
common as intermolecular interactions but can alter the conformation of molecules within a crystal 
and can give rise to conformational polymorphism2 (section 1.3). 
 
1.7.1 Hydrogen Bonding 
The first mention of the term “hydrogen bond” was made in 1930 by Pauling34. Though it goes 
against basic valence bond theory that a hydrogen atom should form more than one chemical bond, 
Pauling said that the hydrogen bond affected by two “parent” atoms and not just one could act like 
a bond between the two atoms, known as a hydrogen bond35. A hydrogen bond is comprised of a 
donor atom (D) bonded covalently to the hydrogen atom (H) attached to acceptor atom (A), where 
H is deficient in electron density as a result of the higher relative electronegativity of D. As a result 
of this difference in electronegativity the D-H bond contains an induced dipole which interacts with 
the concentrated electron density, e.g. a lone electron pair or other polarisable electrons, of the 
acceptor atom (A) (Figure 1.7(i))34, 36, 37. Though H is initially covalently bonded to D, in a hydrogen 
bond H can be located at position equidistant from D and A or in some cases it can even undergo 
proton transfer by which H moves to be located on A rather than D (Figure 1.7(ii)). It also possible 
that hydrogen bonds can form between one donor site and multiple acceptor sites. A hydrogen bond 
with two acceptor sites is known as a three-centre bond or more commonly as a bifurcated hydrogen 
bond36 (Figure 1.7(iii)). 
 
 
Figure 1.7 Different variations in hydrogen bonding between hydrogen donor atom D and hydrogen 
acceptor atom A. i) standard hydrogen bond, ii) hydrogen bond that has undergone proton transfer, iii) 
bifurcated or three-centred hydrogen bond. 
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Hydrogen bonding is the most versatile of intermolecular interactions, due to a wide range of possible 
donors and acceptors and varying bond strengths, and it is additionally valued for its directionality38. 
This diversity has made defining a hydrogen bond a challenge, which has led to a variety of 
definitions over the years. Steiner adjusted the definition previously proposed by Pimental and 
McLellan by stating that ‘An X-H…A interaction is called a “hydrogen bond”, if it constitutes as a 
local bond, and X-H acts as a proton donor” rather than an electron donor36, 39. More recently, in 
2011, IUPAC (the International Union of Pure and Applied Chemistry) defined the hydrogen bond 
as “an attractive interaction between a hydrogen atom from a molecule or a molecular fragment X–
H in which X is more electronegative than H, and an atom or a group of atoms in the same or a 
different molecule, in which there is evidence of bond formation.”40. 
 
Hydrogen bonds vary widely in strength but can be loosely categorised through a system devised by 
Jeffrey (Table 1.3), in which the strength of a hydrogen bond is classified by the distance between 
the donor and the acceptor atoms. There are three ranges, corresponding to strong, moderate and 
weak hydrogen bonds. Hydrogen bonds of D···A distances of <2.5 Å are classed as strong and can 
resemble covalent bonding, while the weak bonds of D···A distances of 3.2 Å to 4 Å are electrostatic 
in character and are similar to van der Waals forces. The intermediate region between 2.5 Å and 
3.2 Å is where the vast majority of interactions lie and these are classified moderate hydrogen bonds 
which are mostly electrostatic in nature36, 39. 
 
Table 1.3. Classification of hydrogen bonds into strong, moderate and weak categories36.  
 
1.7.2 Van der Waals Interactions 
Van der Waals (vdW) interactions are attractive or repulsive intramolecular or intermolecular 
interactions which are relatively weak in comparison to covalent bonds. vdW interactions can be 
subdivided into three categories due to variations in the polarisability of the interacting species 
(Table 1.4). 
 Strong Moderate Weak 
A–H···B interaction  Mostly covalent Mostly electrostatic Electrostatic 
Bond lengths A–H  ≈ H···B A–H  < H···B A–H  << H···B 
H···B bond length (Å) ~1.2-1.5 ~1.5-2.2 2.2-3.2 
A···B bond length (Å) 2.2-2.5 2.5-3.2 3.2-4.0 
Bond angles (o) 175-180 130-180 90-150 
Bond energy (kcal mol-1) 14-40 4-15 <4 
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Table 1.4. Categorization of Van der Waals interactions. 
Interaction type Species 1 Species 2 
Keesom forces Permanent dipole Permanent dipole 
Debye forces Permanent dipole Induced dipole 
London dispersion forces Instantaneously induced dipole Induced dipole 
 
Keesom forces, more commonly referred to as dipole-dipole interactions41, are highly dependent 
upon the orientation of the polarised molecules; they must be precisely aligned before they can 
interact and the strength of this interaction is also contingent of the distance between the interacting 
species. In comparison Debye forces are not as dependent upon orientation. The electrons of a non-
polar molecule can readily respond to the presence of a polar molecule which induces polarity of the 
electron cloud of the initially non-polar molecule. London forces, also known as dispersion forces, 
occur between non polar uncharged molecules due to transient dipoles present due to instantaneous 
movement of the positions of their electrons, known as instantaneous dipoles. The presence of the 
instantaneous dipole can bring about a dipole in a neighbouring non-polar uncharged molecule 
generating an induced dipole which is attracted to the instantaneous dipole lowering the potential 
energy of the molecular pair42. 
 
1.7.3 π-π stacking Interactions 
π-π stacking interactions are weak in comparison to hydrogen bonding interactions, but are also of 
importance. They can play a vital role in the packing of layered structures as the interactions occur 
between stacked aromatic rings. π-π stacking is fundamental in biological structures, for example 
acting between the aromatic rings of stacked nucleobases within DNA helping to stabilise the double 
helix conformation.  
 
Mostly governed by London dispersion forces43, π-π stacking interactions between aromatic rings 
involve polarisation of the delocalised π-electron clouds which induces a dipole moment allowing 
the two rings to interact44. The presence of electron donating or electron withdrawing groups on the 
aromatic rings can significantly affect the polarisation of the electron cloud and influences the 
orientation of the interaction. There are three prevalent orientations by which aromatic rings can 
assemble through π-π stacking interactions, T-shaped, off-centred and centred (Figure 1.8a, b and c). 
The orientation of the assembly and the presence of electron donating or withdrawing substituents 
on the ring has the potential to alter the intermolecular bonding capacity of the molecules.  
Off-centred and T-shaped configurations are more favourable than the centred configuration due to 
the reduction in π-electron overlap which reduces the repulsion between the rings.  
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The presence of electron withdrawing substituents on the aromatic ring can help to improve π-π 
stacking interactions when in the centred configuration (Figure 1.8d).  It was found in studies by 
Mignon et al. that the off-centred parallel configuration improved the potential of a nucleobase for 




Figure 1.8.  Prevalent orientation of aromatic rings through π-π stacking interactions.  
a) T-shaped, b) off-centred c) centred d) centred with electron withdrawing substituents45. 
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2 Introduction II – Crystallisation 
2.1 Supersaturation 
A solution in thermal equilibrium with the solid phase (for a fixed temperature) is termed a saturated 
solution. If a hot saturated solution was cooled down in a controlled manner and without agitation it 
is possible for the solute to remain in solution. The solution would now contain more dissolved solid 
than is expected for a solution in thermal equilibrium at the new, lower temperature, a state known 
as supersaturation, which is an essential part of all crystallisation processes46. A solution in the 
supersaturated state can be subcategorised as either labile or metastable (Figure 2.1), the 
classification depending on whether crystals can nucleate (labile) or not (metastable); in both cases 
they can grow larger from seeds, if such are present.  There is a higher precipitant concentration in 
the former (labile) than the latter (metastable) case, and crystallisation will not normally occur in the 
metastable situation, while it can occur in the labile case47, 48. 
 
Figure 2.1 Schematic to show the solubility and supersolubility curves in relation to solution 
concentration and temperature and to illustrate the concept of metastable zone width (MSZW).  
The solubility curve can be derived from measurements of the clear point (point of dissolution) of a 
solution at a range of solute concentrations. It is well defined for a single component, with little 
variation due to factors other than temperature or concentration. The supersolubility curve, obtained 
from the solution cloud point (point of recrystallisation) can be influenced by external factors such 
as the rate of supersaturation, e.g. the cooling rate and the agitation intensity. This externally 
dependent nature often means that the supersolubility curve is poorly defined; it can prove 
particularly challenging to define the supersolubility in multi-component or polymorphic materials46. 
During the dissolution process of a multi-component material it is likely that the two species will 
dissociate, and depending upon the stability of the two components, it may be more favourable for 
one or both of the species to recrystallise separately. In such a situation the supersolubility 
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measurement obtained is therefore of the single species rather than the multi-component material. A 
similar complication can occur in polymorphic materials, for example where an initial polymorph 
(polymorph A) is dissolved to obtain the solubility measurement, but when the material recrystallises 
it may transform to a second polymorph (B) and consequently the supersolubility measurement 
corresponds to polymorph B rather than polymorph A.  
 
The metastable zone is the region between the solubility and supersolubility curves and the 
metastable zone width (MSZW) indicates the amount of undercooling that a solution can experience 
prior to nucleation commencing. As it is related to the position of the supersolubility curve the 
MSZW varies with a range of external factors as mentioned previously. As the variation of solubility 
with respect to temperature and concentration is not proportional to the variation of supersolubility 
with respect to temperature and concentration then it follows that the MSZW can vary with saturation 
temperature (Figure 2.1). It is therefore important when designing a crystallisation process to balance 
the temperature and concentration and also consider the size of the MSZW that corresponds to those 
conditions. The MSZW can be calculated using a range of different apparatus but this can only be 
used as a guide as the values are highly dependent upon the method of detecting the cloud and clear 
points, of which the most common are focussed beam reflectance measurements (FBRM), particle 
visualisation measurements (PVM), or visually by eye. 
 
Supersaturation can be quantified using the concentration driving force (Δc) (Equation 1), the 
supersaturation ratio (S) (Equation 2) and the relative supersaturation (σ) (Equation 3) as highlighted 
below. 
 
Δc = c – c*   Equation 1 
S = c/c*    Equation 2    
σ = Δc / c*  = S – 1           Equation 3 
 
Where c is the solution concentration and c* is the concentration at equilibrium saturation for a 
specified temperature. It should be noted that the fundamental driving force of crystallisation is the 
difference in chemical potential (μ) of the starting and ending states of a given material (i.e. 
μsolution – μcrystal). 
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2.2 Nucleation  
Nucleation is the “generation of a new solid phase from a supersaturated homogeneous mother 
phase”49. The mechanism by which nucleation occurs is not completely understood. There are two 
types of nucleation (Figure 2.2); primary nucleation, in which nucleation occurs in a system which 
does not contain any previously formed crystalline matter, and secondary nucleation whereby 
nucleation occurs on or near to previously formed crystalline material46. 
 
 
Figure 2.2 Schematic showing the classification of nucleation.  
2.2.1 Primary Nucleation 
Primary nucleation can be further divided into homogenous nucleation and heterogeneous 
nucleation. Homogeneous nucleation is the spontaneous nucleation of crystal from within a single 
phase, for example, a saturated homogeneous solution46, 50, 51. It is uncertain how the initial crystalline 
nuclei are formed, though it is unlikely that the molecules that make up a nucleus should collide with 
exactly the right force at precisely the right time to generate a periodic crystalline solid. Instead it 
has been proposed that it should arise from a consecutive chain of “bimolecular additions”46 which 
build up to form a crystal cluster or nucleus until the nucleus reaches critical size. This theory was 
originally developed to understand the condensation of a vapour to a liquid but was later adapted to 
crystallisation and termed Classical Nucleation Theory (CNT). For each system there is a specific 
size of cluster that allows the nucleus to become self-sustaining and hence grow; this is termed the 
critical nucleus and its size is a function of various factors including the types of molecules involved 
and the degree of saturation of the solution. Upon subsequent addition to this critical nucleus the free 





Figure 2.3. Illustration of the change in free energy as a function of supersaturation and crystal cluster 
size, where (a) depicts a system at low supersaturation, (b) depicts a system at high supersaturation and 
Zc is the cluster size of the critical nucleus under the different conditions. 
This process occurs rapidly at localised supersaturated areas within the system, however until the 
nuclei formed reach critical size they are deemed unstable and prone to dissolution back into the 
system46. The formation of numerous crystallites below critical size increases the free energy within 
the system which is thermodynamically unfavourable and so to counteract this they dissolve back 
into solution. If clusters grow larger than the critical size, they bring about a decrease in the free 
energy within the system and now the process of nucleation becomes thermodynamically favourable 
and spontaneous52. True homogeneous nucleation is rare, nucleation is often unknowingly induced 
by dust and particulates in the surrounding environment46. Therefore it should be classed as 
heterogeneous nucleation which refers to any nucleation induced by foreign surfaces or particles e.g. 
the impurities present in solution or a scratch on the surface of a crystallisation vessel51.  
 
Figure 2.4 Schematic to show the nucleation process following Classical and Two-Step 
nucleation theories.    
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There are several assumptions used by CNT that in recent years computational and experimental 
investigations have called into question and suggested that the theory of nucleation needs to be 
reconsidered. One of the proposed theories is the two-step nucleation theory, also referred to as 
multi-step nucleation theory (MNT)53, 54 whereby a dense liquid cluster of solute molecules is 
produced and once at a critical size the solute cluster reorganises to produce an organised crystalline 
nucleus within this droplet (Figure 2.4). 
2.2.2 Secondary Nucleation 
Secondary nucleation occurs in the presence of pre-formed solute crystals in a supersaturated 
solution, which facilitate nucleation allowing it to take place more readily at lower supersaturation 
values than those required for primary nucleation46, 55. The addition of a small quantity of seed 
crystals can give rise to a significant and unproportioned increase in the number of new nuclei created 
a process referred to as crystal breeding53. Numerous factors have been proposed to induce secondary 
nucleation processes (Table 2.1) but currently a definitive mechanism for secondary nucleation has 
not been adopted by the scientific community. 
 
Table 2.1. Factors inducing different types of secondary nucleation 
Type of Secondary Nucleation Cause 
Initial breeding Seeded by dust or small crystallites present on the 
surface of parent crystals. 
Needle breeding Seeded by dendritic crystallites fractured from the 
parent crystals. 
Polycrystalline breeding Seeded from breakage of irregular polycrystalline 
agglomerates. 
Shear nucleation Fluid shear occurring at a growing crystal face can 
remove the loosely ordered boundary layer which then 
acts as a crystal nucleus. 
Contact nucleation Collision breeding from crystal to crystal contact or 
contact between crystal and crystalliser apparatus. 
 
Three main processes control the rate of secondary nucleation: generation of secondary nuclei at or 
in close proximity to a solid phase; removal of generated clusters; and formation of a new solid phase 
from crystal growth. These processes are affected by the degree of supersaturation, the cooling rate, 
any agitation used and the presence of any impurities within solution55. 
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2.3 Crystal Growth 
As for nucleation, there is no single distinct model for crystal growth, instead there are numerous 
postulated theories; many of these are based around an understanding of the attachment of molecules 
onto crystal faces, and models of such attachments make distinctions between different modes of 
attachment, for example as represented by steps, kinks and flats in the Hartman and Perdock 
Classification (Figure 2.5).  
 
Figure 2.5 The Hartman and Perdock classification of crystal faces.56 
Initial crystal growth mechanisms were based upon the presence of an adsorbed solute layer at the 
solid-liquid interface of crystal nuclei. The Gibbs-Volmer theory proposes that molecules of solute 
adsorb to the crystal surface but do not bind fully, enabling them to move across the surface of the 
crystal. The solute molecules migrate to active sites, e.g. to a site where another molecule is adsorbed 
to the surface, facilitating attractive interatomic or intramolecular forces to hold the molecules in 
place46. This builds to form a circular aggregation of solute molecules known as a two dimensional 
nucleus which can be described by two dimensional nucleation theory. Similarly to its three 
dimensional equivalent, classical nucleation theory, two dimensional nucleation theory is based upon 
the two dimensional nucleus reaching a critical size beyond which the Gibbs free energy favours the 
growth of the cluster. The monolayer of solute molecules spreads to cover the whole crystal face 
which has been described by three possible models; mononuclear growth, polynuclear growth and 
the birth and spread model (Figure 2.6)55.   
 
Figure 2.6 schematic to illustrate the Birth and spread model.57   
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A growing crystal surface can also be modelled as a series of stepped monolayers that appear to 
move continuously across the crystal surface due to solute adsorption, this is known as the Kossel 
model. Kinks present in the step edges are favoured adsorption sites for solute units. The kinks 
propagate along the edge of the step until the surface is completed. The likelihood of crystal growth 
occurring by this model is low as it would only be feasible at high supersaturation due to dependence 
upon surface nucleation and it also relies upon the presence of defects at the crystal surface which 
will reduce over time46. 
 
 
Figure 2.7 Showing a screw dislocation (a) and the self-perpetuating spiral (b) involved in spiral 
growth mechanisms46. 
Three dimensional theories that abandon the monolayer approach are available, including the 
Burton-Cabrera-Frank surface diffusion model and the Chernov bulk diffusion model that are both 
based upon a self-perpetuating growth spiral. The spiral is formed by the presence of steps formed 
by crystal dislocations (Figure 2.7 a), in particular a screw dislocation which allows the crystal face 
to grow continuously round in a spiral  (Figure 2.7 b) as the screw dislocation acts as a kink site to 
which it is favourable for new solute molecules to adhere46. 
 
In addition to nucleation and growth the process of Ostwald ripening (also referred to as ripening or 
coarsening) can occur whereby smaller particles dissolve and larger particles increase in size. This 
process is thermodynamically driven by the minimisation of the surface energy of the system. 
Smaller particles have a higher surface area to volume ratio resulting in a higher surface energy 
making them less stable than the larger particles. The unstable small particles are thus more likely to 
dissolve into solution and, supersaturation levels permitting, in the Ostwald ripening model these 
molecules will tend to adhere to the more stable larger particles further minimising the surface energy 




Figure 2.8 Schematic of Ostwald ripening of crystalline particles in solution (Stable bulk 
molecules and less stable surface molecules are shown in black and blue, respectively). 
2.4 Methods of Multi-component Crystallisation 
2.4.1 Evaporative Crystallisation 
A principal technique used in discovery and crystallisation of multi-component crystalline materials, 
evaporative crystallisation generates a range of conditions which can yield mixtures of different 
crystal forms. This is particularly useful from a discovery perspective (production of new solid 
forms, for example of MMCs), however it can prove a challenge when aiming to implement selective 
control over a crystallisation process. As a result large scale evaporative crystallisation has not seen 
any substantial development within the pharmaceutical and fine chemical industries. 
 
Figure 2.9 Inducing nucleation via supersaturation using evaporation (a) and cooling (b). 
The evaporative crystallisation process involves dissolving one or more components in a chosen 
solvent or solvent mixture to generate an undersaturated solution. The solution is left open to the 
atmosphere at a fixed temperature and as the solvent evaporates the saturation increases reaching a 
state of supersaturation, inducing nucleation and crystal growth. At the point of nucleation the 
solution concentration momentarily decreases due to the removal of solute as solid, but returns to a 
supersaturated state due to the ongoing evaporation process (Figure 2.9, path A). 
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There are many variables in evaporative crystallisation including solvent of crystallisation, saturation 
temperature, concentration, temperature of evaporation, which all have significant effects upon the 
point of supersaturation and the rate of nucleation. The rate of evaporation, governed by the 
temperature and crystallisation vessel, has a considerable impact on the crystal size and crystal habit. 
The methods are often applied in parallel crystallisations covering a range of the possible variables 
using temperature controlled devices including hot plates fitted with DrySyn® holders (Figure 2.10). 
 
   
Figure 2.10 Temperature controlled evaporative crystallisation carried out in 7 mL glass 
vials using custom designed DrySyn® holders (Asynt Ltd.) on hotplates at a range of 
temperatures, allowing the parallel exploration of a range of crystallisation variables. 
 
2.4.2 Cooling Crystallisation 
The principles of cooling crystallisation are similar to those of evaporative methods, but the method 
is in many senses complementary.  In this case the supersaturation is generated by cooling the 
solution, thereby reducing the intrinsic solubility of the solute and hence reaching a state of 
supersaturation, inducing nucleation and crystal growth (Figure 2.9, path B). In comparison to 
evaporative crystallisation techniques it is possible to afford more control over the crystallisation 
process as the rate of cooling can be accurately controlled. If the MSZ is identified (by determining 
the solubility and supersolubility curves) it is possible to cool to the labile zone to induce nucleation 
and then control the cooling profile to remain within the meta-stable region which promotes crystal 
growth and reduces spontaneous primary nucleation and often leads to enhanced crystal attributes. 
For this reason cooling crystallisation has been the main technique used in industrial crystallisation, 
particularly in the pharmaceutical industry and many continuous crystallisation technologies have 




Figure 2.11 ReactArray Solo Microvate reaction block for temperature-controlled crystallisation. 
   
Figure 2.12 Cooling crystallisation using the Cambridge Reactor Design (CRD) Polar Bear Plus on 
a range of scales. (2 mL 20 mL and 100 mL) 
Typical small scale cooling crystallisation apparatus (Figure 2.11 Figure 2.12) includes the 
Cambridge Reactor Design (CRD) Polar Bear Plus which, using interchangeable vessel holders, 
facilitate scale-up of cooling crystallisation from 2 mL up to 500 mL. These pieces of apparatus have 
helped to bridge the gap between small scale crystallisation required for materials discovery and 
industrial scale cooling crystallisation. 
2.4.3 Anti-solvent Crystallisation 
The final method of crystallisation to be described here is that of anti-solvent crystallisation. During 
such a process, the supersaturation required to induce nucleation is created by adding a second 
solvent to the system, in which the target is poorly soluble, known as an anti-solvent or non-solvent. 
The overall solubility of the solvent in the now-mixed solvent system is lower, hence again reaches 
a state of supersaturation, inducing nucleation and crystal growth (Figure 2.13, path C). 
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Figure 2.13 Inducing nucleation via supersaturation using anti-solvent addition (c). 
Anti-solvent crystallisation is not as well studied as cooling crystallisation, but proves particularly 
useful in materials where there is little variation in solubility with temperature60, 61. It is also a 
favoured method for crystallisation of materials that are unstable at high temperatures. Industrially 
it is often used in combination with cooling61 and has been used in a range of studies as a route to 
control of morphology, CSD62 and in some cases as a route to polymorph control63. With inherently 
rapid nucleation kinetics, anti-solvent crystallisation can allow access to metastable polymorphs that 
can often be difficult to obtain using other crystallisation techniques64-66. Anti-solvent crystallisation 
can also be added as a final step to enhance the yield of the crystallisation process67, 68. 
2.4.4 Mechano-crystallisation 
Mechano-crystallisation, which is commonly referred to as grinding or kneading, has proven to be a 
useful route to rapid screening for co-crystals69, 70, as demonstrated by Caira et al. in a co-grinding 
study on sulfadimidine and a range of aromatic carboxylic acids71. The heat and pressure generated 
by these processes can enable intermolecular interactions in the original materials to be weakened 
affording freedom to the molecules which can orientate to form other more favourable intermolecular 
interactions. This can result in either a new polymorph of either of the starting components or 
formation of an MMC. It is important to note that mechano-crystallisation can allow access to solid 
forms that would have remained unidentified if only solution crystallisation techniques were used. 
 
The crystallisation processes can take a matter of minutes or may take days of mechanical action. 
This can be facilitated by addition of a few drops of solvent which helps to solubilise some of the 
material, acting as a plasticiser, and is termed solvent-drop grinding or liquid assisted grinding 
(LAG). Apparatus for mechano-crystallisation (Figure 2.14) varies from a basic pestle and mortar to 
ball mills and single or twin screw extruders. The choice of milling equipment and the material from 




Figure 2.14 Apparatus used for mechano-crystallisation. 
The mechanism of mechano-crystallisation is still not well understood. Models for this mechanism 
are based upon the effect of mechanical work on the material; this has two effects: (i) disrupting the 
intermolecular interactions, breaking down the crystalline order and allowing for the generation of 
new intermolecular interactions, for example allowing molecular complex formation; and (ii) 
introducing localised hot-spots of increased heat and pressure. The material thus often becomes 
significantly less ordered, for example adopting an amorphous state, prior to recrystallisation. If an 
amorphous solid form is desired, which has become common in recent years, cryo-grinding can be 
used as the reduced temperature is said to help prevent recrystallisation and reordering of the 
material. In essence this represents the converse of LAG. 
 
Research by Medina et al. demonstrated that it is possible to scale up mechanical grinding processes 
using twin screw extrusion techniques72 Their studies focused on the caffeine oxalic acid co-crystal 
system previously produced through small scale grinding by Trask et al.73 and the AMG-517 ascorbic 
acid salt produced by Amgen74. Heating can be coupled with extrusion to give a hot melt extrusion 
process (HME); the additional heat aids the co-crystallisation process as shown by Moradiya et al. 
in HME co-crystallisation experiments on the carbamazepine and trans-cinnamic acid system75. 
There are several benefits to using grinding techniques over more traditional solution based 
crystallisation, of which one of the key benefits is in the reduction of solvent used in the 
manufacturing process which is one of the main targets in approaches to sustainable chemistry76.  
 
Just as in crystallisation from solution, the choice of solvent in mechano-crystallisation can have a 
significant effect on the product of crystallisation. In LAG co-crystallisation studies of the 1:1 
caffeine-glutaric acid co-crystal system77, Trask and co-workers demonstrated that the polarity of 
the solvent used in LAG can have a significant effect on the polymorph produced (Table 2.2).  
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Table 2.2 Solvents used by Trask et al to produce each polymorph of the caffeine-glutaric acid 
co-crystal by liquid-assisted grinding. 









The solvent effects were rationalised by differences between the crystal packing of each polymorph. 
Of particular interest was a non-polar cleavage plane (200) observed in form I (but not form II), 
which presented a surface of exposed methyl and methylene groups with which polar solvents can 
interact, influencing growth of form I. 
2.4.5 Seeding in Crystallisation 
Seeding can be applied to all methods of crystallisation, in particular solution-based techniques. A 
small quantity of crystals, known as seeds, can be added to a crystallisation solution to promote 
nucleation and/or further growth of crystals around these seed centres and can allow greater control 
over the crystal properties including solid form and particularly particle size distribution (PSD). 
However, this is dependent upon the bulk properties of the seed crystals used.   
 
Figure 2.15 Diagram to highlight the importance of the point of seeding (A, B or C) combined 
with an appropriate cooling profile where either primary nucleation is dominant (blue), 
secondary nucleation is dominant or where nucleation doesn’t occur and the seed crystals 
dissolve (red). 
If the solution is metastable at the point of seed addition the seeds are able to form a suspension 
(Figure 2.15, B). Cooling the solution following the trajectory of the MSZ (Figure 2.15, black 
trajectory) maintains the conditions for crystal growth; secondary nucleation will dominate affording 
well controlled crystal attributes and avoiding uncontrolled primary nucleation, which occurs in the 
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labile regions. If the cooling is such that the solution enters the stable region where the solution is 
under-saturated the seed crystals added will dissolve (Figure 2.15, A) and will not act as sites for 
crystal growth (Figure 2.15 red trajectory). On the other hand if the supersaturation is too high and 
the solution enters the labile zone some secondary nucleation will occur, but once again unwanted 
primary nucleation will dominate (Figure 2.15, blue trajectory). Overall, seeding helps to reduce 
unwanted spontaneous and uncontrolled primary nucleation events, which often lead to 
heterogeneous crystal properties and promote secondary nucleation regulated by the bulk properties 
of the seed. 
 
2.5 Current Practice in Industrial Crystallisation 
2.5.1 Batch vs Continuous Crystallisation 
Current pharmaceutical manufacture is predominantly carried out using batch processes but there is 
potential to transform the industry with the conversion to continuous manufacturing. Continuous 
crystallisation techniques will be highly beneficial to the pharmaceutical industry as continuous 
crystallisers require smaller footprints than large batch reactors and so can reduce overheads accrued 
from large production sites or enable manufacture of higher product volumes than batch processes 
at a site of an equivalent size. Due to a reduction in the mass of material and solvent used at any 
given time, less energy is required for heating and cooling in crystallisation cycles in continuous 
crystallisers than in batch crystallisers. Even though a smaller mass is used per residence time (total 
time spent within the crystalliser), overall the continuous process can have a much higher throughput, 
enabling increased productivity. Continuous manufacturing also promotes increased flexibility and 
product quality through the more targeted use of process analytical technologies (PAT) that can 
closely monitor the product in situ and allow for real-time process tuning.  This has benefits over the 
use of PAT in batch processes, as in continuous crystallisation a small sample of the material is being 
monitored, all of which has experienced identical conditions; hence the required change in 
parameters calculated for the 'sampled' material will be directly relevant to the required treatment of 
the following material. 
 
Benefits of Continuous Crystallisation 
The drive towards developing platforms and processes for the continuous crystallisation of fine 
chemicals and pharmaceuticals stems from the benefits offered by the methodology over traditional 
batch manufacturing methods (Table 2.3). It should be noted that continuous manufacturing methods 
are well established in a range of sectors, but the work pursued here is part of the effort targeting its 
establishment in the chemical and pharmaceuticals sectors, where it is not yet widely used.  
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The general benefits of continuous over batch manufacturing include the general areas of 
sustainability (e.g. reduction of solvent use, recovery and recycling of solvent), footprint reduction 
of production plant; speed of scale-up of continuous platform technologies (which in many cases are 
more easily scalable than batch platforms) and improved control of the quality of crystals and 
particles that is possible in continuous processes, particularly with the potential for the integration 
of in-line process analytical technologies in continuous process design. 
 
For pharmaceuticals and fine chemicals in particular, the methodology is well suited to the increasing 
trends in developing personalised medicines, by which adaptable, small volume production methods 
will become increasingly important. This concept also plays strongly into current, more general, 
trends towards localised and distributed manufacturing, which has the added element of such 
localised systems having the potential to have in-built re-configurability and adaptability. In the 
context of the present work (see Chapter 6 below), one example of this capability is the reconfiguring 
of the Continuous Oscillatory Baffled Crystalliser (COBC) at the University of Bath to a quarter of 
its original size over just one afternoon. Such re-configurability will become increasingly important 
in the development of more efficient and adaptable manufacturing processes. 
 
Table 2.3 A comparison of batch and continuous processing for crystallisation of fine chemicals 
Batch process (e.g. STR) Continuous process (e.g. COBC) 
Non-linear 
scale up 
 Difficult to transfer  from 
lab to industry 
Linear scale 
up 
 Can transfer from lab to 











 Uniform temperature 
gradient. 
 More uniform products. 
 Allows in-line monitoring 
equipment to be used. 
Large mass  Lots of energy required to 
heat and cool 
crystallisation cycles 
 Long crystallisation cycle 
Small mass  More energy efficient 
Low 
throughput 
 Reduced efficiency High 
throughput 
 Enables high productivity, 
even with small masses 
Large 
footprint 









 Large base of prior 
knowledge 




 High capital required to 
convert batch 
manufacturing sites 





Factors Limiting Adoption of Continuous Crystallisation in Industry 
As mentioned in Table 2.3 above, continuous crystallisation processes are based upon developing 
technologies in comparison to the routine batch crystalliser technologies that have been tried and 
tested over decades. Consequently there is a lesser amount of technical knowledge around the 
developing continuous platforms although a lot of the theory can be modified from batch 
crystallisation processes and continuous processes in other areas of manufacturing and other 
industries and until the technology is established, this initially results in a higher risk to 
manufacturers who may look to adopt such processes.  
In addition batch technology is heavily imprinted in industrial crystallisation; pharmaceutical and 
fine chemical manufacturers have a significant amount of capital invested in batch crystallisation 
equipment. Further investment would be required to move towards continuous processing and thus 
if the continuous crystallisation platforms can build upon or modify existing batch equipment or 
stand alongside existing batch equipment then the adoption of continuous crystallisation processes 
is likely to be more favourable. 
It is also important to note that continuous crystallisation processes should not be considered as catch 
all approach. Many industrial crystallisation processes are efficient in batch e.g. industrial 
crystallisation of paracetamol which is very cheap to produce that it is often thought of as a 
commodity. In cases such as these, switching to a continuous crystallisation process offers very 
limited potential improvement. 
2.5.2 Current Crystallisation Platforms 
Any of the methods of crystallisation previously described in 2.4 can be utilised in a range of 
crystalliser technologies however crystallisation within the pharmaceutical industry has been 
dominated by cooling crystallisation and this has persisted in designs for newer crystallisers.  
 Batch Crystallisers 
Development of batch crystallisation for industry started from the most basic tank crystalliser 
operates by allowing a saturated solution is left to cool in a large open tank allowing some of the 
mother liquor to evaporate after which excess liquor is drained and the resulting crystals harvested. 
This approach amounts essentially to large scale uncontrolled evaporative crystallisation. In the 
development of industrial crystallisation, this was then modified with agitation, most commonly 
through stirring using an impeller, and by introducing control of the cooling process by jacketing the 
vessel walls and circulating temperature-regulated fluid. These developments produced the 
workhorse of pharmaceutical crystallisation, the batch stirred tank reactor (STR). Batch crystallisers 
have developed over the years, some using evaporation and adiabatic cooling, such as the Swenson-
Draft Tubed baffled crystalliser, and some cooling crystallisation, for example in the case of 
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classified suspension crystallisers (Oslo crystallisers)78. These crystallisers are more commonly used 
in the petrochemical, mining and bulk chemical industries and so from a pharmaceutical context are 
beyond the scope of this report.  
 Continuous Crystallisers 
Continuous crystallisation technologies include a cascade of STRs (cSTRs) of which a particular 
subset include the continuous mixed-suspension mixed-product removal (MSMPR)79 systems that 
have been utilised in this work, continuous Couette-Taylor crystallisers80, the COBC, microfluidic 
crystallisers81 and other custom designed tubular crystallisers82, including the Kinetically-Regulated 
Automated Input Crystalliser (KRAIC) which was designed at the University of Bath and is used in 
this work. The details of these crystallisers (shown in Figure 2.16) are discussed below. 
 
Figure 2.16 Images of continuous crystallisers technologies, some commercially available and 
others developed in academia.  
Mixed-Suspension Mixed-Product Removal (MSMPR): Conventional (batch) STRs can be 
modified to form a cascade of STRs (cSTR) in which the reaction solution is transferred from tank 
to tank by a range of means. Of particular relevance here is the variant of cSTR known as  
MSMPR which applies to crystalline solids in suspension rather than reactive solutions. The mode 
of operation of cSTR or MSMPR can be continuous, i.e. as fluid (or suspension) enters the vessel it 
is continuously withdrawn from the vessel at the same rate. Alternatively it can be operated in a 
periodic mode (PMSMPR), in which case (see Chapter 5.2), the operation is arranged such that there 
is a significant dwell time of the crystallisation solution in each STR, prior to pumping the suspension 
to the next STR whilst simultaneously replenishing the solution in the current STR with feedstock. 
Each STR is normally set to different temperatures, thus executing a cooling crystallisation regime 
as the solution passes through the MSMPR cascade. 
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Couette-Taylor crystallisers are based on the principles of Taylor-Couette flow, generated within 
a fluid contained between two rotating cylinders.  Depending on the parameters of the device and 
the fluid, the flow can be of two types – azimuthal (circular Couette flow) or, when the angular 
velocity of the inner cylinder is increased, various types of vortex flow, initially toroidal Taylor 
vortex flow but eventually breaking up into the regime of turbulence. The various types of flow offer 
possibilities for the control of crystallisation processes.  
Continuous Oscillatory Baffled Crystalliser (COBC): The COBC is a tubular crystalliser which 
couples the generation of oscillatory flow (generated by a periodic piston operating through a bellows 
arrangement) with the inclusion of baffles (annular constrictions) at regular intervals along the 
tubular pathway.  By combining the baffled cylindrical with fluid oscillation, eddies are generated 
when fluid flow passes through the baffles, enabling significant radial motions where events at the 
wall are of the same magnitude as these at the centre. These eddies create uniform mixing in each 
baffled cell, collectively along the reactor. As each baffled cell acts as a continuous stirred tank 
reactor, with a number of baffled cells in the reactor/crystalliser, COBC plug flow conditions are 
achieved under laminar flow. The COBC offers the opportunity to vary flow and oscillation rates to 
control the eddies formed and hence the mixing characteristics and residence times in each segment 
of the crystalliser. Cooling regimes imposed along the tubular pathway give the cooling conditions 
required for crystallisation to occur. The COBC used in this work is the NiTech DN15 (ID 15mm). 
Corning Advanced Flow Reactor: One of the earliest continuous reactors that allowed scale-up of 
continuous flow processing into production, the Corning Advanced Flow Reactor allows for 
continuous process production capacity of up to hundreds of kilograms per hour for pharmaceuticals 
and fine chemicals. One critical design feature of the Corning Advanced Flow Reactor is the 
incorporation of various mixing devices that allow for efficient mixing of multiple input streams, 
which affords a high degree of flexibility on either flow chemical reaction or crystallisation 
processes. The flexibility is enhanced by the use of corrosion-resistant glass and/or ceramic fluidic 
modules with integrated piping connecting these modules with the feeding and mixing sources. 
KRAIC and other segmented flow devices: The KRAIC (Kinetically-Regulated Automated Input 
Crystalliser) flow reactor/crystalliser developed at the University of Bath combines the ideas of 
optimised pre-mixing from multiple feed vessels (as implemented, for example, in the Corning 
Advanced Flow Reactor) with the exploitation of segmented flow (in which air or liquid volumes 
are incorporated in the reactant flow along the crystalliser, breaking this into regular segments (or 
slugs), each of which effectively acts as an independent reactor offering a stable environment with 
internal vortex circulation (see Figure 6.1)  in which crystallisation can occur as the fluid moves 
along the reactor pathway. As with other crystallisers discussed here, the flow passes through a series 
of temperature-controllable regimes, offering the potential for controlled cooling crystallisation to 
be implemented. The KRAIC is representative of a variety of technologies exploiting segmented 
flow, and is described in detail in Chapter 6.  
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CRD Rattlesnake: The Rattlesnake continuous crystalliser from Cambridge Reactor Design offers 
a new platform for scalable crystallisations. Recently developed, the Rattlesnake combines various 
features alluded to above, including uniform mixing and precise temperature control over the entire 
reactor volume, incorporation of multiple ports and windows for monitoring and analysis (for 
example using process analytical technologies), various features to minimize encrustation and a 
range of construction materials options. The Rattlesnake has been deployed in various crystallisation 
campaigns within CMAC, but has not been exploited in the present work. 
 
It is important to select the most suitable continuous crystallisation platform for the individual 
crystallisation process, taking into account the solvent system, solid loading and crystallisation 




3 Theory of Analytical Methods 
3.1 Optical Microscopy 
Crystalline samples were assessed for suitability for single crystal X-ray diffraction using an optical 
microscope fitted with a polarising lens. When viewed under non-polarised conditions the crystal 
shape can be checked. Crystals are rejected if deformities can be seen, such as cracks, fractures 
and/or passenger crystals. The crystal morphology can also indicate if a crystal is starting material, 
if the morphology of the starting material is distinct and has already been determined. If the selected 
crystals are able to transmit polarised light, when viewed under such light and slowly rotated on the 
microscope stage the crystal should sharply extinguish, i.e. turn dark, at 90o intervals.  A crystal may 
not extinguish fully or not at all, indicating that it is not a single crystal but possibly several smaller 
aggregated crystals, and that it is therefore unsuitable for single crystal X-ray diffraction.   
 
3.2 Scanning Electron Microscopy 
In scanning electron microscopy (SEM), a focused beam of high-energy electrons (typical energies 
up to 40 keV) interacts with the sample, resulting in a decrease in kinetic energy of the incident 
electrons as they decelerate as a result of a range of processes. Detecting the signals resulting from 
these deceleration processes gives information about the sample, specifically the surface structure 
and composition of solid specimens. For the SEM images obtained in this work, the relevant signals 
are those from secondary electrons, which show the morphology of samples (at typical resolution of 
10 to 100 nm). Backscattered electrons are also frequently used in studies of crystalline samples, as 
they allow the determination of composition, and thus examination of difference in composition in 
multiphase samples, which can be explored point by point across the sample. To generate an SEM 
image, SEM data are collected over a selected area of the sample (the area can be in a wide range 
between 1 cm and 5 m linear dimension), and a 2-dimensional image is generated. 
 
3.3 X-ray Diffraction 
X-rays have a wavelength in the region of 0.5 Å to 3 Å which is comparable to the interatomic 
distances within molecules or ions in a crystal. As a result X-rays are an ideal tool for probing the 
atomic structure of crystalline materials83, 84. A coherent X-ray beam directed through a crystal, 
brings about interactions between the electric field of the X-ray beam and the vibrating electrons 
present within atoms of the crystalline solid. The interference with individual electrons induces 
emission of secondary X-ray radiation scattering the incident X-ray beam, termed Thomson 
scattering. The electromagnetic waves scattered from electrons within an atom can interact 
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constructively or destructively. Constructive interference occurs when the interacting scattered 
waves are in phase; this has an additive effect, increasing wave amplitude. In contrast, destructive 
interference occurs if the scattered waves interact out of phase with each other decreasing the overall 
wave amplitude. A diffracted beam is only observed at a point of constructive interference. This only 
occurs if a particular reflection condition is upheld for a family of lattice planes 83. 
 
This is often analysed in terms of the Laue Equations (Equation 4); all three equations must be 
satisfied for constructive interference to occur which results in the presence of a single diffraction 
spot in the diffraction pattern. This is equivalent to noting that for two waves to interact 
constructively they must be in phase with one another, i.e. the path length between the waves must 
be an integer number of wavelengths.  
 
a (cosα – cosα0) = hλ 
b (cosβ – cosβ0) = kλ 
c (cosγ – cosγ0) = lλ    Equation 4 
The diffracted waves are collected using an area detector, such as a charge coupled device (CCD) or 
an image plate, where the presence of each beam is recorded as an individual spot forming part of a 
two dimensional diffraction pattern. This is an image comprising a series of spots arranged in a 
geometrical configuration which reflects the symmetry and geometry present in the crystal. 
3.3.1 Bragg’s Law 
In 1912 W. L. Bragg (1890-1971) reported a proof for calculating the angle (θ) at which the reflection 
conditions, involving the originally developed Laue equations describing diffraction geometry, are 
satisfied, and in the subsequent year published his findings in the paper The Diffraction of Short 
Electromagnetic Waves by a Crystal85. 
 
Figure 3.1. Diffraction of X-rays from a parallel set of lattice planes (in red) with their corresponding path 
difference (in purple). 
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An X-ray is diffracted from a family of parallel lattice planes that have a constant inter-planar 
spacing, d, and each family can be represented by a Miller Index (hkl) (Figure 3.1).  The Miller indices 
are related to the reciprocals of the intersects of the lattice plane with the unit cell edges, and are also 
used to denote the coordinates of an equivalent point in the reciprocal lattice (see below). The angle 
of the incident X-ray beam (θ) is equivalent to the angle of the diffracted beam and can be calculated 
using the path difference between an X-ray diffracted by one plane and an X-ray diffracted by the 
neighbouring plane within the family (Equation 5). The path difference must be an integral number 
of wavelengths in order to ensure constructive interference. 
 
 nd sin2   (n= 1, 2, 3…)  Equation 5 
 
Where θ represents the scattering angle, commonly referred to as the Bragg angle, λ represents the 
X-ray wavelength and d corresponds to the spacing between neighbouring parallel lattice planes. It 
is common practice that the integer term n is assumed to be unity.  
 
The amplitude of X-ray scattering is dependent on the number of electrons present in the atom (Z) 
and also on the scattering angle θ, which both contribute to the atomic scattering factor (
jf ). The 
scattered X-rays from an individual atom interfere constructively in phase when the scattering angle 
is equivalent to zero degrees i.e. directed straight forward. At zero degrees 
jf  is equivalent to the 
atomic number of the scattering atom. As the X-rays are scattered at increasing angles (greater than 
zero) destructive interference occurs leading to a reduction in scattered X-ray intensity and hence a 
smaller value of
jf . The intensity falls off as a function of (sinθ)/λ (Figure 3.2). It should be noted 
that the X-ray scattering amplitudes for hydrogen atoms are low, as Z = 1, and this makes it more 
difficult to assign the positions of hydrogen atoms within a unit cell from X-ray data. 
 
3.3.2 Reciprocal Lattice and Ewald Sphere  
The reciprocal lattice is a useful tool in crystallography helping to interpret the workings of X-ray 
diffraction. The reciprocal lattice is the polar reciprocal transform of the direct lattice whereby the 
base vectors of the direct lattice (a, b and c) and the volume of the unit cell can be used to generate 
the base vectors of the reciprocal lattice (a*, b* and c*) (Equation 6)  
 




Figure 3.2. X-ray atomic scattering factors for hydrogen, carbon and fluorine86 
The reciprocal lattice can be generated in geometrical terms that illustrate its close link to the concept 
of (real space) lattice planes. The reciprocal lattice point (r.l.p.) corresponding to the lattice plane hkl 
is produced by dropping a perpendicular from the (hkl) lattice plane to the unit cell origin. This gives 
the direction of the r.l.p., and its distance from the origin of reciprocal space is given by 1/dhkl where 
dhkl is the real space separation of the (hkl) lattice planes. Thus each r.l.p. is related to a particular 
lattice plane; since diffraction measurements (which are effectively made in reciprocal space) capture 
the scattered intensity at each r.l.p. they can be thought of, loosely, as measuring the scattering from 
that lattice plane. 
 
3.3.3    Structure Solution 
Each diffraction spot within a diffraction pattern has a specific intensity (Ihkl), which is related to the 
electron density at positions x, y, z within the unit cell via Fourier transformation (FT) (Equation 7 
to Equation 9) and can be used to form an electron density map from which atom positions within 
the unit cell can be identified84. 
 
    lzkyhxixpeiF
V hkl
hklhklxyz    2exp
1
 Equation 7 
 
The intensities, Ihkl, of the diffraction spots are proportional to the square of the structure factor (Fhkl) 
(Equation 8). The structure factor Fhkl has amplitude and a phase (Equation 9), but it is only possible 
to determine the amplitude from the measured Ihkl values as the squared term in the relationship 
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between Fhkl and Ihkl removes the phases. This lack of phase determination is more commonly 
referred to as “the Phase Problem”, which is commonly solved by the use of Patterson or, more 
frequently, Direct Methods (see below). 
2
hklhkl FI      Equation 8 
 hklhklhkl iFF exp   Equation 9 
The structure factor contains information about all the types of atoms present in the unit cell along 
with their corresponding atomic positions as shown by the atomic scattering factor term
jf  and the 









  Equation 10 
In this work, Direct Methods and charge flipping have been used to solve the crystal structures of 
materials obtained in multi-component materials screening studies. These methods are therefore 
outlined briefly here. 
 
 Direct Methods 
Direct methods have become one of the most popular methods of structure solution after the 
computing-intensive aspects of the methods became more tenable – and now very rapid and routine 
– with the advancement of CPUs. Direct methods can be used to solve a diverse range of structure 
types and are especially useful for solving organic structures comprised of small molecules84. 
 
The structure factors and phases of reflections are related through the electron density present which 
is in turn the Fourier transform of the structure factor, as discussed above. Direct methods try to 
overcome the phase problem by attempting to derive the phases of the structure factors by 
probabilistic means. Approximations of the phases are obtained from the measured structure factor 
intensities combined with knowledge about the properties of electron density that can be written as 
a series of mathematical constraints on the function ρ(xyz). These properties include that electron 
density is confined to concentrated areas and it cannot be negative, only positive or zero87. An initial 
estimate of phases of some of the strongest reflections are developed through statistical relationships 
between the phase of the stronger reflections in the diffraction pattern, leading to sets of possible 
solutions (sets of phases assigned to the initial set of reflections) that can be used to calculate 
preliminary electron density maps. The approximated phases and known structure factor amplitudes 
are used to calculate the values of ρ(xyz) and obtain an approximate electron density map. 
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The phases determined from the approximate electron density map undergo further iterative 
mathematical treatment to determine several converging sets of new phase values which is 
subsequently repeated many times. Each set of new phase values is analysed for its acceptability 
using several mathematical phase functions known as the figures of merit. A final electron density 
map is calculated using the most appropriate sets of phase values which upon interpretation can yield 
the atomic positions within the unit cell by using knowledge of a predicted molecular structure, 
common structural features and known stereochemical principles84. 
 Charge Flipping 
Charge flipping (CF) is an iterative method for structure solution which is particularly useful for 
solution of periodic, incommensurate and quasi-crystalline crystal structures but can also be used for 
more common crystal structure solution. A computationally intensive technique, CF has proved more 
popular in recent years due to advancements in computer processing power88.  Like classical direct 
methods CF applies constraints to the diffraction data in reciprocal space, however as it is a dual-
space method it also uses constraints on real space (electron density) 89. Similar to direct methods, 
the two most significant constraints applied to the data are that the electron density must be positive 
and that the unit cell consists of individual atoms.  One of the advantages of CF over direct methods 
is that it does not require any information on the chemical composition or the symmetry of the 
material to reconstruct the electron density. It is important to note that using CF all electron density 
is treated using P1 symmetry. 
Outlined here is the stepwise procedure of the simplest CF algorithm adapted from the clear and 
concise description by Oszlányi et al.89  The process of structure solution using the CF algorithm is 
an iterative cycle which starts by assigning random phases to experimental (observed) amplitudes 
generating a trial set of structure factors88-90. 
1. Using an inverse FT on the trial set (of experimental amplitudes and assigned phases) it is 
possible to calculate the electron density.  
2. The calculated electron density is then modified using charge flipping. A positivity threshold 
value (δ) is assigned where all points on the grid with an electron density below δ are charge 
flipped by multiplying by -1 and any values that remain below zero are removed to comply 
with the positivity constraint. 
3. FT of the modified electron density calculates a set of temporary structure factors, which 
have associated calculated phases.  
4. The phase of the temporary structure factors are then combined with the experimental 
amplitudes to give a new trial set of structure factors which can be input into the subsequent 
iteration cycle (repeating from step 1). 
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The process is repeated until certain convergence criteria are met. Weak reflections can pose a 
problem. In SUPERFLIP90, a program used for structure solution using CF, the CF algorithm has 
been modified in the way weak reflections are handled, to help the convergence of the algorithm. In 
SUPERFLIP, if a reflection is weak then the calculated amplitude of the temporary calculated 
structure factor is retained instead of pairing it with the experimental amplitude and the phase is 
shifted by π/2. This has been found to improve the function of the algorithm90. 
 
After convergence the symmetry information obtained from the symmetry in the diffraction pattern 
can be input into the solution. Due to the nature of the CF algorithm used in SUPERFLIP there may 
be a risk that the electron density has been shifted and so it may be necessary to redefine the space 
group origin90.  
 
3.3.4 Structure Refinement 
Least squares structural refinements are carried out to improve the model determined during structure 
solution, and to highlight other atoms remaining unidentified by initial structure determination. The 
parameters that can be refined during a structural refinement process include atomic positions and 
thermal displacement parameters for each of the atoms in the structure, occupancies of atomic sites 
(for potentially disordered structures) and a range of others. These parameters (typically several 
hundred in number) are refined using least squares methods, against the data set of observed 
reflection intensities (of which there are usually several thousand). Using the trial structure obtained 
in a refinement cycle, a calculated diffraction pattern can be obtained via forward Fourier 
transformation (equation 2) which is formed on the basis of the trial structure. This calculation 
generates a series of calculated structure factors (Fcalc) each with amplitude (|Fcalc|), and unlike the 
observed structure factors (Fobs) they each have an associated phase (φcalc). The calculated structure 
factors are compared to the experimentally obtained observed structure factor amplitudes (Equation 











R    Equation 11 
As the calculated structure converges towards the observed structure, the R-factor lowers until it 
reaches a typical value of around 0.02-0.06. 
 
Weighting factors can be applied to the reflection intensities. A common weighted residual factor 
wR2 (Equation 12) multiplies the difference between corresponding Fobs and Fcalc values by its own 
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weight (w) assigned based upon the (reciprocal of the) standard uncertainties (S.U.) of the observed 
value. This provides a more realistic assessment as it takes into account the “relative reliability” of 















2     Equation 12 
 
Once the structure is completed the goodness of fit (S) (Equation 13) should tend towards unity when 











    Equation 13 
3.3.5  Powder X-ray Diffraction 
PXRD uses a polycrystalline sample in which the crystallites and the lattice planes within will be 
arranged in a wide range of orientations (for an ideal powder all possible orientations will be present 
and with an equal distribution). PXRD is measured using a powder diffractometer which typically 
operates in “-2” geometry: the detector scans through the (Bragg) scattering angle 2, while the 
sample scans  (Figure 3.3, left), thus bring successive reflections (with distinct dhkl values) into the 
diffracting position according to Bragg’s Law. At higher 2 values, smaller dhkl values are accessed. 
 
 
Figure 3.3 Schematic of a powder diffractometer with detector moving through 2θ angle from 
position (a) to (b) and an example of a powder X-ray diffraction image showing the Debye-
Scherrer rings around the incident X-ray beam. 
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As the detector moves through the 2θ angle, a number of crystallites will have lattice points in the 
appropriate orientation to satisfy the Bragg equation for the refection (or reflections) with a 
corresponding d-spacing; these will constructively diffract the incident beam creating a series of 
diffraction spots some of which will overlap. Each crystallite produces its own set of Bragg 
reflections which overlay to form Debye-Scherrer rings which appear as a set of concentric circles 
with the incident beam positioned at the centre as 0° θ (Figure 3.3, right).  
 
Figure 3.4 Schematic showing diffraction from (a) a single crystal, (b) four single crystals of 
different orientations, (c) a polycrystalline material (with multiple orientations) from which the 
intensities can be extracted and plotted against the angle 2θ to give a diffraction pattern (d).84 
A PXRD pattern, essentially a cross section through the Debye-Scherrer rings, can be produced by 
plotting the intensity of each ring against the measured 2θ angle (Figure 3.4 d).  
 
SXRD uses a single crystal that is preferentially selected using optical microscopy, as noted above, 
which increases the chance that it may not represent the bulk sample. This may not be as important 
for initial materials discovery but at large scale in industry this can be vitally important. This is why 
the bulk technique of powder X-ray diffraction is such a useful tool as it can be used to verify the 
homogeneity of the sample, complementing the structural data obtained through SXRD. This is 
carried out by generating a PXRD pattern from the crystal structure determined from the SXRD data 
and comparing this to the PXRD pattern from the bulk sample; for a single phase product (i.e. only 
comprising the material for which the SXRD has been obtained), all peak positons will match 
between the observed and calculated PXRD patterns.  The intensities should also match, but these 
are susceptible to effects such as preferred orientation and the position-matching is usually taken as 
the primary indicator for this “fingerprinting” approach. 
 
Through a combination of instrumentation improvements, with high resolution instruments available 
both in the laboratory and at synchrotron sources, and computational advances, PXRD has also 
become a valuable tool in determining a complete crystal structure for polycrystalline samples. In 
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the past it was difficult to obtain a full structural solution from PXRD data, from which the available 
techniques often were only capable of structure refinement, primarily using the Rietveld method 
which uses the full powder profile to aid the refinement process. In trying to use PXRD for structure 
solution, difficulties arise due to problems with peak overlap, as the 3D information in a single crystal 
pattern is reduced to 1D in PXRD. As in SXRD structure solution methods, traditional PXRD 
methods for structure solution analysed individual reflections to provide a series of Ihkl values which 
could then be used in Direct or Patterson methods for structure solution, but these techniques cannot 
resolve peak overlap inherent in PXRD. Instead direct space approaches have been devised where 
multiple theoretical crystal structures are created independently of the diffraction data (for example 
using simulated annealing techniques) and a PXRD pattern generated for each theoretical structure. 
The fit of these synthesised patterns are measured against the experimental diffraction pattern using 
a weighted profile R factor (Rwp) analogous to that of Rietveld refinement. Both Rietveld-based 
refinement and structure solution from powder data based on model-generation and testing, focus on 
the overall shape of the PXRD pattern, not the individual peak intensities, thus overlapped peaks do 
not hinder structural solution so severely83, 91. 
3.4 Mid-IR, Infrared Spectroscopy 
Infrared spectroscopy (IR) results from the absorption of electromagnetic radiation by molecules at 
characteristic resonant frequencies that are directly related to the bond vibrations in the molecule and 
hence are characteristic of functional groups. The absorption process relies on the vibration resulting 
in a change in dipole moment of the molecule and is sensitive to bond strength, the masses of the 
atoms that are bonded, and the local molecular environment including, for some vibrations, the 
intermolecular interactions. Many functional groups can thus be identified by their vibrational 
frequencies observed as absorption peaks in an IR spectrum. Characteristic peaks corresponding to 
vibrations within the molecules (normal modes) are observed in the infrared region (typically 
400cm−1 to 4000cm−1).  The samples required for IR need not be crystalline (or even solid).   
Fourier transform IR (FTIR) can increase the sensitivity of IR measurements by employing an 
interferometry approach in which the interference pattern generated by recombination with the 
reference beam can be Fourier transformed to produce the IR spectrum. FTIR has the benefit of 
decreasing the required sample size and allowing more rapid collection of the spectrum, and is 
adopted as standard in modern IR spectrometers such as those used in this project. 
Hydrogen bonding effects are observed within an IR spectrum by analysis of the OH or NH bands 
which characteristically appear at the high frequency end of the spectrum as a result of the low mass 
of the hydrogen atom. The strength of a hydrogen bond may be observed by analysis of the frequency 
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of these bands; a stronger hydrogen bond will increase the covalent OH or NH bond length, 
lowering the vibration frequency and leading to a broader absorption band. 
3.5 Raman Spectroscopy 
Raman spectroscopy is a complementary technique to infrared spectroscopy, which again probes the 
vibrational modes of that molecule (though it can also examine molecular rotations). In this case, 
however, instead of the vibrational mode having to result in a change in dipole moment to allow 
absorption, it for Raman signals it must involve a change in the molecular polarisability. Raman 
typically uses incident visible or UV radiation, produced by a laser source. This high energy incident 
radiation excites the electronic state of a molecule from a ground state to a higher energy (virtual) 
state. Upon relaxation, a small number of the photons are re-emitted at a different energy, thus 
exhibiting a change in frequency. If the system returns to a more energetic state than that of the 
original state, a photon of a lower frequency will be emitted from the sample. This is termed a Stokes 
shift, and the shift corresponds to the absorbing process (a molecular vibration in this case). If it is 
less energetic, the frequency of the emitted photon will be higher, causing an anti-Stokes shift to be 
observed, the shift again corresponding to the molecular vibration. 
 
Similarly to X-ray powder diffraction, Raman scattering provides fingerprint information on small 
samples by analysing peak positions and comparing them to pure references. It is a very powerful 
tool for determining the presence of small changes between samples, for example between two 
polymorphs of the same material (in which there will be changes in the intermolecular frequencies 
and hydrogen bonding within the structure). 
 
3.6 Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry (DSC) is a thermal technique that can be used to gain information 
about the crystalline behaviour of a material highlighting any desolvation events and polymorph 
transitions as well as the melting point and eutectic behaviour. The technique focuses on how 
temperature affects the heat capacity of a material, the amount of heat energy required to raise the 
temperature of one unit mass of material by one degree. Changes in the heat capacity are measured 
as changes in heat flow which are affected by events such as melting and recrystallisation which are 
endothermic and exothermic processes, respectively. 
 
A DSC instrument comprises a single furnace with an empty reference pan and sample pan 
containing a few milligrams of material (Figure 3.5). The two pans are connected and the DSC 
experiment measures the temperature variation between the sample and reference, known as the heat 
flux, as the temperature of the reference pan is increased at a specified rate. Heat flux can be 
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converted to heat flow using calibration data from a known reference (commonly indium or 
sapphire). The differential heat flow required to ensure that sample and reference temperatures 
increase at the same rate is derived and applied during the DSC measurement. Data are plotted as 
heat flow as a function of the sample temperature; the energy of any thermal events that occur can 
be calculated through integration of the area under the curves. For example, the area of the 
characteristic endotherm of melting gives the heat of fusion, a key parameter in many computational 
calculations. It is also possible to use DSC to gain some information about the kinetics as well as the 
thermodynamics of the process, while the shape of the DSC peaks gives information about sample 
purity.  
 
Figure 3.5. Schematic of a differential scanning calorimeter 
As a sample is heated, say from room temperature to its decomposition temperature, peaks with 
positive and negative ΔdH/dt may be recorded. Each peak corresponds to a heat effect associated 
with a specific process, e.g. crystallisation or melting. The information obtainable from a DSC curve 
includes: 
 Temperature at which a certain process occurs, for example, the melting point of a material; 
 Temperature at which a reaction, such as decomposition, starts (peak position corresponds 
to T of max reaction rate); 
 Phase transition temperatures, and whether these are endothermic or exothermic; 
 Glass transition temperatures, Tg (important in polymers, for example); 
 Enthalpies of transitions; 
 Changes in heat capacity; 
 Phase purity of the material being studied. 
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Even though it may be simple to identify if thermally induced phase transitions are present in a DSC 
pattern it can often prove much more challenging to directly assign these transitions as the thermally 




Figure 3.6. Schematic of a differential scanning calorimetry (DSC) trace, showing some of the 
characteristic thermal events that can be identified (Image used with permission).51 
 
The types of events that are commonly observed in a DSC trace (Figure 3.6) include: 
 Endothermic events: melting, sublimation, (some) solid-solid transitions, desolvation, 
(some) chemical reactions; 
 Exothermic events: crystallisation, (some) solid-solid transitions, decomposition, (some) 
chemical reactions; 
 Baseline shifts: glass transitions in polymers or amorphous materials. 
 
3.7 Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis (TGA) measures the change in mass of a specimen with respect to 
temperature whilst the specimen is subjected to a controlled heating programme93. A mass loss will 
occur when a volatile component is lost in processes such as desolvation, dehydration and 
decomposition, which are shown as a sigmoidal step in a plot of mass against temperature (Figure 
3.7). The weight loss as a percentage can provide useful information about the stoichiometry of 
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hydrates, solvates or decomposition products. Volatile components may not be evolved from all 
materials that undergo some form of reaction or transformation with respect to temperature and it is 
therefore important to perform complementary Differential Scanning Calorimetry experiments94.  
TGA can also be coupled with mass spectrometry (TG-MS) to confirm the type of material evolved 
and can aid characterisation of unknown volatile decomposition products. 
 
 
Figure 3.7 Example of a TGA plot 
3.8 Dynamic Vapour Sorption (DVS) 
Dynamic vapour sorption is useful in measuring the stability of crystalline materials and their ability 
to form hydrates and solvates. A sample is exposed to a series of stepped humidity conditions by 
varying the vapour concentration around the sample and the change in sample mass is measured as 
a function of time. It is important that the sample reaches gravimetric equilibrium before adjusting 
to the next humidity level. A sorption isotherm is created using the equilibrium mass values at each 
humidity level. A recording microbalance monitors the mass of the sample as the vapour 
concentration of the environment is changed. This is achieved by a flowing gas system whereby a 
constant stream of carrier gas (N2 or air) is passed over the sample. The stream of gas is saturated to 
different solvent vapour pressures (relative humidity in the case of water vapour) and is constantly 
delivered to the sample. The different vapour concentrations are created by using mass flow 
controllers to mix a dry and a saturated gas stream. A mass increase indicates a sorption process; 
either absorption or adsorption and a mass loss is indicative of desorption. Square hysteresis in the 
sorption and desorption isotherms indicates the formation of stoichiometric hydrates or solvates 
Mass loss:  
4.08 mg (73%) 
 
Onset: 150 oC 
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whose composition can be calculated from the change in mass relative to that of the non-solvated 
material. A typical DVS system, as used in this work, is shown below in Figure 3.8. 
 
 




4 Crystallisation & Properties of Polymorphic Solid 
Forms of Urea Barbituric Acid 
 
Barbituric acid is not an API itself but is used as a precursor for 5-5-substituted barbiturate drugs 
including amopental, barbitone and phenobarbital95, used in the past as analgesics and more recently 
as general anaesthetics, anticonvulsants in epilepsy treatment and in treatment for anxiety96. Due to 
their pharmaceutical relevance and due to the geometric positioning of the hydrogen bond donating 
and accepting groups barbituric acid and its derivatives have been the subject of a range of crystal 
engineering studies. 
 
The polymorphic urea-barbituric acid co-crystal system (UBA) was first documented by Gryl et al. 
in 200814. UBA was originally studied to investigate potential non-linear optical (NLO) properties 
as previously studied in the barbituric acid melamine (cyanuric acid) co-crystal system by Zerkowski 
and Whitestides97-99. Three polymorphs of the 1:1 co-crystal were produced using evaporative 
crystallisation under different crystallisation conditions (Table 4.1). 
 
Table 4.1. Crystallographic details and crystallisation conditions used by Gryl et al. to obtain 
each of the UBA polymorphs14 
UBA polymorph I II III 
Crystallographic information 
Crystal habit plate block block 
Crystal colour “yellowish” colourless colourless 
Collection temp. (K) 293 293 293 
Space group P21/c Cc P1¯ 
a (Å) 6.962 5.098 8.159 
b (Å) 7.886 8.369 9.112 
c (Å) 14.428 10.553 10.927 
α (o) 98.03 109.55 100.25 
β (o) 90.00 90.00 91.52 
γ (o) 90.00 107.73 99.19 
Volume (Å3) 784.356 401.546 787.821 
Z 4 4 4 
Z’ 1 1 2 
R Factor (%) 4.29 3.25 5.34 
CSD Ref Code EFOZAB EFOZAB01 EFOZAB02 
Crystallisation conditions  
Solvent  Methanol Ethanol Methanol 
Ratio of U:BA 1:2 or 1:3 2:1 2:1 
Dissolution temp. (°C) 50 50 50 
Evaporation temp.  Room temperature Room temperature Room temperature 
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All three polymorphs are stable between 100 K and 295 K as indicated during single crystal X-ray 
diffraction experiments. Gryl et al. noted that over time samples of UBAI and UBAII converted to 
UBAIII and concluded that UBAIII was the most thermodynamically stable form under ambient 
conditions.  
 
This polymorphic nature makes the UBA system an ideal candidate for investigating control of 
polymorphism in co-crystals. The main purpose of this study is to scale-up from evaporative 
crystallisation to laboratory scale cooling crystallisation and develop strategies for producing 
specific polymorphic forms consistently via cooling crystallisation. The starting materials urea and 
BA are safe, cheap and readily available which is important when moving into larger scales and 
working in academic environments. Even though urea and BA are small molecules which do not 
necessarily represent the large floppy molecules typical of APIs, the complexity of the system with 
polymorphic starting materials, formation of hydrates and polymorphic co-crystal products is 
representative of the multifarious nature of pharmaceutical crystal systems.  
 
4.1 Characterisation of Barbituric Acid: polymorphic starting material 
As fine chemical manufacturers are not usually concerned with the polymorph of the material 
obtained, only the chemical identity, purity and yield, it is common to obtain previously unidentified 
polymorphs of starting materials from suppliers; an example of this was found with 4-Cl-3,5-
dinitrobenzoic acid (section 7.4.5) in which Wittering et al. thought that they had discovered a 
previously unreported polymorph through cooling crystallisation experiments, but in fact the new 
polymorph could be traced back to the commercial starting material100. It is well known in the 
pharmaceutical industry that the physical properties of starting materials used for manufacturing 
drug substances can have a large impact upon the outcome of the synthesis including effects on yield, 
purity and solid form. The same starting component may show variation between suppliers and even 
between batches from the same supplier. It is therefore very important to monitor the properties of 
the starting materials used, to enable any changes in the product to be attributed to, or discounted 
from, variations in the starting material and allow the physical properties to be monitored and 
controlled accordingly to control the synthesis.  
 
The same is true for crystallisation processes and is particularly important when using polymorphic 
starting materials such as barbituric acid and urea. Urea is known to have one polymorph at ambient 
pressure and temperature101, however there are several phases that have been identified under high 
pressure102, 103 and non-ambient temperature conditions. Although in standard solution-based 
crystallisation processes these conditions will not be met the material may encounter high pressure 
environments especially in down-stream processes such as granulation and tabletting. 
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Barbituric acid (BA) can display a significant degree of tautomerism (Figure 4.1) and is polymorphic 
with four identified forms. BAI 104 and BAII 105 are both stable under ambient conditions, the latter 
determined to be more stable in lattice energy calculations carried out by Braga et al.106 The full 
structures of forms III and IV have been characterised using solid state NMR studies 107, 108 but have 
not been characterised using SXRD to date and therefore are not present in the CSD. Additionally 
BA can form a dihydrate 109, 110 when exposed to water or humid conditions; as noted in the 
Introduction above, identification and prevention of hydrate formation is a key objective in industrial 
crystallisation processes, and this is clearly also important here, in delivering anhydrous BA reliably 
into the co-crystallisation experiments to ensure process consistency. 
 
Figure 4.1 Several potential tautomers of barbituric acid. The keto-tautomer a) features in BAI 
and BAII and the enol-tautomer b) is present in BAIV.  
 
All three commercial samples of BA starting material were characterised using a range of solid state 
techniques with the aim of polymorph identification in these candidate starting materials. 
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4.1.1 Powder X-ray Diffraction 
Powder X-ray diffraction data were collected in flat plate mode on a Bruker D8 Advance equipped 
with monochromated Cu Kα radiation (λ=1.54056 Å) in reflection geometry at 298 K. 
 
 
Figure 4.2 For comparison PXRD patterns of BA starting material obtained from a) Acros 
Organics, b) Sigma Aldrich and c) Tokyo Chemical Industries are displayed alongside patterns 
calculated from SXRD data for BA I (d), BA II (e), BA dihydrate I (f) and BA dihydrate II (g). (Note 
BA II and BA dihydrate II were calculated from data at 150 K) 
All three commercial starting materials could be co-crystallised with urea to form UBA co-crystals 
however there were some significant differences observed in the physical properties of these starting 
materials. PXRD was used to identify which polymorph of BA was produced by each supplier 
(Figure 4.2). BA-AO and BA-SA were identified as BAII 105, however the PXRD pattern of BA-TCI 
did not correspond to BAI, BAII or BA dihydrate. 
 
This may be a new polymorphic form of BA; indeed, studies by Chierotti et al.108 to investigate 
induction of solid state phase transformations in BA by grinding BAII (about 200 mg) with 3-4 drops 
of absolute ethanol using a ball mill for 24 hours and identified an unknown phase which displays 
different X-ray diffraction behaviour to BAI and BAII and through solid state NMR, which could 
represent previous occurrence of one of the uncharacterised solid forms of BA. 
 
BAIII, the enol tautomer, was identified in a later study by Schmidt et al. through slurry experiments 
of BAII. In this study the material was characterised using solid state NMR, DSC and PXRD, 
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however no SXRD data was collected and therefore a PXRD pattern cannot be calculated from the 
data for comparison with the PXRD pattern of BA-TCI. Instead the PXRD patterns obtained in the 
study by Schmidt et al. are shown below for comparison (Figure 4.3). 
 
Figure 4.3 PXRD patterns of BAII (red) and BAIII (blue) obtained in the discovery of BAIII by 
Schmidt et al 107 
The PXRD pattern of BAIII (Figure 4.3, blue) clearly matches the PXRD pattern of BA-TCI (Figure 
4.2 c) indicating that the BA-TCI starting material is BAIII. The industrial process used by TCI to 
manufacture BA may by chance have the optimum conditions to produce BAIII.  
 
4.1.2 Scanning Electron Microscopy 
Whilst on placement at AstraZeneca Macclesfield samples of crystalline materials were analysed 
using a Hitachi TM-1000 table-top scanning electron microscope. Samples were gold coated prior 
to examination, using a Quorum EMS 150R gold sputter coater, to prevent charge build up on the 
surface of the samples. 
 
Although different polymorphs of a material may exhibit different crystal morphologies, the 
environment in which a material is crystallised tends to have such a large influence upon the 
morphology and size distribution that these cannot generally be used as a definitive way of 
distinguishing between polymorphs. 
 
Interestingly from SEM imaging the crystals of BA-SA and BA-AO appear to have similar shape 
and size (Figure 4.4 a to d) but BA-TCI looks much more cube like and appears to be more regular 
(Figure 4.4 e and f). These differences may be due to the polymorphic form or, more likely, indicate 
that the manufacturing processes for BA used by TCI are very different to those used by SA and OS, 














Figure 4.4 SEM images showing the morphology of BA-SA (a and b), BA-AO (c and d) and  
BA-TCI (e and f) 
4.1.3 IR and Raman Spectroscopy 
Samples were analysed using a Thermoscientific Nicolet 6700 FT-IR with ATR head. A resolution 
of 4 cm−1 was used with 32 scans collected (Figure 4.5) over a scan range of 3600-600 cm−1. Raman 
analysis was carried out using a Thermofisher Scientific DXR Raman microscope equipped with 780 
nm laser (Figure 4.5).  Data were analysed with OMNIC software v8.1.210 (© 1992-2009 Thermo 















Figure 4.5 IR and Raman spectra of BA-AO (a and b), BA-SA (c and d) and BA-TCI (e and f) 
As observed using other methods of analysis the IR and Raman spectra of BA-AO and BA-SA are 
identical however the spectra from BA-TCI are significantly different indicating a different form of 
BA starting material. BAIII was fully characterised in a study by Schmidt et al 107; the FTIR spectra 




Figure 4.6 FTIR spectra of BAII (black) and BAIII (red) obtained in the discovery of BAIII by 
Schmidt et al 107 
On comparison with the FTIR spectrum obtained in this study on the BA starting materials it is clear 
that BA-AO (Figure 4.5 a) and BA-SA (Figure 4.5 c) match with BAII (Figure 4.6, black) and BA-
TCI (Figure 4.5 e) corresponds to BAIII (Figure 4.6, red) as characterised by Schmidt et al.    
4.1.4 Differential Scanning Calorimetry 
DSC on BA starting materials obtained from Sigma Aldrich, Acros Organics and TCI was carried 
out using a Thermal Advantage Q20 DSC from TA Instruments, equipped with Thermal Advantage 
Cooling System 90 and operated with a dry nitrogen purge gas at a flow rate of 18 cm3 min1. The 
samples were placed in sealed Tzero aluminium pans and a heating/cooling rates of 2 to 10 K min1 
were used. Data were collected using the software Advantage for Qseries. 
 
 
Figure 4.7 DSC of BA starting materials, BA-TCI, BA-SA and BA-AO 
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Table 4.2 Temperatures of thermal events in DSC traces of the BA starting materials for 
comparison with temperatures for BAII (reported by Roux et al.) and  
BAIII (reported by Schmidt et al.) 
Thermal event 
Onset temperature of event for each material (°C) 
BA-SA BA-AO BA-TCI BAII 111 BAIII 107 
Phase transition BA III → BA II - - 170 - 172 
High temperature phase 245 241 241 243 243 
Melt and decomposition 251 253 252 253 251 
 
The endothermic event in the DSC trace of BA-TCI (Tonset = 170 °C) (Figure 4.7, green) is indicative 
of a phase transition characteristic of BAIII, which was confirmed to be a phase transition between 
BAIII and BAII by Schmidt et al. Both BA-SA and BA-AO (Figure 4.7 blue and red, respectively) 
display two endothermic events. The first event (at 245 °C and 241 °C for BA-SA and BA-AO) 
corresponds to a phase transition to an unknown high temperature phase of BA and the second event 
(at 251 °C and 253 °C for BA-SA and BA-AO) corresponds to the melting and decomposition of 
this phase107, 111. This analysis agrees with the identification of BA-SA and BA-AO as BAII and BA-
TCI as BAIII.  
4.1.5 Dynamic Vapour Sorption 
Dynamic vapour sorption was carried out on BAII (BA-SA). Using a Surface Measurement Systems 
DVS Intrinsic, approximately 20-30 mg of material was weighed into an aluminium sample pan.  
The relative humidity (RH) was taken from a starting humidity of 0% RH up to 90% RH in 10% 
steps then decreased down to 0% RH in 10% steps at a constant temperature of 25 °C.  This relative 
humidity cycle was repeated.  Equilibration at each humidity step was set such that the rate of change 
of weight with time (min) was less than 0.0005%/min. for 5 minutes before moving on to the next 
humidity step. 
 
BAII (BA-SA and BA-AO) readily forms BA dihydrate (CSD ref BARBAD) 109, 110, 112 upon 
exposure to moisture, and this is clearly demonstrated by the hysteresis in the DVS plot (Figure 4.8). 
The mass increase at 80% RH corresponds to the mass of two mole equivalents of water (relative to 
the number of moles of BA in sample), consistent with the formation of BA dihydrate. The dihydrate 
persists in DVS experiments down to 40% R.H. below which the original BA starting material is 
produced, indicating that once formed the BA dihydrate is stable under ambient humidity conditions 
(usually around 60% RH). Interestingly on the second cycle the onset of hydrate formation occurred 
at 70% RH. Access to DVS equipment was not readily available and as a result BAIII (BA-TCI) was 
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not analysed using DVS. It would be interesting to see if BAIII formed BA dihydrate and if so under 
what humidity conditions; this is therefore proposed as future work.  
 
 
Figure 4.8 Dynamic vapour sorption experiment on BAII (BA-SA) showing reversible hydration 
to BA dihydrate 
 
4.1.6 Humidity studies 
Access to DVS equipment was available during a three month secondment at AstraZeneca, 
Macclesfield. For studies carried out at the University of Bath, samples were subjected to humidity 
testing using a sealed container filled with 200 g sodium chloride mixed with approx. 10 mL 
deionised water and fitted with a humidity sensor suspended upon a plastic shelf inserted into the 
container (Figure 4.9). The container was placed in an oven set at 50 °C and the conditions allowed 
to equilibrate for 24 hours. The humidity stabilised at 78% RH at a temperature of 45 °C. The samples 
that were subjected to RH ageing were monitored on a weekly basis using PXRD (Figure 4.10 -  
Figure 4.12).  
 
 
Figure 4.9 Rudimentary set-up for long term humidity exposure testing comprising airtight 




Figure 4.10 Weekly PXRD analysis of BA-AO subjected to 78% RH at 45 °C for four weeks. 
 
Figure 4.11 Weekly PXRD analysis of BA-SA subjected to 78% RH at 45 °C for four weeks 
 
Figure 4.12 Weekly PXRD analysis of BA-TCI subjected to 78% RH at 45 °C for four weeks 
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All three commercially available BA starting materials remained unchanged after four weeks at 
45 °C and 78% RH. Conversion between BAIII (BA-TCI) and BAII (BA-SA and BA-AO) under 
these environmental conditions is not expected as the phase transition occurs at much higher 
temperatures (170 °C). There is no indication of BA hydrate formation within the PXRD patterns 
however DVS analysis of BAII (Figure 4.8) shows that the hydration of BAII is a reversible process 
and as the PXRD experiments are not carried out under humidity controlled conditions then it would 
be expected that any BA dihydrate produced would dehydrate under ambient conditions. 
Investigations using variable humidity PXRD have been carried out previously on BAII by Zencirci 
et al.96 and in future data could be collected for BAIII to complement this.  
 
4.1.7 Conclusions 
Analysis was conducted of commercially available BA obtained from three suppliers; Sigma Aldrich 
(BA-SA), Acros Organics (BA-AO) and TCI (BA-TCI). None of the suppliers identified which 
polymorphs of BA was provided. The range of solid state characterisation confirms that BA-SA and 
BA-AO are BAII and BA-TCI is the BAIII polymorph. BAIII and BAIV are not deposited in the 
CSD, often a crystal engineer’s first port of call for information about the polymorphic behaviour of 
a material and initially they were overlooked until the wealth of information was discovered in the 
ESI of the paper published by Schmidt et al. which lead to confirmation that BA-TCI was BAIII. 
Further analysis of the solubility of BAIII is required to compare to solubility data obtained for BAII 
as this may affect the dissolution behaviour of the BA starting material during cooling crystallisation 
which will have implications upon the crystallisation conditions required.  
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4.2 Evaporative Crystallisation of UBA 
The discovery / initial production of solid forms of the UBA system was carried out in the present 
work by small scale evaporation, using the conditions detailed in Table 4.1 (above)14. As the previous 
studies carried out by Gryl et al. did not investigate the bulk properties from their evaporative 
crystallisation experiments it is difficult to know if the single crystals used for structure solution in 
that work were representative of the bulk. The evaporative crystallisation experiments were 
replicated and built upon here in order to ascertain if different evaporative conditions could be 
designed that were able to isolate the individual UBA polymorphs.   
 
4.2.1 Materials 
Urea (98% bio-reagent grade) was purchased from Sigma Life Science and BAII (98% reagent 
grade) was purchased from Sigma Aldrich. All reagents were used without further purification. 
Laboratory reagent grade solvents purchased from Sigma Aldrich were used for all crystallisations. 
 
4.2.2 Method 
Urea and barbituric acid, weighed out into a 7 mL glass vial, in either a 1:1 ratio (23 mg urea and 
50 mg BA) or a 2:1 ratio (47 mg urea and 50 mg BA) were dissolved in approximately 5 mL of either 
methanol or ethanol. The vials were capped with a pierced plastic lid and left to evaporate at a fixed 
temperature (RT, 30°C or 50°C) until dry (24 to 48 hour on average). The conditions of each 
crystallisation are detailed in Table 4.3. 
 
The entire content of each vial was removed and gently kneaded in a pestle and mortar for 10 s, long 
enough to ensure that the samples are uniform and to reduce preferred orientation in PXRD analysis, 
but short enough to prevent any mechano-chemical transformations. All samples were analysed 
using PXRD.  
 
4.2.3 Results and Discussion 
A summary of the qualitative results obtained from PXRD analysis are detailed in Table 4.3 and the 
PXRD patterns are shown in Figure 4.13. 
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Table 4.3 Summary of crystallisation conditions and results obtained from PXRD analysis of UBA 






Product (from PXRD analysis) 
UBAI UBAII UBAIII BAI BA (H2O) U 
1 Methanol RT 1:2 X  X  X  
2 Methanol 30 1:2   X X   
3 Methanol 50 1:2  X X X   
4 Methanol RT 2:1   X X  X 
5 Methanol 30 2:1 X  X   X 
6 Methanol 50 2:1 X  X X  X 
7 Ethanol RT 2:1 X  X   X 
8 Ethanol 30 2:1 X     X 
9 Ethanol 50 2:1 X  X   X 
10 Ethanol RT 1:2 X    X  
11 Ethanol 30 1:2 X   X   
12 Ethanol 50 1:2 X  X X   
RT = 18°C in a temperature controlled laboratory 
X = positive identification in PXRD pattern 
 
Crystallisation trials from neither the methanol nor ethanol solvent selectively produced a single 
UBA polymorph. However, in all experiments using methanol UBAIII was always present, whilst 
when using ethanol UBAI was always present in the mixture. This is particularly clear in experiments 
2 and 4 (from methanol) and experiments 8 and 10 (from ethanol). It may be that the change in 
solvent could have a templating effect on the UBA polymorph, but this is unlikely due to the 
similarity in functionality of ethanol and methanol, and the differing tendency for dominant 
polymorph production in these trials is more likely to be due to differences in solubility of UBA in 
the different solvents or the difference in volatility of the solvents.  
 
In summarising the above trials, all experiments produced mixtures of the UBA polymorphs in which 
residual urea and BA starting materials were also present, as qualitatively identified through PXRD. 
If further work were to pursue selectivity and yield in such evaporative crystallisation approaches in 
a quantitative way, the proportions of each solid form present in the mixtures could be quantified 
using multi-phase Rietveld analysis of the PXRD patterns. 
 
4.2.4 Conclusion  
The systematic evaporative co-crystallisations carried out on the UBA system have shown that it is 
possible to produce each of the UBA polymorphs. The more stable pair of polymorphs (UBAI 
UBAIII) are produced under a range of conditions, while the most metastable polymorph UBAII is 
only produced in one of the trials carried out; this is in keeping with its metastable nature, and its 
known status as an elusive solid. Although all forms of UBA have been produced, and on some of 
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the trials only one solid form of UBA is found, it should be noted that UBAI and UBAIII frequently 




Figure 4.13 PXRD patterns of evaporative crystallisation experiments 1-12 for comparison with 
urea and BA starting materials and the UBA polymorphs 
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4.3 Small Scale Mechano-crystallisation of UBA 
As discussed in section 2.4.4 mechano-crystallisation can be a useful route to producing MMCs and 
has particular environmental benefits over solution based crystallisation. Small scale evaporative 
crystallisation was the only technique reported by Gryl et al. for producing UBA co-crystals now 
complemented by the successful cooling crystallisation of UBA is detailed in section 4.2 above. The 
aim of this study is to explore whether it is possible to co-crystallise urea and BA by mechano-
crystallisation and if so which polymorphs of UBA are produced. This will allow access to questions 
such as whether it is possible to access different UBA polymorphs, or different selectivity amongst 
the known polymorphs, using this different crystallisation method. Successful production of UBA 
using mechano-crystallisation would be particularly useful for the generation of seeds especially if 
it is possible to isolate a single UBA polymorph.  
 
4.3.1 Materials 
Urea (98% bio-reagent grade) was purchased from Sigma Life Science and BA (98% reagent grade) 
was purchased from Sigma Aldrich. All reagents were used without further purification. Laboratory 
reagent grade solvents purchased from Sigma Aldrich were used for all crystallisations. 
 
4.3.2 Method 
Urea and barbituric acid in either a 1:1 ratio (23 mg urea and 50 mg BA) or a 2:1 ratio (47 mg urea 
and 50 mg BA) were combined in a pestle and mortar, kneading for 15 minutes. This was carried 
out using both dry and solvent assisted grinding. Solvent assisted experiments involved dropwise 
addition of either water, methanol, ethanol or isopropyl alcohol to produce and maintain a paste 
texture. The solvent readily evaporated from the end sample prior to PXRD analysis. Three control 
samples, a 1:1 mixture, a 2:1 mixture and a 1:2 mixture (U:BA) of urea and BA, that were simply 
mixed with a spatula for a few seconds (i.e. without compression) were produced and analysed using 
PXRD as a control for comparison to the kneaded samples. 
 
4.3.3 Results and Discussion 
A summary of experimental conditions and the qualitative results obtained from PXRD analysis are 
detailed in Table 4.4 and the PXRD patterns for the samples are shown in Figure 4.15 to Figure 4.17. 
 
The control experiments highlight that without the mechanical work from grinding the urea and BA 
do not interact to form co-crystals (Figure 4.14). When the materials are exposed to heat and pressure 
from grinding in the absence of any solvent UBAI is produced. As all UBA co-crystals are of a 1:1 
 92 
stoichiometry when a 2:1 ratio of urea:BA is used an excess of  urea is present in the final product 
as would be expected. One would anticipate that if a 1:1 ratio of urea:BA is used complete conversion 
can be achieved. However in practice in addition to UBAI there is also BA II starting material present 
in the product and no indication of urea in the PXRD pattern. One suggestion could be that some of 
the urea has become amorphous and will not be detected explicitly in the PXRD pattern.  
 
Table 4.4 Summary of crystallisation conditions and results obtained from PXRD analysis of UBA 




Product (from PXRD analysis) 
UBAI UBAII UBAIII BA BA (H2O) U 
- CONTROL 1:1    X  X 
- CONTROL 2:1    X  X 
- CONTROL 1:2    X  X 
1 N/A 1:1 X   X   
2 N/A 2:1 X     X 
3 N/A 1:2 X   X   
4 Water 1:1 X    X  
5 Water 2:1 X     X 
6 Water 1:2 X    X  
7 Methanol 1:1 X      
8 Methanol 2:1   X *      
9 Methanol 1:2 X    X  
10 Ethanol 1:1 X      
11 Ethanol 2:1   X *      
12 Ethanol 1:2 X    X  
13 IPA 1:1 X      
14 IPA 2:1   X *      
15 IPA 1:2 X   X X  
X = positive identification in PXRD pattern 
*Additional peaks are present that do not match UBA polymorphs, starting materials  
or hydrates.  
 
 
LAG experiments with water produced UBAI using a 1:1, 2:1 and 1:2 ratio of starting materials. As 
observed for solvent free experiments an excess of urea was present from the 2:1 ratio and the 1:1 
ratio, but BA dihydrate was present in the final product rather than BAII starting material. For all 
other LAG experiments (using methanol, ethanol or IPA) UBAI was produced exclusively when 
using a 1:1 ratio of starting materials. When a 2:1 ratio of urea:BA was used UBAI was also produced 
although additional peaks present in the PXRD patterns (Figure 4.16) that do not correspond to any 
of the UBA polymorphs, the starting materials or hydrates, suggest there may be an additional 





Figure 4.14 Control mixtures of urea and BA 
in a 1:1, 2:1 and 1:2 ratio (urea:BA) 
Figure 4.15 PXRD analysis of mechano-
chemical experiments using 1:1 ratio 
(urea:BA) and a range of solvents 
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Figure 4.16 PXRD analysis of mechano-
chemical experiments using 2:1 ratio 
(urea:BA) and a range of solvents 
Figure 4.17 PXRD analysis of mechano-
chemical experiments using 1:2 ratio 
(urea:BA) and a range of solvents 
 
4.3.4 Conclusion 
The mechano-crystallisation experiments give access exclusively to UBAI, and in 1:1 LAG 
experiments using either methanol, ethanol or water UBAI is formed as the sole product. Thus 
mechano-crystallisation, although accessing only one polymorph, does so selectively in a way that 
was not possible with the evaporative approaches trialled. This facile and selective route to UBAI 
that can be exploited as a method for UBAI seed production to be used in future UBAI selective 
crystallisation experiments.  
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4.4 Small Scale Cooling Crystallisation of UBA – Design of Experiments (DoE) 
Design of experiments (DoE) is a statistical method that is used to sample the entire problem space 
in a systematic and even manner. In an experiment, one or more process variables (or factors) are 
normally changed, in order to observe the effect the changes have on one or more response variables. 
DoE is an efficient procedure for planning experiments so that the data obtained can be analysed to 
yield valid and objective conclusions.  
 
DoE begins with determining the objectives of an experiment and selecting the process factors for 
the study. An Experimental Design is the laying out of a detailed experimental plan in advance of 
doing the experiment. Well-chosen experimental designs maximize the amount of "information" that 
can be obtained for a given amount of experimental effort. DoE is a far more effective method of 
exploring process variables as it uses a computer-enhanced, systematic approach to experimentation 
that considers all factors simultaneously. DoE provides information about the interaction of factors 
and how the total system works, while also showing how interconnected factors respond over a wide 
range of values, without requiring the testing of all possible values directly. 
 
DoE fits (multi-dimensional) response data from the experiments carried out to mathematical 
equations. Collectively, these equations serve as models to predict what will happen for any given 
combination of values once the model has been deduced from the discrete, systematically sampled 
experiments. With these models, it is possible to optimize critical responses and find the best 
combination of values to produce a particular response (which can be a property, process variable, 
etc). The most commonly adopted method for sampling the parameter space is that of full factorial 
design, in which every setting of every factor appears with every setting of every other factor. A 
common experimental design is one with all input factors set at two levels each; these levels are 
called `high' and `low' or `+1' and `-1', respectively. A full factorial design for such a system, with 
N factors, would require 2N experiments for a full factorial design (i.e. for four factors, 16 
experiments, for five factors, 32 experiments, etc). Other designs are possible and are usually 
implemented for N=5 or more. One common method used is to run only a fraction of the full factorial 
design which, while less than optimal, is more feasible experimentally as it reduces the number of 
experiments required. The so-called fractional factorial design effectively reduces the number of 
factors by relating some of these to functional combinations of others; these “constraints” reduce the 
dimensionality of the problem113. 
 
DoE here was applied to the optimisation of the crystallisation of UBA. Seven factors (Table 4.5) 
were identified as potentially influential in UBA crystallisation (based on the available studies on 
UBA). These were used to form a DoE matrix with a 24 fractional factorial design involving 16 
experiments and four control points (see Table 4.5 below), with the aim to decide which of the 
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experimental variables is most influential in controlling UBA crystallisation. A fractional factorial 
design was chosen over a full factorial design as with seven factors (27 design) 128 experiments 
would be required to map the design space as opposed to 20 in the 24 fractional factorial design 
significantly reducing the experimental time required to understand the experimental space. This is 
where the fractional factorial design becomes really helpful. 
 
4.4.1 Materials 
Laboratory reagent grade methanol (99.8% Sigma Aldrich), urea, 98% bio-reagent grade from Sigma 
Life Science and either BAIII from TCI Europe (98% pure) or BAII from Sigma Aldrich, were used 
for all crystallisations.  
 
4.4.2 Methods 
Each experiment was prepared using 100 ml methanol which was heated to 50 °C in a 250 ml round 
bottomed flask using the CRD Polar Bear Plus followed by addition of the urea and BA starting 
materials (quantities specified in Table 4.5). The solution was then heated to 60 °C and held for 
either 10, 35 or 60 minutes with stirring from a 2.5 cm magnetic stirrer bar at either 200, 400 or 
600 rpm. 
 
4.4.3 Results and Discussion 
PXRD analysis (Figure 4.18) shows that of the 24 experiments (16 standard experiments, four control 
experiments and four extra experiments), six produced some UBA III (Experiments 2, 8, 10, 16, 21 
and 23 Table 4.6), one of which was pure UBAIII (Experiment 10). UBAII was not present in any 
of these experiments. However UBAII was subsequently obtained from batch cooling crystallisation 
using a two-step cooling profile (section 5.1) as opposed to the linear cooling profiles used to obtain 
UBA I and UBAIII and in the DoE protocols investigated here.  
 
All the experiments that produced UBAIII were not carried out in a consecutive order showing that 
there was no seeding of UBAIII from previous experiments. UBAIII was produced in experiments 
that used BAIII (from TCI) however it does not follow that all experiments using UBAIII starting 







Table 4.5 Conditions used to carry out a 24 fractional factorial design of experiments for UBA cooling crystallisation on 100ml scale using CRD Polar Bear Plus 
expt. no. run order 
concentration 
(g/g wrt BA) 
Ratio BA:U         
Stirring 
speed (rpm) 




Addition BA polymorph 
Initial dwell 
time (mins) 
1 10 0.0125 2:3 200 0.1 5.0 U then BA BAII 10 
2 14 0.0168 2:3 200 0.1 5.0 BA then U BAIII 60 
3 16 0.0125 1:2 200 0.1 25.0 U then BA BAIII 60 
4 19 0.0168 2:3 200 0.1 25.0 BA then U BAII 10 
5 22 0.0125 2:3 600 0.1 25.0 BA then U BAIII 10 
6 13 0.0168 2:3 600 0.1 25.0 U then BA BAII 60 
7 11 0.0125 1:2 600 0.1 5.0 BA then U BAII 60 
8 8 0.0168 1:2 600 0.1 5.0 U then BA BAIII 10 
9 4 0.0125 2:3 200 2.0 25.0 BA then U BAII 60 
10 6 0.0168 2:3 200 2.0 25.0 U then BA BAIII 10 
11 21 0.0125 1:2 200 2.0 5.0 BA then U BAIII 10 
12 24 0.0168 1:2 200 2.0 5.0 U then BA BAII 60 
13 5 0.0125 2:3 600 2.0 5.0 U then BA BAIII 60 
14 12 0.0168 2:3 600 2.0 5.0 BA then U BAII 10 
15 18 0.0125 1:2 600 2.0 25.0 U then BA BAII 10 
16 7 0.0168 1:2 600 2.0 25.0 BA then U BAIII 60 
Control 17 20 0.0147 4:7 400 1.0 15.0 Mixture BAII 35 
Control 18 17 0.0147 4:7 400 1.0 15.0 Mixture BAII 35 
Control 19 15 0.0147 4:7 400 1.0 15.0 Mixture BAIII 35 
Control 20 23 0.0147 4:7 400 1.0 15.0 Mixture BAIII 35 
Extra 21 1 0.0110 2:3 600 2.0 5.0 U then BA BAIII 60 
Extra 22 2 0.0110 2:3 200 2.0 14.0 BA then U BAII 60 
Extra 23 3 0.0125 2:3 200 2.0 25.0 BA then U BAIII 60 




All experiments that produced a yield over 55% (total solids) were carried out using high 
concentration (0.0168 M wrt. BA) and a low final temperature (5 °C). Experiments 12 and 24 have 
identical crystallisation conditions except for stirring rates, which are 200 rpm and 600 rpm, 
respectively. The yield for these experiments is identical which suggests that stirring rate does not 
have an effect on the yield of these crystallisation trials. This conclusion may be more widely 
applicable for the UBA system but this was not investigated systematically.   
 
 
Table 4.6 Yield and Polymorphic form of UBA crystals obtained from experiments in DoE set-up. 
expt. no. Yield (%) 
Dominant Polymorph                            
(from PXRD analysis) 
1 39.2 UBAI 
2 58.1 UBAI and UBAIII 
3 23.9 UBAI 
4 45.5 UBAI 
5 8.0 UBAI 
6 38.9 UBAI 
7 52.0 UBAI 
8 57.6 UBAI and UBAIII 
9 9.0 UBAI 
10 37.4 UBAIII 
11 47.3 UBAI 
12 59.1 UBAI 
13 40.7 UBAI 
14 55.0 UBAI 
15 24.5 UBAI 
16 43.7 UBAIII and UBAI 
Control 17 44.2 UBAI 
Control 18 39.0 UBAI 
Control 19 40.9 UBAI 
Control 20 40.1 UBAI 
Extra 21 39.3 UBAIII and UBAI 
Extra 22 17.8 UBA I 
Extra 23 18.1 UBAIII and UBAI 
Extra 24 59.1 UBA I 




Figure 4.18 PXRD patterns of 100 mL scale cooling crystallisation experiments 1-20 in UBA DoE 
for comparison with the UBA polymorphs. 
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4.4.4 Conclusions 
DoE highlights that within the experimental space investigated UBAI was the dominant polymorph. 
And as observed in evaporative and mechano-chemical co-crystallisation experiments UBAII proved 
elusive. There is very little correlation between the conditions observed and the polymorphic 
outcome. This may be due to the fact that polymorphs UBAI and UBAIII have very similar 
physicochemical properties (section 4.5) and the design space may not be broad enough to discover 
UBAII.  
 
This DoE study is in its early stages. Further analysis using software for multivariate analysis on the 
results collected can be used in future to carry out regression analysis and create regression models 
based upon the raw data will be able to help to map out the conditions required to produce a specific 
UBA polymorph. This is an approach that is being taken within the Wilson group (A. J. P. Cousen, 
CMAC PhD project, University of Bath) as a result of this work.  
 
Quantitative analysis of the PXRD patterns using software such as PolySNAP-3114 (a cluster analysis 
software programme) may be of benefit to identify which crystallisation conditions yielded the 
highest amounts of each polymorph. This may not prove representative due to potential issues with 
preferred orientation owing to the nature of the sample preparation for PXRD analysis. 
 
4.5 Analysis and Characterisation of the UBA Co-crystal System 
The crystal structures of UBAI, UBAII and UBAIII were determined in 2008 by Gryl et al. and the 
packing arrangements within these structures have been described focusing on the hydrogen bonding 
interactions and graph set notation to distinguish the three polymorphs. As the work by Gryl et al. 
focused on discovery of NLO active materials particular attention was paid to the resonance forms 
of the BA molecules within each polymorph with an emphasis on charge density studies.  
 
The purpose of the work detailed here is significantly different, attempting to reproducibly isolate 
each of the UBA polymorphs in bulk; a task in which the relative stability of each UBA polymorph 
is critical. One observation reported by Gryl et al. regarding UBA stability was that when crystals of 
UBAI and UBAII were left in their mother liquor at 293 K over a period of several weeks the crystals 
transformed to UBAIII. From this finding Gryl deduced that UBAIII is the most stable UBA 




4.5.1 Structural Comparison of Three Polymorphs of UBA 
In this section elements of the UBA crystal structures are discussed, and in later sections correlated 
with experimental characterisation in attempts to rationalise the polymorphic stability within the 
UBA co-crystal system.  
 
Figure 4.19 The asymmetric unit for UBA polymorphs I, II and III 
 UBAI 
Urea and BA can crystallise in the space group P21/c forming a 1:1 co-crystal with the unit cell 
parameters, known as UBAI. The asymmetric unit comprises of one urea and one BA molecule 
which are positioned such that the carbonyl group of urea and the cyclic amide carbonyl of BA are 
orientated in the same direction (Figure 4.19). Urea and BA interact to form a heterodimer between 
BA and urea through N3-H5···O1 and N2-H3···O4 hydrogen bonds (Figure 4.20 a and b, 




Figure 4.20 Hydrogen bonded tetramer unit present in UBAI 
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Figure 4.21 UBAI tape comprising tetramers hydrogen bonded through a urea-urea 𝑹𝟐
𝟐(𝟖) motif 
Both urea molecules in the tetramer interact with urea in two neighbouring tetramers via two 
symmetry related hydrogen bonds N1-H1···O1 (Figure 4.21 d). This forms a tape of tetramers 
connected through 𝑅2
2(8) motifs (Figure 4.21). The remaining four hydrogen bond donors (primary 
amine group in urea and secondary amine in BA) and four hydrogen bond acceptors (two carbonyl 
groups on each BA molecule) on each tetramer are involved in hydrogen bonding to a further four 
tetramers units each of which is involved in a separate UBA tape102; (Figure 4.22). These connections 
are formed through DD-A bifurcated hydrogen bonds, comprising N1-H2···O3 and N4-H6···O3 
(Figure 4.22 e and f, respectively), between a urea and BA molecule from one tape and a BA 
molecule from a neighbouring tape.  
 
Figure 4.22 Each tetramer bonds to another four tetramers through bifurcated hydrogen bonds 
(e and f). (1) BA (in red) interacts with BA and urea (in blue) of a neighbouring tape  and (2) BA 
and Urea (red) interact with BA (blue) in another neighbouring chain  
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The chains stack up on top of one another interacting though π-π interactions between urea and BA 
in neighbouring layers (3.320 Å carbon to BA centroid distance) and form layers of chains with 
alternating orientations (Figure 4.23). The full interaction map (FIM) is shown in Figure 4.24; this 
type of map highlights the similarity in the location of the proposed donor and acceptor sites within 
molecular components in a crystal structure.  In this case the observed spatial relationship between 
hydrogen bond donors and acceptors within the UBAI structure is shown to be highly probable and 
favourable, due to the arrangement of the components in the packing of the complex. 
 
 
Figure 4.23 Alternating layers of tapes in UBA I highlighted in the shift in orientation when 
rotated through 90o about the c-axis (left) 
 
Figure 4.24 Full interaction map (FIM) of UBAI, calculated using Mercury Solid Form Tools 
showing a) both urea and BA in asymmetric unit, b) proposed hydrogen bond donor sites for BA 
in the asymmetric unit and c) proposed hydrogen bond donor and acceptor sites for urea in the 
asymmetric unit (potential donor sites shown in blue, potential acceptor sites shown in red and 




UBAII crystallises in the space group Cc, in a 1:1 ratio of urea to BA, with an asymmetric unit 
comprising one molecule of urea and one molecule of BA as observed in UBAI. However unlike 
UBAI, the urea carbonyl group and the BA cyclic amide carbonyl are orientated opposing one 
another (Figure 4.19).  As in UBAI urea and BA from a homodimer unit through two N-H···O 
hydrogen bonds (N2-H3···O2 and N3-H5···O1, Figure 4.25 a and b, respectively). 
 
 
Figure 4.25 Within the UBA II structure urea-BA homodimer units (circled in red) interlink to 
form a UBA chain 
The urea-BA homodimers form a UBA chain through N1-H2···O3 hydrogen bonds between the BA 
carbonyl and free primary amine in urea within neighbouring homodimers (Figure 4.25 c). 
  
 
Figure 4.26 Alternating layers of chains in UBAII highlighted in the shift in orientation when 
rotated through 90o about the c-axis (left) 
As in UBAI, the most obvious - stacking is in this case between the carbonyl on a urea molecule 







Figure 4.27 Full interaction map (FIM) of UBAII, calculated using Mercury Solid Form Tools 
showing a) both urea and BA in asymmetric unit, b) proposed hydrogen bond donor sites for BA 
in the asymmetric unit and c) proposed hydrogen bond donor and acceptor sites for urea in the 
asymmetric unit (potential donor sites shown in blue, potential acceptor sites shown in red and 
potential π-π interactions shown in green) 
 UBAIII 
UBA III crystallises in the space group 𝑃1̅ Unlike the previous two polymorphs UBAIII has two 
molecules of urea and two molecules of BA in the asymmetric unit (Figure 4.19), but it is still a 1:1 
co-crystal as is UBAI and UBAII. 
 
Figure 4.28 Hydrogen bonded UBA chain within the UBA III structure  
 










Figure 4.30 Layered structure of UBA III when viewed down the c-axis 
 
Figure 4.31 Full interaction map (FIM) of UBAIII, calculated using Mercury Solid Form Tools 
showing a) both urea and BA in asymmetric unit, b) proposed hydrogen bond donor sites for BA 
in the asymmetric unit and c) proposed hydrogen bond donor and acceptor sites for urea in the 
asymmetric unit (potential donor sites shown in blue, potential acceptor sites shown in red and 
potential π-π interactions shown in green) 
 Density Rule for Polymorph Stability 
The densities of UBAI, UBAII and UBAIII are 1.593, 1.556 and 1.586 mg m-3, respectively, as 
reported by Gryl et al. from calculations using single crystal data collected at room temperature14.  
 
The density rule for polymorphs stability proposes that based upon the principle of closest packing 
the most stable polymorph will have the highest density (at absolute zero). Kitaigorodskii identifies 
that for hydrogen bonded systems this principle becomes far more complex and cannot be accurately 
predicted although it can be used to get a rough estimation115.  
 
The densities presented here are calculated for the hydrogen bonded UBA system from data collected 
at room temperature (293 K) and so are certainly not a perfect representation. However, the density 
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of UBAI and UBAIII are very similar and UBAII is significantly less dense indicating that UBAII 
is the least stable polymorph, which complements results from other characterisation techniques 
discussed later in this chapter. 
4.5.2 Evaluating Hydrogen Bonding Propensity Within the UBA Co-crystal System 
Using Mercury CFC Tools 
CCDC launched the Crystal Form Consortium, a collaborative project between software, database 
and research experts at the CCDC, and industrialists specialising in solid state science from over 14 
different organisations (predominantly from the pharmaceutical and agrochemical sectors), in 2008. 
The objective was to provide routes to solid form design using tools based upon structural 
informatics harnessed from the wealth of structural data held within the CSD.  The software, which 
is under continual development, is capable of providing information on the stability of materials, the 
risk of polymorphism and on hydrogen bond propensity in single component and multi-component 
systems, information particularly helpful for crystal engineering studies.   
 
As mentioned previously, UBAI and UBAII both have Z’ = 1; the asymmetric unit comprises one 
urea molecule and one barbituric acid molecule, within which there is a total of five and six defined 
hydrogen bonds, respectively. UBAIII, on the other hand, has Z’ = 2; the asymmetric unit comprises 
two urea molecules and two barbituric acid molecules, thus having an increased number of defined 
hydrogen bonds, twelve in total. The interactions for UBAIII can be classified into four groups, 
Urea1-BA1 (four hydrogen bond interactions), Urea2-BA2 (four hydrogen bond interactions), Urea1-
BA2 (two hydrogen bond interactions) and Urea2-BA1 (two hydrogen bond interactions). 
 
Using a statistical model the likelihood for hydrogen bond pairings to form in the target system are 
calculated, built using relevant structures from within the CSD. The model 116-118 utilises information 
on the environments of the functional groups, tailoring the prediction to the target system. The 

















Figure 4.32 Target selection for UBA interactions, in which H-bond donor and acceptor sites are 
identified (a) and functional group are defined; (b) cyclic amide, (c) urea and (d) amino group 
Hydrogen bonding descriptors are extracted from the structures within this training dataset upon 
which the regression model is based. The hydrogen bonding analysis process identifies any data 
relating to rare cases of donors or acceptors that may skew the outcome and give a poor fit to the 
model. These can be removed if present.  
 
The H-bonding model is then fit using a range of different variables including the donor and acceptor 
atom type, the competition and the aromaticity of the donors and acceptors. Regression analysis 
identifies the goodness of fit of the data. This model can then be used to calculate the hydrogen bond 
propensities for each of the UBA polymorphs to allow for comparison of these and investigate 
whether the H-bond propensities affect the structure and properties of the UBA solid forms. 
 
A range of potential alternative polymorphic forms can be produced computationally by combining 
the hydrogen bonding propensities with information about the frequency of hydrogen bond 
participation for each functional group essentially a map of the he resultant view of the solid state 
landscape addresses questions such as: how likely is polymorphism, and is there the possibility of a 
more stable form? 
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Table 4.7 Summary of the donor and acceptor combinations observed in the structures of UBAI, 
UBAII and UBAIII and their corresponding hydrogen bond propensities (urea-urea interactions 
in yellow, urea-BA interactions in red and blue and BA-BA interactions in green) 
 
 
UBAI and UBAII both have one molecule of urea and one molecule of BA in the asymmetric unit 
with a potential to form 16 hydrogen bonds. UBAI forms five hydrogen bonds in total three of 
moderate propensity between urea and BA molecules, one high propensity bond between urea 
molecules and another lower propensity bond between BA molecules. UBAII forms six moderate 
propensity hydrogen bonds all occurring between urea and BA molecules.  
 
As UBAIII has four molecules in the asymmetric unit (two urea molecules and two BA molecules) 
it has the potential to form 64 hydrogen bonds, of which 12 of these are observed in the crystal 
structure. Two high propensity hydrogen bonds are formed between urea1 and urea2 similar to those 
observed in UBAI. There are eight moderate propensity hydrogen bonds observed between urea and 
BA (four between urea1 and BA1, and four between urea2 and BA2). Note that no interactions are 
observed between urea1 and BA2, and urea2 and BA1. Additionally there are two low propensity 
hydrogen bonds observed between BA1 and BA2.  
 
The presence of the favourable urea-urea hydrogen bonding interactions which are prevalent in 
structures within the CSD and occur in UBAI and UBAIII may provide added stability to the crystal 
structures which are not present in UBAII which appears to be less prevalent as shown by results 
from small scale crystallisations discussed previously. However in order to identify if there is any 
other correlation between the likelihood of the hydrogen bonds present in each UBA polymorph and 
their physical properties further investigation is required.  
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4.5.3 Solubility Measurement 
Solubility measurements of UBAI, UBAII, UBAIII and BAII were obtained in both water and 
methanol solvent systems using a Crystal16 parallel crystalliser (Figure 4.33) from Technobis 
Crystallization Systems BV (formerly Avantium Pharmatech BV). Vials were cycled through 
temperature ranges from 20 °C to 75 °C in water and from 20 °C to 55 °C in methanol  using a 
heating rate of 0.5 °C min-1 and stirring at 800 rpm using standard (4 mm) magnetic stirrer bars. Data 
were analysed using CrystalClear software to obtain the temperature of each clear points to construct 
each solubility curve. Due to the complexity of the UBA system cloud points were not considered 
accurate representations of the supersolubility and therefore the MSZW has not been determined. 
 
Figure 4.33 The Crystal16 parallel crystalliser from Technobis Crystallization Systems BV 
(formerly Avantium Pharmatech BV) 
Figure 4.34 and Figure 4.35 show the solubility of each UBA polymorph and the BAII starting 
material for comparison. Each UBA polymorph displays increased solubility in comparison to the 
BA starting material. UBAI and UBAIII have very similar solubility in both water and methanol 
further highlighting their similarity in lattice energy and stability. UBAII is the most soluble of the 
three UBA polymorphs in water (with respect to BA content within the co-crystal), in comparison 
to BA which would indicate that this is the meta-stable polymorph which supports the evidence from 
small scale evaporative, mechano-chemical and cooling crystallisations in which UBAI was obtained 




Figure 4.34 Solubility of UBAI, UBAII, UBAIII and BA starting material in water obtained using 
the Crystal16 
 
Figure 4.35 Solubility of UBAI, UBAII, UBAIII and BA starting material in methanol obtained 
using the Crystal16 
In methanol UBAI and UBAIII again have very similar solubilities, however the relationship with 
UBAII solubility is very different to that found in water. UBAII remains more soluble than UBA I 
and UBAIII in water between 20 °C and 70 °C, but in methanol at temperatures above 37 °C the 
solubility of UBAII drops below that of UBAI and UBAIII. If UBAI and UBA III are more soluble 
 112 
at higher temperatures, under cooling crystallisation conditions UBAII may be produced first, 
however once lower temperatures are reached the formation of UBAI and UBAIII become more 
prevalent and UBAII converts to UBAI or UBAIII. Similarly the increase in solubility at high 
temperatures may be due to potential conversion in solution as UBAII has been shown to be less 
stable than the other polymorphs. Further investigation using sampling and off-line PXRD analysis 
or potentially using a non-invasive Raman probe may be able to provide more clarity on this. 
 
From a crystal engineering perspective co-crystallisation of urea with BA leads to an enhancement 
of BA solubility, although from an industrial perspective this increase is not considered significant 
and would not be reason enough alone to warrant adoption of multi-component crystallisation. 
However if coupled with other physical property enhancements it would strengthen the case. 
 
If the solubility of each polymorph is known it is possible to use the data to maintain cooling 
crystallisation conditions within the MSZ close to the solubility curve of each polymorph, a process 
known as supersaturation control. This has been used in other systems to selectively produce a 
chosen polymorph.63 For the UBA system it is very difficult to implement this process especially to 
select between UBAI and UBAIII which have very similar physical properties including solubility. 
Supersaturation control for the UBA system is doubly hindered not only by the polymorphic nature 
but also the multi-component nature of the system. It is particularly challenging to obtain 
supersolubility curves in order to determine the MSZW of a polymorphic material as there may be 
polymorphic transformation in solution and for multi-component materials the target and co-former 
are likely to dissociate in solution so upon cooling it may be either a different polymorph or one of 
the starting materials that crystallises first. 
4.5.4 Morphology 
SEM measurements were carried out on small crystals of each of the UBA forms (Figure 4.36), 
selected from preparations in which representative samples of each could be located. The samples 
were prepared by vacuum filtration and subsequent drying at room temperature. A Quorum QT 
Chrome Coater (UK) with a film thickness of 5 nm was used to coat the samples. The images were 
then obtained via use of a Hitachi TM-1000 table-top scanning electron microscope. 
 
The SEM analysis of UBA shows that the UBA polymorphs have very different morphology.  UBAI 
is very plate-like (Figure 4.36 a and b), UBAII has a crescent prism morphology and UBAIII displays 
a bipyramidal form. Agglomeration was common to all three samples analysed, in particular UBAIII 










e) f)  
  
Figure 4.36 SEM images showing the morphology of UBAI (a and b), UBAII (c and d) and UBAIII  
(e and f). 
 
The BFDH morphology tool in Mercury can be used to predict the morphology of a crystal structure 
based upon the Bravais, Friedel, Donnay and Harker (BFDH) approximation. The BFDH model is 
based on an original proposition by Bravais that the largest face of a crystal should be that 
corresponding to the largest (lowest index) interplanar spacing. This is equivalent to stating that the 
speed at which a face grows is inversely proportion to its interplanar spacing, as the area of a plane 
in the growing crystal is inversely proportional to its linear growth velocity. Originally verified as a 
legitimate approximation by Friedel, the model was extended by Donnay and Harker to include the 
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effects of lattice centring, screw axes and glide planes (which effectively reduce the interplanar 
spacings), to produce the BFDH model119.  
 
The BFDH model can make a first estimate of the crystal morphology on the basis of these simple 
rules. However this model assumes that the crystals were grown in water and it is well documented 
that solvent interactions can affect the crystal morphology. Additionally this model does not take 
into account the effects of hydrogen bonding which play a significant role in the hydrogen bonded 
networks of the UBA co-crystals. For these reasons, the morphologies observed differ significantly 
from those predicted using the BFDH morphology tool (Figure 4.37). 
 
a) b) c) 
 
Figure 4.37 Crystal morphology prediction of UBAI (a), UBAII (b) and UBAIII (c) using the BFDH 
morphology tool in Mercury. 
4.5.5 IR and Raman Spectroscopy 
IR-spectroscopy was conducted by loading a small amount of each of the UBA polymorphs onto a 
Thermoscientific Universal ATR Sampling Accessory mounted on a Thermoscientific Nicolet 6700 
FT-IR A resolution of 4 cm−1 was used with 32 scans collected (Figure 4.5) over a scan range of 
3600-600 cm−1.  
 
A ThermoFisher Scientific DXR Raman microscope equipped with 780 nm laser was used as a 
supporting tool for polymorph characterization by both spectral acquisition and imaging. Raman 
















Figure 4.38 IR and Raman spectra of UBAI (a and b), UBAII (c and d) and UBAIII (e and f). 
Comparing the IR and Raman spectra for the three UBA polymorphs shows that there are significant 
differences between these for both types of spectra. The IR spectra show particular differences in the 
hydrogen bonding region above ~3000 cm−1, as might be expected, together with differences in the 
region around 1700 cm−1, the C=O stretch region. In the Raman spectra, the latter region shows 
particularly pronounced changes, both confirming the IR findings and demonstrating the value of 
Raman in offering a very clear characteristic fingerprint for the different UBA polymorphs. This 
emphasises one of the reasons that Raman probes are often the spectroscopic method of choice in 
PAT development and exploitation.  
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4.5.6 Phase Transformations and Polymorph Stability of UBA Polymorphs 
In order to gain a better understanding of the relationships between the polymorphs of the UBA 
system each of the polymorphs were investigated using a range of solid state and solution state 
stability techniques.  
 DSC of UBAI, UBAII and UBAIII 
About 3mg of each UBA polymorph was weighed into a Tzero aluminium pan fitted with a lid. The 
pan was heated over the temperature range 50 °C to 300 °C at a constant heating rate of 10 °C per 
minute using a TA Instruments Q2000 DSC under a constant nitrogen purge. The melting points of 
the urea and BA starting materials are 133 °C and 251 °C, respectively (note BA transitions to a high 
temperature phase at 245 °C) (section 4.1.4). All temperatures and enthalpies of the thermal events 
for UBAI, UBAII and UBAIII are summarised in Table 4.8 below. 
 
Figure 4.39 DSC of UBAI from 50 °C to 300 °C at 10 °Cmin-1 
 
Figure 4.40 DSC of UBAII from 50 °C to 300 °C at 10 °Cmin-1 
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Figure 4.41 DSC of UBAIII from 50 °C to 300 °C at 10 °Cmin-1 
 
Table 4.8 Comparison of temperature and energy of thermal events observed in DSC of UBAI, 
UBAII and UBAIII  
Thermal event 
Onset temperature (°C) / ΔH (J/g) of event 
UBAI UBAII UBAIII 
a - 117 / 18 - 
b 187 / 40 188 / 5 193 / 16 
c 189 / 100 196 / 93 198 / 57 
d  192 / 59 197 / 57 199 / 57 
e 243 / 188 256 / 182 251 / 202 
 
The DSC trace of UBAII displays a low energy endothermic event (18 J/g) at 117 °C (Figure 4.40 
a), which is believed to represent a phase transition of UBAII to UBAIII (as observed in VT-PXRD 
analysis, section 4.5.6.2 below). This is not present in either UBAI or UBAIII. 
 
All three polymorphs of UBA display four other thermal events when heated from 50 °C to 300 °C 
(denoted as b to e in Figure 4.39 to Figure 4.41). The small endothermic event, b, is indicative of a 
melt prior to the large exothermic recrystallisation peak (c) that occurs at 189, 196 and 198 °C for 
UBAI, UBAII and UBAIII, respectively. This is thought to be a high temperature form of UBA to 
which all three polymorphs convert.  
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The endothermic events d and e may correspond to further high temperature phase transitions or a 
decomposition event which is shown by TGA to occur at 203 °C correlating with event d (section 
4.5.6.3 below) 
 
It should be noted that as with the solubility analysis the events within the DSC traces of UBAI and 
UBAIII occur at very similar temperatures, again highlighting the similarities in stability of these 
two polymorphs. 
 
 Variable Temperature (VT) PXRD of UBA on beamline I11 at Diamond Light Source 
As a result of the complex DSC results it was thought to be beneficial to investigate the UBA 
polymorphic material using VT-PXRD and the opportunity arose to run VT experiments on the high 
resolution diffraction beamline (I11)120 at the Diamond Light Source, UK (Figure 4.42) via which 
attempts were made to understand the phase transitions within the UBA system and to identify the 





Figure 4.42 Photo of experimental hutch on beamline I11 at Diamond Light Source 
  
MAC detectors 









Samples of each of the UBA polymorphs were prepared in 0.5 mm borosilicate capillaries and data 
were collected over a range of temperatures on the high resolution diffraction beamline (I11) (λ = 
0.825698(2) Å and 2θ zero point = -0.003209). In order to gain an overview of the thermal transitions 
present in each of the UBA polymorphs fast experiments were carried out using the PSD detector 
with a 30 second exposure at each temperature point. The temperature range of 22-202 °C was 
selected for based upon the previous DSC results, detailed above.  
 
MAC Detector Experiments 
The transitions in UBAI and UBAII samples were investigated in more detail in experiments using 
MAC detectors (Figure 4.43 and Figure 4.44, respectively). Particular attention was paid to 
temperature ranges where variation in the PXRD patterns were observed (160-195 °C for UBAI, and 
127-147 °C then 160-195 °C for UBAII) Once again the samples were mounted in 0.5 mm 
borosilicate capillaries and every 5 °C a 30 minute scan was taken. Due to the increased exposure 
time and the high intensity of synchrotron radiation the capillary was moved into the X-ray beam in 
increments of 2 mm every hour to reduce any degradation effects. 
 
Figure 4.43 VT-PXRD MAC experiment heating UBAI from 160 °C to 195 °C in 5 °C increments 
(the sample was analysed at 22 °C before and after heating) 
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Figure 4.44 VT-PXRD MAC experiment heating UBAII from 127 °C to 147 °C and from 160 °C to 
195 °C in 5 ° increments (the sample was analysed at 22 °C before heating) 
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Figure 4.45 VT-PXRD PSD experiment heating UBAIII from 22 °C to 152 °C and from 160 °C to 
195 °C in 10 °  and 2 ° increments, respectively (note that due to no changes between 22 °C and 
161 °C some patterns have been omitted) 
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The temperatures of the phase transitions observed in the VT-PXRD data is summarised in Table 
4.9 below. Both UBAI and UBAIII when heated convert to an unknown high temperature phase of 
UBA between 160 and 175 °C and this phase persists when the sample is cooled back down to room 
temperature (Figure 4.44 and Figure 4.45). Due to the loss of crystallinity at high temperature it 
proved particularly challenging to solve the unknown phase from the PXRD data collected. Further 
investigation into this will form part of the future work. UBAII when heated between 142 and 160 °C 
undergoes a phase transition to UBAIII prior to conversion to the same high temperature phase of 
UBA above 160 °C. 
 
Table 4.9 Comparison of temperatures of phase transitions observed in VT-PXRD of UBAI, UBAII 
and UBAIII 
Phase transition 
Temperature at which the phase transition is complete (°C) 
UBAI UBAII UBAIII 
UBAII → UBAI  - 127 *  - 
UBAI → UBAIII 165 160 *  - 
UBAIII → HT form 170 170 175 
*mixture of both phases are present at this temperature, transition occurred before this but no data was recorded. 
 
When comparing the results from DSC to those from VT-PXRD the trends of the phase transitions 
are found to be the same; UBAII displays a clear transition to UBAI and all samples convert to 
UBAIII prior to transformation to the uncharacterised high temperature form. However, the 
temperatures of transitions observed in DSC data are significantly higher than those observed using 
VT-PXRD (approx. 20 °C). This effect has previously been noted in the literature; it is not 
uncommon to observe significant temperature variation between DSC and VT-PXRD data121, 122 as 
it is difficult to replicate exactly the same experimental conditions across two different instruments. 
DSC uses continuous variation in temperature whereas the VT-PXRD usually uses a quasi-
isothermal method with (in this case) a 30 minute isothermal step prior to each PXRD scan. This 
allows more time for the phase transitions to occur at each temperature and would result in an 
apparently lower transition temperature being determined using VT-PXRD; this agrees with the 
trend found in the UBA experiments. In addition the geometry of the sample holders in each 
instrument are different (metal pan vs. borosilicate capillary) which will affect the heat transfer 
through the sample. This is a well know issue, and in many cases the indications from the different 
types of data are used primarily to confirm assignment of phase transitions.  However, in light of 
variation observed between DSC and VT-PXRD results Rigaku have developed a combined DSC-
XRD instrument which allows both techniques to be used simultaneously on the same sample123.  
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These findings further support the UBA polymorph relationships proposed based upon DSC analysis 
and solubility studies indicating that UBAI and UBAIII are very similar in stability and UBAII is 
the most metastable form.  
 
 TGA of UBA 
TGA measurements were carried out for each of the three UBA solid forms, with scans from room 
temperature to 300 °C for each. The TGA plots of UBAI, UBAII and UBAIII were all very similar 
showing two mass losses of 7-10%, with onset temperatures of approximately 150 °C and 200 C, 
as shown in the TGA of UBAI (Figure 4.46). In previous studies of the thermal decomposition of 
urea such as those carried out by Schaber et al.124, events have been observed at 152-190 °C and 
190-250 C which can be attributed to decomposition of urea and its thermal decomposition product 
biuret, respectively. As urea decomposes, ammonia (NH3) is evolved. With an RMM of 17.03 gmol−1 
ammonia would equate to 9% of the mass of UBA (RMM of 188.12 gmol−1) which is consistent with 
the percentage mass loss observed in the TGA plots. The second starting component BA starts to 
decompose at around 180 °C (Figure 4.47), but the mass loss is far more significant than those 
observed in the TGA of UBA, and can be discounted in the interpretation of Figure 4.46. 
 
 
Figure 4.46 TGA of UBAI (from 25 – 300 °C at 10 °Cmin−1) showing two mass loss events at 
149 °C and 203 °C  
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Figure 4.47 TGA of BAII starting material (from 25 – 300 °C at 10 °Cmin-1) showing a significant 
but incomplete decomposition event with an onset temperature of 189 C 
Following the TGA scans, the samples that had been heated to 300 °C were analysed by PXRD 
(Figure 4.48).  These confirm the interpretation of the TGA plots, with no correlation of the PXRD 
peaks in the post-TGA experiments with those of any of the starting materials or UBA polymorphs; 
the samples have decomposed. 
 
 
Figure 4.48 PXRD Patterns of UBAI, UBAII and UBAIII after TGA to 300°C (patterns h to j, 
respectively) for comparison with a) UBA I, b) UBA II, c) UBAIII, d) BA dihydrate I ,  
e) BA dihydrate II, f) BAI and g) BAII  
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Further analysis of the material using thermogravimetric mass spectrometry (TG-MS) would allow 
the gases evolved to be analysed, and confirm the interpretation that urea decomposition is being 
observed (with the loss of ammonia), or if other unidentified decomposition products are present. In 
future work on this system, more information could be gained about the chemical identity and 
stoichiometry of the high temperature crystalline material indicated in the VT-PXRD above  
~175 C, using NMR or elemental analysis, for example, which may also aid in the identification of 
the decomposition products. Importantly, the TGA has confirmed that the decomposition of UBA 
does not commence until 140 C, a temperature significantly higher than would normally be required 
for the stability of a pharmaceutical compound.  
 Stability of UBA Polymorphs in Solution 
In order to ascertain the relative stabilities of the three UBA polymorphs in water and methanol, 
slurries comprising 40 mg of UBA (either polymorph I, II or III) and 1 g of solvent (methanol or 
water) were prepared in 2 mL glass vials and stirred continuously using a 7 mm magnetic stirrer in 
the Crystal16 with temperature regulated at 20 °C. Samples were left for 96 hours and subsequently 
analysed using PXRD to identify if any changes had occurred in the solid form. 
 
Competition slurry experiments were also set up using 1:1 mixtures of UBAI with UBAII, UBAII 
with UBAIII and UBAI with UBAIII, all in methanol, to explore the relative stability of the UBA 
polymorphs during the crystallisation process. The mixtures were again analysed using PXRD, both 
before and after the slurry process. A summary of the results is given in Table 4.10 below. 
 
Table 4.10 Experimental conditions and products obtained from UBA stability and competition 
slurry experiments using the Crystal16 
Starting material Solvent 





UBA II BA dihydrate 




UBA II UBAI 
UBA III UBAIII 
UBA I and UBA II 
Methanol 
UBAI (some residual UBAII) 
UBA I and UBA III UBAI 



















Figure 4.51  PXRD patterns showing results from 1:1 competition slurries in methanol for a) 




Figure 4.52 PXRD pattern of a solution 2:1 U:BA in methanol maintained in a sealed quiescent 
beaker at 20 °C for six months 
Upon slurrying each UBA polymorph in water at 20 °C for 96 hours both UBAI, UBAII and UBAIII 
dissociated in solution and converted to BA dihydrate (Figure 4.49). When the experiment was 
repeated in methanol no BA dihydrate was produced instead UBAI remained as UBAI, UBAII 
converted to UBAI and UBAIII remained as UBA III. This indicates that at room temperature for a 
period of 96 hours Both UBAI and UBAIII are stable in methanol and the most metastable 
polymorph UBAII converts to UBAI. This corresponds with the data collected in solubility analysis, 
although the solution state transformation of UBAII → UBAI does not follow the solid state 
transition observed in the DSC analysis of UBAII which showed conversion to UBAIII.  
 
When a 1:1 mixture of UBAI and UBAII were stirred in methanol, again for 96 hours UBAII 
appeared to convert to UBAI (Figure 4.51 a) as observed previously in the individual polymorph 
experiments. In the mixture of UBAII and UBAIII PXRD analysis showed conversion to UBAIII 
(Figure 4.51 c), which also substantiates that both UBAI and UBAIII are more stable than UBAII.  
 
The most important experiment was for the mixture of UBAI and UBAIII as these polymorphs are 
particularly close in stability. PXRD analysis (Figure 4.51 b) showed that UBAI was dominant in 
the sample but there was still some UBAIII present. Perhaps if the experiment was allowed to 
continue for longer complete conversion to UBAI would be achieved.  
 
Interestingly, U:BA in a 2:1 ratio was added to methanol and left to stand at room temperature in a 
quiescent beaker for six months. PXRD analysis of the filtered sample (Figure 4.52) indicates that 
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the starting materials have converted to UBAIII, as was observed by Gryl et al. Unlike the previous 
experiments this experiment was carried out without any stirring and so at room temperature it would 
be plausible to propose that UBAIII is the most thermodynamically stable and UBAI is the most 
kinetically stable with UBAII existing as a highly metastable polymorph.  
 
Future work will involve solution stability experiments at a range of temperatures and different 
rations of UBA starting materials in order to build up a ternary phase diagram of the UBA system in 
methanol or another chosen solvent system (A.J.P. Cousen, CMAC PhD project, University of Bath). 
 
 Solid state kneading of UBA Polymorphs 
To investigate the stability of UBA solid forms with respect to pressures typical of those encountered 
in some industrial processing routes, phase pure samples of each UBA polymorph were kneaded 
with a pestle and mortar over a period of 15 minutes with the sample periodically analysed using 
PXRD to identify if and at what point a phase transition may occur.   
 
The sample of UBAII remained unchanged after fifteen minutes of kneading, however the peaks 
were not as sharp, indicating a loss of crystallinity (Figure 4.53a). It is important to note that due to 
the elusive nature of UBAII the initial sample used appeared to contain traces of UBAI, these 
remained throughout the experiment but did not increase suggesting that UBAII  UBAI conversion 
as observed in the solution state was not favourable under this form of processing.  
 
UBAIII however, converted to UBAI with a characteristic cluster of peaks at 17.5° 2θ and a strong 
peak at 29° 2θ appearing after 2 minutes of kneading which continue to increase in intensity over 
time (Figure 4.53b). The relationship between the most intense peaks of UBAIII (27.4 °2θ) and 
UBAI (28.9 °2θ) changes over the duration of the kneading experiment with the UBAI peak growing 
in throughout the kneading process. Further investigation would be required to ascertain if complete 
conversion can be achieved. This is earmarked as a future experiment on the UBA system, to be 
carried out using the more regulated mechano-chemical environment provided in a ball mill device 





Figure 4.53 Experiments to test mechanical stability of UBA co-crystals. Graphs show PXRD 
analysis at intervals (time in minutes) throughout the kneading process for (a) UBAII and (b) 
UBAIII.  
 DVS of the UBA System 
In order to identify the most suitable phase of an API or API-containing material for pharmaceutical 
development it is important to understand the behaviour of the material when exposed to moisture, 
as this may be encountered during the manufacturing process and during transportation and storage. 
If not properly managed or understood, phase transformations such as hydrate formation may occur; 
these can affect the behaviour of the material in downstream manufacturing processes and, more 











Figure 4.54 DVS profile BAII starting material for comparison with sorption characteristics of 
UBAI, UBAII and UBAIII. 
DVS analysis of the UBA co-crystals, on the other hand, shows that none of the three polymorphs 
form hydrates, nor are they hygroscopic. The mass increase observed in the DVS experiments was 
minimal, less than 0.5% for all polymorphs, and is probably due to surface interactions (Figure 4.54 
b, c and d). This indicates that through co-crystallisation of BA with urea it is possible to improve 
the humidity stability of the pharmaceutically-relevant BA component, removing the risk of hydrate 
formation during processing.  
 
 Humidity – “Ageing” Stability of UBA Solid Forms 
Samples of all three UBA polymorphs were subjected to high humidity conditions (75% RH at 
45 °C) for a period of four weeks (see Section 4.1.6 for experimental conditions), with weekly 
analysis of the materials using PXRD, in order to ascertain if there are any long term phase 




Figure 4.55 Weekly PXRD analysis of UBAI subjected to 75% RH at 45 °C for four weeks. 
 
Figure 4.56 Weekly PXRD analysis of UBAII subjected to 75% RH at 45 °C for four weeks. 
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Figure 4.57 Weekly PXRD analysis of UBAIII subjected to 75% RH at 45 °C for four weeks. 
PXRD analysis shows that over a period of four weeks under high humidity conditions the 
polymorphic form of UBAI, UBAII and UBAIII is maintained, with no growth of new peaks or 
disappearance of peaks present in the initial sample (Figure 4.55 to Figure 4.57). In all samples there 
is a noticeable loss of crystallinity especially in UBAII and UBAIII where peak broadening and loss 




4.6 Conclusions – U-BA-UBA Phase Relationships 
This chapter has explored the variation in UBA solid form produced through a range of batch 
crystallisation methods, and has also investigated the factors that can influence the solid forms 
adopted.  Among these, experiments were undertaken to investigate if the initial polymorph of BA 
(a known polymorphic material) used had any impact upon the polymorph of UBA produced. The 
solid form of BA from three different suppliers were analysed prior to crystallisation experiments 
and solid state analysis identified that BA from two suppliers (Sigma Aldrich and Acros Organics) 
adopted the BAII polymorph, while that supplied by TCI was found to be BAIII. Both BAII from 
Sigma Aldrich and BAIII from TCI were subsequently used as starting materials in the small scale 
cooling crystallisation DoE investigation. Results from the DoE indicated that there was no 
correlation between the polymorph of BA used and the UBA polymorph produced.  
 
Evaporative crystallisation experiments used to replicate those carried out by Gryl et al produced a 
mixture of UBA polymorphs and residual starting material. There appeared to be some indication of 
a possible relationship between the solvent used (either ethanol or methanol) and the prevalence of 
the UBA polymorph produced, with crystallisation from ethanol producing predominantly UBAI, 
while from methanol predominantly UBAIII resulted. The elusive metastable UBAII polymorph was 
only identified in one experiment (via evaporation from methanol of a 1:2 ratio of U:BA at 50 °C). 
The use of different solvents will affect evaporation not only through differing solubility and 
supersaturation, but also the rate of supersaturation due to the differences in solvent volatility. While 
methanol was chosen as the solvent to be used to investigate the cooling crystallisation of UBA in 
this research, future work using different solvents would allow investigation into whether cooling 
crystallisation from ethanol or other solvents may favour crystallisation of alternative UBA 
polymorphs. 
   
A range of other crystallisation methods were also used to investigate further the potential for 
selectivity in generating UBA polymorphs, and in helping to design processes that could be 
transferred into continuous crystallisation. Mechano-crystallisation of UBA using dry and liquid 
assisted techniques with a range of solvents yielded mixtures of UBAI with residual starting 
materials. The studies found that mechano-crystallisation in the presence of water produced UBAI 
with additional unwanted BA hydrate. To reduce the likelihood of this hydrate, the addition of 
methanol, ethanol or IPA was investigated; using a 1:1 ratio of U:BA combined with a few drops of 
any of these solvents produced pure UBAI. This represents a facile route to formation of phase pure 
UBAI on the small scale which could be used in future to produce seeds for UBAI-selective seeded 
cooling crystallisation. In addition it may be possible to investigate mechano-crystallisation of UBA 
in continuous operation using equipment such as a twin screw extruder. 
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DoE (with a 24 fractional factorial design) of batch cooling crystallisation using the CRD Polar Bear 
Plus highlighted that within the design space investigated there was little correlation between the 
experimental conditions investigated and the polymorphic form of UBA isolated. The conditions 
varied included solution concentration, ratio of urea to BA starting materials, BA starting material 
polymorphic form, order of addition of starting materials, stirring speed and cooling regime. Of the 
24 experiments, the majority produced UBAI under a variety of experimental conditions. Pure 
UBAIII was isolated in a single experiment which was not reproducible and five experiments 
produced mixtures of UBAI and UBAIII, within which the only similarity was that BAIII starting 
material was used, but this was not exclusive to these experiments. UBAII was not observed under 
the conditions explored. Future investigations to be carried out in the Bath CMAC research group 
will use a modified design space to see if UBAII and UBAIII can be obtained reproducibly. 
 
All small scale crystallisation experiments highlighted that formation of UBAI was generally 
dominant but was often produced in a mixture with UBAIII. UBAII has proved elusive through all 
crystallisation methods, produced only in one evaporative crystallisation experiment; this supports 
the conclusion that this form is metastable or suggests that that there is a high energy barrier for 
conversion to UBAII from both UBAI and UBAIII. Fortunately UBAII was isolated later through 
cooling crystallisation (under conditions detailed in Chapter 5) allowing solid state analysis and 
polymorph stability testing to be performed. 
 
The preparation of the UBA polymorphs was augmented by characterisation of their physical 
properties and phase transition behaviour. Turbidimetric solubility measurements of each UBA 
polymorph (in both water and methanol) indicated that all three polymorphs exhibited improved 
solubility (when calculated in terms of the concentration of BA delivered into solution) in 
comparison to the BA starting material although it would not be sufficiently significant to warrant 
the use of UBA over BA from a pharmaceutical perspective. The solubility measurements 
highlighted that in methanol and in water UBAI and UBAIII exhibit nearly identical solubility, 
supporting their similarity in energy, while in water UBAII is more soluble than UBAI and UBAIII; 
this substantiates the hypothesis that UBAII is metastable and difficult to isolate. Interestingly, unlike 
in water, the solubility of UBAII in methanol falls below that of UBAI and UBAIII at temperatures 
above 40 °C. This may be as a result of dissociation of urea and BA at higher temperatures, resulting 
in precipitation of less soluble BA; the turbidimetric methods employed do not allow for 
discrimination of the precipitate. 
 
DSC and VT-PXRD indicate a phase transition from UBAII to UBAI between 140-170 °C and this 
conversion is also seen in solution in slurries of UBAII and mixtures of UBAI and UBAII in 
methanol. VT-PXRD studies of UBAI show mixtures of UBAI and UBAIII to be present at around 
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160-165 °C prior to conversion to an uncharacterised high temperature phase at 170-190 °C; the 
presence of UBAII at 160-165 C would indicate that there is conversion from UBAI to UBAIII. 
UBAI is not present in the VT-PXRD patterns determined on heating UBAIII, which remain 
consistently representative of UBAIII until conversion to the same uncharacterised high temperature 
form occurs at 170-190 °C. The conversion from UBAI to UBAIII is only observed in solid state 
thermal studies such as VT-PXRD and not in solution state slurry experiments or mechanical stability 
testing where the converse is observed with transitions from UBAIII to UBAI. The thermally induced 
UBAI to UBAIII transition requires further investigation using DSC with temperature cycling 
combined with PXRD or analysis using a coupled XRD-DSC instrument to fully characterise this 
transition. In addition UBAIII was produced when U and BA were initially slurried in methanol and 
were subsequently left to rest in a quiescent beaker for over six months.  
 
 
Figure 4.58 Schematic of crystallisation of UBAI, UBAII and UBAIII and the relationship between 
the UBA polymorphs and with the BA starting material. 
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Figure 4.58 summarises the relationships between the polymorphs of UBA discussed above, together 
with their relation to the solid forms of the BA starting material that were discovered from literature 
sources and from characterisation experiments detailed in this chapter. This diagram also includes 
the conditions under which each phase is formed, or under which the phase transformations occur. 
 
It can be concluded is that UBAII is the least stable polymorph, although once obtained it remains 
stable against conversion at ambient conditions (as illustrated in Figure 4.59 a and b). The 
interconversion from UBAI to UBAIII and UBAIII to UBAI under different conditions and the 
difficulties encountered in separating these polymorphs via selective crystallisation makes it 
challenging to conclude which of UBAI and UBAIII is most stable (Figure 4.59 c).  
 
 
Figure 4.59 Schematic highlighting the energetic relationship between the UBA polymorphs 
deduced from the work carried out here, showing the similarity in energies between UBAI and 
UBAII, the highly metastable nature of UBAII, and the barriers to conversion that are evident 
between the polymorphs. 
UBAI is the most prevalent polymorph under the solution state conditions encountered in cooling 
crystallisation; UBAI was thus chosen as the initial target polymorph in scale up to continuous 
crystallisation described below, in Chapters 5 and 6. 
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5 Scaling-up Batch Cooling Crystallisation of UBA and 
Transfer to MSMPR 
5.1 Batch Cooling Crystallisation on a 500 mL Scale 
5.1.1 Introduction 
In order to transfer UBA crystallisation into the continuous platform offered by the mixed-
suspension mixed-product removal (MSMPR) set-up at Loughborough, it is necessary to establish a 
cooling crystallisation route and to ensure that this scales to the volumes used in the MSPMR device. 
These experiments were carried out at Loughborough, where access to appropriately scaled batch 
vessels (STR) was readily available. This section notes the successful establishment of UBA cooling 
crystallisation at volumes up to 500 mL, with analysis of the range of solid forms produced in these. 
5.1.2 Aim 
As the majority of continuous crystallisation platforms operate via cooling crystallisation it is 
necessary to translate the evaporative crystallisation of UBA into a cooling crystallisation 
environment as a first step to developing a continuous process for this system. This was first carried 
out on the small scale (100 mL) to investigate the effect of the stoichiometry of the starting materials 
on yield of co-crystals of (1:1) UBA, and the effect of cooling rates on the selectivity for different 
UBA solid forms. The scale of these experiments was then increased within the context of the first 
stage 500 mL STR within the MSMPR platform.  
5.1.3 Materials 
BA starting material was obtained from three suppliers; BA 98% pure Tokyo Chemical Industries 
(TCI), BA 98% pure Sigma Aldrich (SA) and BA 98% pure Acros Organics (AO) (linked to Fisher 
Scientific). The BA polymorphic form in the commercial materials was not indicated by the 
suppliers.  
5.1.4 Method 
Two different methods of batch crystallisation were used; the first where both the urea and BA 
components were dissolved together in the 2:1 molar ratio (U: BA) and then subjected to the 
respective cooling profile and the second in which one molar equivalent of BA was dissolved 
completely in 500 mL methanol at 43 °C to which two molar equivalents of urea solids were added 
directly. The urea was allowed to dissolve and the solution was cooled and held at several 
temperatures (40, 30, 25 and 5 °C). 
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5.1.5 Results and Discussion 
Experiments carried out using method 1 were initially monitored using a thermocouple, an FBRM 
probe and a Raman Probe, Method 2 was monitored using a Raman Probe. The FBRM counts and 
temperature profiles of experiments using method 1 are shown below in Figure 5.1 indicating the 
detectable onset of crystallisation. The in-situ Raman measurements were later shown to be 
unreliable in identifying the polymorphic state of crystals in suspension due to fouling on the Raman 
probes and so were only used as a qualitative indicator of solid form production (Figure 5.2). PXRD 
used as the prime method for identification of the solid forms produced in each experiment. 
 







Figure 5.1 Temperature profiles (in red) used to obtain different polymorphic forms of UBA  
(a) UBAI, 0.5 °Cmin-1 (b) UBAII, 1 °Cmin-1 to 35 °C then 0.05 °Cmin-1 to 10 °C  
(c) UBAIII, 0.05 °Cmin-1. Total particle counts (in blue) were monitored using an FBRM probe.  
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It was discovered that within the STR environment cooling rates of 1-2 °Cmin-1 could be used to 
obtain UBAI, but to obtain UBAIII a much slower cooling rate of 0.05 °Cmin-1 was required (see 
Figure 5.1). This would indicate that UBAIII is the most thermodynamically stable form which 
agrees with original theories proposed by Gryl et al. However, under certain kinetic conditions it is 
possible to favour production of UBAI. The metastable form UBAII, on the other hand, proved 
elusive and very difficult to isolate. Only a single experiment in the STR, using a two-step cooling 
profile of 43 °C to to 35 °C  at 1 °Cmin-1 followed by slow cooling to 10 °C at 0.05 °Cmin-1, produced 
UBAII. Some traces of UBAI were also present. 
 
Method 2: When using the separate dissolution method, in which urea is added after the dissolution 
of BA, all crystallisations yielded UBAI. Across the trials conducted using this method, the only 
significant variation was in the induction times for crystallisation, which ranged from over 9 hours 
when the solutions were held at 40 °C to under a minute when the solution was cooled to 5 °C. 
 
In-situ Analysis 
IR analysis was ruled out for in-line PAT due to the strong signal from the methanol solvent. Raman 
analysis was used to test the possibility of identifying the UBA polymorphic form produced from 
solution. The signals from experiments used to produce each of the UBA polymorphs did show 
significantly different Raman signals (Figure 5.2). Further evaluation of the signals using Principal 
Component Analysis (PCA), performed by Dr A. Saleemi (University of Loughborough, now at 
GSK, Stevenage), identified three key clusters which correspond to each of the UBA polymorphs 
(Figure 5.3). As a result in situ Raman spectroscopy was considered a useful technique in monitoring 
cooling crystallisation of the UBA system. However, it was later discovered that these signals were 
attributable to solid state signals from fouling of UBA crystals on the optical window of the Raman 
probe. 
 
Figure 5.2 Raman spectra of UBAI, UBAII and UBAIII obtained in situ during three different 
experiments in which the respective polymorphs were isolated. These are qualitative 
measurements showing the formation of the three UBA solid forms; the signals were later 
found to be hampered by fouling of the respective polymorphs on the probe. 
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Figure 5.3 Three clusters identified in a first and second principal component plot from in-situ 
Raman spectra (qualitatively, this confirmed the production of all three UBA forms, but later 
these measurements were found to suffer from fouling of the probe) 
 
5.2 UBA Crystallisation Through MSMPR  
5.2.1 Introduction 
This study is a collaborative effort within CMAC, building upon the knowledge obtained on the BA 
co-crystal system in the Department of Chemistry at the University of Bath (Chapter 4) and the 
understanding of MSMPR and the mode of continuous periodic operation as developed by Powell 
and co-workers in the Department of Chemical Engineering at Loughborough University (LU)125.  
 
Continuous mixed suspension mixed product removal (CMSMPR), as termed by Randolph et al. in 
1988 126, 127, is a form of continuous crystallisation that involves a continuous input of reactants to a 
single STR and a constant withdrawal of product, balancing the flow rates to maintain the working 
volume of the STR. The objective is to achieve a steady state which will be reached after a short 
period of operation, and which will help to attain regular crystal properties such as CSD and 
polymorphic form.128 
 
This definition focuses upon a single STR, however several STRs can be connected in series adding 
more flexibility to the continuous crystallisation through which cooling profiles can be introduced. 
There are several studies in the literature that use two or more STRs in conventional CMSMPR 
crystallisation.79, 129-134 
 
As an alternative approach, the work presented here introduces the unorthodox method of continuous 
periodic operation of MSMPR (PMSMPR)127, 135. PMSMPR, as with the more traditional continuous 
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MSMPR methods, couples the addition and withdrawal processes to maintain a constant working 
volume, but it operates at much higher flow rates which are cyclically interrupted by regular hold 
periods. This offers a range of operational advantages in that the higher flow rates help to prevent 
sedimentation and encrustation within the transfer lines136, and PMSMPR offers access to longer 
residence times, particularly useful for slow growing systems or when trying to isolate a 
thermodynamic polymorph.  
 
Key to the operation of PMSMPR is the concept of a “state of controlled operation” (SCO), which 
has been introduced as a means of characterisation of continuous periodic operation. In contrast to 
the established theory of “steady-state operation”, SCO describes a system that experiences 
perturbations in its conditions due to controlled periodic operation yet still sustains a stable state of 
operation within a range of operation limits i.e. an oscillating steady state125. The PMSMPR 
crystalliser employed here was configured and operated as a three-stage cascade in order to allow 
the selective isolations of the polymorphic forms of the UBA co-crystal system. 
 
The work presented here also examines the application of an integrated PAT array based on Raman 
and ATR-UV/vis, used to track changes in the solution phase, and FBRM and PVM, used to track 
the changes in solid phase. An in-house (CMAC-LU) developed commercial crystallisation process 
informatics system software tool, CryPRINS137, was also used for real-time monitoring and 
implementation of the temperature control policy during the periodic flow crystallisation of UBA in 
a PMSMPR. 
 
The results discussed below provide evidence that the proposed PMSMPR cascade system, with a 
suitably designed dissolution stage, can provide a platform for the consistent production of the 
desired polymorphic form of the model UBA co-crystal system, significantly decreasing product 
variability compared to the batch operation. 
 
Following this work, the production of UBA solid forms was also carried out using a second MSMPR 
platform, made available to the author while on secondment to AstraZeneca, Macclesfield (AZ). 
These results are also presented below. 
 
The value of this study, and of the development of the MSMPR-based approaches for continuous 
crystallisation, is very relevant to the key interest of the pharmaceuticals and fine chemicals 
industries in moving from batch to continuous. One of the great benefits of this type of crystallisation 
platform is that in many ways it is a hybrid between batch and continuous approaches.  The STR 
elements of the MSMPR platforms use current industrial crystallizer technology, potentially 
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lowering the barrier to their adoption as continuous manufacturing systems in comparison to plug 
flow crystallisers. 
 
Partly as a consequence of their being rooted in STR technology, there has been a significant increase 
in the use of MSMPR cascades over the past few years79, 129, 131, 134. The hybrid nature of the 
continuous MSMPR cascade means that it has two different types of mixing.  Within the STR there 
is mixing with a wide residence time distribution, while within the transfer tubes the system delivers 
mixing with a narrow residence time distribution, as in a plug flow reactor130. 
 
However, in spite of these analogies, the de-supersaturation within an MSMPR cascade is very 
different to that of either a batch STR or a plug flow crystalliser (PFC); this has the advantage of 
potentially offering access to otherwise unattainable polymorphs (Figure 5.4). With respect to this 
element of polymorph selectivity, it has been noted that within MSMPR cascades the kinetic factors 
play an increased role in the polymorphic outcome130.  
 
 
Figure 5.4 Desupersaturation in a PFC or batch cooled crystalliser (shown in red) and in an 
MSMPR system (discrete points).  
5.2.2 Aim 
This work explores multi-component crystallisation of UBA within the MSMPR crystalliser. The 
aim is to investigate what effect the continuous and periodic operation of the MSMPR apparatus has 
upon the polymorph of the UBA co-crystals produced and if there is a method by which a single 
UBA polymorph can be preferentially produced. The main focus is to isolate either UBAI or UBAIII; 
this is a challenge as they are very similar in energy and display very similar solubility profiles 
(section 4.5.2). This has been tested in two different MSMPR set-ups, one with peristaltic transfer 
(at LU) and the other with vacuum line transfer (at AZ).  
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5.2.3 Three-stage Continuous MSMPR with Peristaltic Pump Transfer 
 Materials 
All cooling co-crystallisation experiments using MSMPR with peristaltic pump transfer were carried 
out using urea (99% pure), purchased from Sigma Aldrich UK, BA II (99% pure, purchased from 
Fisher Scientific UK; sourced from Acros Organics), and methanol solvent (analytical reagent grade, 
99.97% purchased from Fisher Scientific UK).  
 
 Method 
The three-stage continuous PMSMPR (Figure 5.5, Figure 5.6, Figure 5.7) comprises three 500 mL 
jacketed STRs (one nucleator (Nuc), two growth (GV) vessels), each fitted with a PTFE lid and a 
PTFE four-pitched blade impeller with overhead motor. All STRs are temperature controlled using 
separate thermofluid bath circulators regulated using a feedback control mechanism operated 
through the CryPRINS software137. In order to maintain a good suspension each STR was operated 
at a stirring speed of 450 rpm which was identified in preliminary experiments as striking a good 
balance between the best mixing conditions for effective crystal suspension and preventing 
formation of bubbles. To transfer the suspension from the Nuc to growth vessel 1 (GV1) two, glass 
dip-tubes (5 mm ID) were fitted into each vessel with the openings positioned a few centimetres 
clear of the impeller to ensure the transferred suspension is optimally dispersed. This was repeated 
for transfer between GV1 and GV2. The dip-tubes in neighbouring vessels were connected using 
Masterflex® L/S 16 platinum cured silicone tubing (3.1 mm ID), with each transfer line fitted to a 
Masterflex® L/S digital peristaltic pump (with EasyLoad head) set to operate in time dispense mode.  
The final transfer line exiting GV2 was pumped directly into a Buchner vacuum filter where the solid 
was washed, dried and removed. 
 
 
Figure 5.5 Photograph of the MSMPR set-up (from left-feed vessel, nucleator and growth 
vessels 1 and 2) used in experiments carried out within CMAC at Loughborough University (LU).   
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The apparatus was set up with one of two different feed configurations (combined and separate). The 
only difference between the combined and separate configurations is the way in which the starting 
materials are introduced into the cascade of STRs. The combined configuration (Figure 5.6) features 
a single feed vessel (6 L jacketed STR) with urea and BA starting materials dissolved together prior 
to pumping into the nucleator vessel. The separate configuration (Figure 5.7) contains separate urea 
and BA feed vessels (a 1 L jacketed STR and a 6 L jacketed STR, respectively), the contents of 
which are first introduced together in the Nuc.  
 
 
Figure 5.6 Schematic showing combined UBA feed configuration of MSMPR set-up at LU. 
 
Figure 5.7 Schematic showing separate U and BA feed configuration of MSMPR set-up at LU. 
Four methods of operation (MOs) were used for MSMPR experiments with peristaltic transfer  
(Table 5.1). MO1 uses the combined urea and BA feed configuration, while MO2 uses simultaneous 
urea and BA addition from separate feeds. MO3 also uses simultaneous urea and BA addition but 
decouples the first addition of urea and BA; for the first addition the full volume of BA is primed 
into the Nuc and the full volume of urea (74 mL of 0.078 g urea/ g methanol) is added in one quantity 
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directly from a beaker, which when added to the BA solution that has pumped into the nucleator 
produces a 2:1 urea: BA solution. Finally, MO4 is a continuously operated version of MO2. 
For all experiments a fixed working volume of 400 mL was used and the peristaltic pumps were 
operated in time dispense mode whereby a fixed volume of solution is pumped across in a set time 
period. For Methods 1-3 400 mL of 2:1 urea: BA feed solution was transferred into the Nuc using 
pump 1 at 52.72 g/min taking 7.4 minutes. For MO1, MO2 and MO3 the solution was held 
subsequently in the nucleator (Nuc.) for 12.6 minutes prior to transfer to GV1 using pump 2 at  
52.72 g/min. Pump 1 restarts at the same time as pump 2 to replenish the UBA solution in the Nuc 
as it is transferred into GV1. Efficient mixing is required in each vessel to ensure that the solution 
pumped from each vessel is representative of the bulk. The residence time of each particle will not 
be exactly the same within the PMSMPR as it is not guaranteed that an older particle will be 
withdrawn and transferred to the next vessel before a younger particle. This is known as residence 
time distribution (RTD) and the theory is to keep the RTD as narrow as possible to regulate the 
physical attributes of the particles.  
Once 400 mL has been transferred, pumps 1 and 2 then stop simultaneously for 12.6 minutes to allow 
the solution environment to equilibrate. Pump 3 is coupled with the operation of pumps 1 and 2 and 
begins to transfer solution into GV2 whilst GV1 is replenished from the Nuc which in turn is 
replenished from the feed vessel. After another hold period of 12.6 minutes in all three vessels, pump 
4 can begin to pump from GV2 into a filtration unit where the UBA solid is isolated. The process 
described here represents one residence time of the PMSMPR; this can be repeated continuously as 
required. It often takes several residence times before a continuous system reaches a steady state of 
operation, or in the case of periodic MSMPR mode, a state of controlled operation. 
In MO4 the system is operated continuously rather than periodically the conditions remain the same 
except that the 12.6 minute hold periods are removed, reducing the total time in each vessel from 20 
minutes down to 7.4 minutes and the residence time for the whole crystalliser reduces from 60 
minutes to 22.2 minutes. 
Table 5.1 Experimental conditions used for each method of operation (MO)  
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The temperatures of the cascade of vessels used in the PMSMPR experiments were altered aiming 
to obtain either pure UBAI or UBAIII, based on the preliminary results from batch and semi-batch 
UBA co-crystallisation reported above. The experimental conditions used in each of the nine UBA 
PMSMPR crystallisations with peristaltic transfer are given in Table 5.2.  
 
Experiments LU6 to LU9 were seeded with either UBAI or UBA II obtained from previous batch 
cooling crystallisation experiments; seeds were introduced prior to delivery of the combined solution 
(method 1) into the Nuc. The UBA concentration of the feed solutions used in seeded experiments 
was kept the same as in previous unseeded experiments. The solutions were prepared at 55 °C and 
cooled to 43 °C before seeding with the desired UBA co-crystal (10% of the theoretical mass of 
UBA (1:1 ratio of U:BA) present in solution). The UBA seed suspension was left to mature at the 
saturation temperature (43 °C) for 30 min before commencing the periodic operation. Subsequently 
the seed suspension was pumped to the Nuc vessel of the PMSMPR at a rate of 52.7 gmin-1 for all 
experiments, except for LU6. LU6 used a flow rate of 41.7 gmin-1, but upon visual inspection particle 
settling was observed in the transfer lines at this lower flow rate. All subsequent experiments were 
thus carried out with the higher flow rate of 52.7 gmin-1 which helped to overcome this issue. 
 
Table 5.2 Experimental conditions for crystallisation of UBA through PMSMPR using peristaltic 
transfer 
Expt. MO Seed 
Temperature (°C) 
Nuc. GV1 GV2 
LU1 1 N/A 20 30 10 
LU2 2 N/A 20 30 20 
LU3 3 N/A 20 30 20 
LU4 3 N/A 15 10 5 
LU5 4 N/A 20 30 20 
LU6 1 UBAI 27 17 10 
LU7 1 UBAI 33 23 10 
LU8 1 UBAIII 20 20 10 
LU9 1 UBAIII 35 30 25 
 
 In-line Analysis – Process Analytical Technologies (PAT) 
FBRM 
In-situ focused beam reflectance measurement (FBRM), using Mettler Toledo model D600, was 
used for nucleation and dissolution detection and for monitoring the PSD in solution. 
 
Raman 
An RXN1 Raman system from Kaiser Optical Inc. (785 nm laser) with immersion probe was used 
in attempts to implement in-situ polymorphism monitoring. 
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ATR-UV/vis 
UV/vis measurements were collected using a Hellma 661.822 ATR probe connected to a Carl Zeiss 
MCS621 UV/vis spectrometer. 
 
Video-microscopy 
Images of the crystals in solution were captured using Metler Toledo Process and Vison 
Measurement (PVM) probe.  
 
All PAT probes and thermocouples were inserted just a few centimetres above the impeller in each 
vessel to ensure optimum process monitoring and temperature control. 
 
 Off-line Analysis 
Particle Size Measurement 
A Malvern MasterSizer® 2000 instrument fitted with Hydro SM dispersion unit was used for particle 
size analysis by laser diffraction. Filtered and dried crystalline samples were dispersed in IPA  
(pre-cooled to 0 °C) and introduced into the flow cell of the Mastersizer® unit via a circulation system 
for measurement. Three representative measurements of each sample were performed and the 
average value reported. 
 
Raman Spectroscopy 
A Thermofisher Scientific DXR Raman microscope equipped with 780 nm laser was used as a 
supporting tool for polymorph characterisation by both spectral acquisition and imaging. The Raman 
microscope was fitted with an Olympus TH4-200 optical component which was used for image 
analysis.  
 
Methanol has particularly significant Raman activity (Figure 5.8 a) and this coupled with a 
particularly low UBA concentration owing to the poor solubility of BA in methanol, meant that it 
proved challenging to detect UBA in solution (Figure 5.8 c). Shortly after nucleation occurred there 
was a significant increase in the intensity of the Raman signal which upon further inspection was as 
a result of fouling on the Raman probe (Figure 5.8 d and e). The signal reverted to the normal solution 




Figure 5.8 Signals from in situ Raman probes in a) methanol, b) urea in methanol, c) urea and 
BA in methanol for comparison with signals obtained d) 5 minutes and e) 8 minutes after UBA 
nucleation was detected.   
PXRD 
Solid products from all MSMPR runs were analysed by PXRD using a Bruker D8 Advance equipped 
with monochromated Cu Kα radiation (λ=1.54056 Å) at 298 K in flat plate mode in reflection 
geometry. The samples were pressed onto a 1 cm square glass slide which was mounted on a 
magnetically held rotating sample holder.  
 
 Results 
The XRPD patterns of the dried, filtered products of runs LU1-LU5 are given in Figure 5.9-Figure 
5.13, with the corresponding Raman spectra on samples extracted from GV2 given in Figure 5.14.  





Figure 5.9 PXRD analysis of samples from Experiment LU1 of UBA continuous crystallisation 
using peristaltic transfer. 
 
Figure 5.10 PXRD analysis of samples from Experiment LU2 of UBA continuous crystallisation 
using peristaltic transfer. 
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Figure 5.11 PXRD analysis of samples from Experiment LU3 of UBA continuous crystallisation 
using peristaltic transfer 
 
Figure 5.12 PXRD analysis of samples from Experiment LU4 of UBA continuous crystallisation 
using peristaltic transfer 
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Figure 5.13 PXRD analysis of samples from Experiment LU5 of UBA continuous crystallisation 
using peristaltic transfer 
 
The presence of UBAI and UBAIII in a sample can be identified by two characteristic peaks present 
at 27° and 29° 2θ, which are unique peaks in the patterns of UBAIII and UBAI, respectively. The 
PXRD patterns indicate clearly the polymorphic composition in each stage of the PMSMPR and 
highlight the changes in polymorphic composition over time. In experiments LU1 and LU2 a mixture 
of UBAI and UBAIII is initially produced (Figure 5.9 and Figure 5.10). As the PMSMPR run 
progresses the peak at 27° 2θ reduces in intensity indicating a reduction in UBAIII and in LU3 the 
peak disappears completely with only UBA I in NUC sample 5 taken at 150 minutes into operation 
(Figure 5.11). PXRD analysis of samples from LU4 and LU5 indicates that there is no UBAIII 
present throughout these experiments, preferentially producing UBAI (Figure 5.12 and Figure 5.13). 
Raman spectroscopy of samples 1 and 10 from GV2 for each experiment indicates conversion from 





Figure 5.14 Raman spectra of sample 1 and 10 taken from GV2 for experiments LU1 to LU5 for 
comparison with the Raman spectra for UBAI and UBAIII 
Experiments LU6 and LU7 were seeded with UBAI. PXRD and Raman analysis of samples 1 and 
10 from GV2 of experiments LU6 and LU7 indicate that UBAI was preferentially produced 
throughout the crystallisation process (Figure 5.15, Figure 5.16 and Figure 5.19). On the other hand 
experiments LU8 an LU9 were seeded with UBAIII. Products from LU8 and LU9 are dominated by 
UBAIII as would be expected when seeding with UBAIII however there is some indication of UBAI 
in the PXRD patterns of samples 1 and 10 (Figure 5.17 and Figure 5.18) although Raman analysis 
indicates sample 1 and 10 of LU8 are both UBAIII and that LU9 converts to UBAI (Figure 5.19). 
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Figure 5.15 PXRD analysis of samples from Experiment LU6 of UBA continuous crystallisation 
using peristaltic transfer. 
 
Figure 5.16 PXRD analysis of samples from Experiment LU7 of UBA continuous crystallisation 
using peristaltic transfer. 
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Figure 5.17 PXRD analysis of samples from Experiment LU8 of UBA continuous crystallisation 
using peristaltic transfer. 
 
Figure 5.18 PXRD analysis of samples from Experiment LU9 of UBA continuous crystallisation 
using peristaltic transfer. 
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Figure 5.19 Raman spectra of sample 1 and 10 taken from GV2 for experiments LU6 to LU9 for 
comparison with the Raman spectra for UBAI and UBAIII. 
A summary of the crystallisation conditions and the results from Raman and PXRD analysis are 
given in Table 5.3. 
 
Table 5.3 Summary of UBA polymorphs identified using PXRD and Raman microscopy for 
MSMPR experiments LU1 to LU9 
Expt. MO Seed Temp. (°C) Product (PXRD) Product (Raman) 
LU1 1 N/A 20/30/10 UBAI & UBAIII UBAI & UBAIII 
LU2 2 N/A 20/30/20 UBAI & UBAIII UBAI & UBAIII 
LU3 3 N/A 20/30/20 UBAI UBAI & UBAIII 
LU4 3 N/A 15/10/5 UBAI UBAI & UBAIII 
LU5 4 N/A 20/30/20 UBAI UBAI & UBAIII 
LU6 1 UBAI 27/17/10 UBAI UBAI 
LU7 1 UBAI 33/23/10 UBAI UBAI 
LU8 1 UBAIII 20/20/10 UBAIII & UBAI UBAIII 




In this study at LU, pure UBAI was successfully isolated using seeded PMSMPR (LU6 and LU7), 
but isolation of pure UBAIII remained elusive (even with seeding) and there was no evidence of the 
highly metastable UBAII. The periodic flow PMSMPR process shows potential as operating strategy 
for polymorphs selective industrial crystallisation as it provides a different operating trajectory 
through the phase diagram compared to batch and continuous processes. The PMSMPR is 
particularly useful for slower-growing systems such as UBA that require long mean residence times 
to produce large crystals. The increased residence time in each vessel can also be used to alleviate 
common problems such as fouling, encrustation and blockage that are often observed in conventional 
continuous MSMPR operations normally due to lower velocities in transfer lines. 
5.2.4 Three-stage Continuous MSMPR with Vacuum Line Transfer 
 Materials 
In all cooling co-crystallisation experiments using MSMPR with vacuum line transfer the materials 
were urea (99% pure), purchased from Sigma Aldrich UK, BA (form II) was sourced from Sigma 
Aldrich (99% pure) and methanol (Laboratory reagent grade) purchase from Fisher were used. 
 
 Method 
In contrast to the peristaltic pump operated transfer used in the PMSMPR set-up at LU the continuous 
MSMPR set-up used at AZ (Macclesfield) was operated using vacuum transfer (Figure 5.21).  
 
Figure 5.20 Photograph showing the set-up of vessels used in UBA MSMPR experiments at 
AstraZeneca, Macclesfield.  
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Figure 5.21 Schematic showing MSMPR set up used in experiments at AstraZeneca, Macclesfield 
with a separate urea and BA feed. 
As per the separate configuration used at LU, two separate feed vessels were used for urea and BA 
(a 500 mL Duran bottle and a 2 L Duran bottle, respectively) which were pumped into the nucleator 
vessel using Masterflex® L/S digital peristaltic pumps fitted with a PTFE pump head and PTFE 
connector with Masterflex® L/S 16 norprene tubing (3.1 mm ID) (Note that the choice of pump head 
was not specific to the process and chosen solely due to availability of pumps). 
 
The nucleator (Nuc), growth vessel 1 (GV1) and growth vessel 2 (GV2) (three jacketed STRs, 
500 mL, 250 mL and 1 L, respectively) were fitted with a glass lids with four ground glass necks, a 
stainless steel three-retreat curve impeller and an overhead motor. The vessels were connected using 
PTFE transfer lines (5 mm ID) fitted into the lids using Quickfit® ground glass adaptors to ensure a 
good seal to maintain the vacuum, with the final vessel connected to the vacuum system. All three 
vessels were temperature regulated using separate thermofluid bath circulators. 
 
During the experiments presented above using peristaltic transfer (section 5.2.3), the residence time 
in each vessel was controlled by the flow rate of suspension entering and exiting the vessel as 
determined by the rate of the coupled peristaltic pumps. This allowed the transfer tubes to be 
positioned just above the impeller where the solid suspension would have the best dispersion. 
However when operating with vacuum transfer, it is not possible to fine tune the suction from the 
vacuum to achieve the slow flow rate required for continuous MSMPR experiments. Instead, the 
residence time inside each vessel is governed by the position of the transfer tube opening which 
controls the fill level and working volume within the vessel. The opening of the transfer tube exiting 
each vessel was positioned at the surface of the working volume of the vessel, in order that the flow 
rate of the feedstock into the Nuc (controlled using peristaltic pumps) will increase the fill level at a 
controlled rate and regulate the transfer into the next vessel. All transfer tubes entering the vessels 
were positioned a few centimetres above the working volume surface for two reasons: to minimise 
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any splashing up the sides of the vessels, and to ensure flows were not hampered during liquid 
transfer; the flow rate used is not sufficient to allow liquid to flow through the liquid already in the 
vessel. The vacuum line operates all transfer lines simultaneously which automatically couples the 
flow from each vessel to the next. This eliminates the need for peristaltic pumps with a time dispense 
mode and the difficulties that would be faced with coupling the pumps. 
 
All experiments used a separate urea and BA feed of 0.014 g/g MeOH and 0.015 g/g MeOH, respectively. 
Due to the analogue nature of the vacuum produced and the fact that it has to be operated manually, 
the experiments were run in continuous mode with no hold period as previously used in PMSMPR 
experiments at LU. The flow rate though the system was dictated by the flow rates from the urea and 
BA feed vessels which were operated as 1.6 g min−1 and 10.9 g min−1, respectively, which combine 
to give a total flow rate through the system of 12.5 g min−1. The residence times for each set-up is 
dependent on the flow rate and volume of the crystalliser; 38 min for AZ1, AZ2 and AZ3; 51 min 
for AZ4 and AZ5. The temperature working volume in the vessels and the stirring speed were varied 
to create different crystallisation environments in an attempt to isolate UBAI preferentially (Table 
5.4). 
  
Table 5.4 Experimental conditions for UBA crystallisation using continuous MSMPR with 
vacuum transfer. 
Expt. Mode Seed 
Temperature (°C) Working Vol. (mL) Stirring (rpm) 
Nuc. GV1 GV2 Nuc. GV1 GV2 Nuc.  GV1 GV2 
AZ1 Conti. N/A 20 30 20 200 200 200 250 250 250 
AZ2 Conti. N/A 20 30 20 200 200 200 250 250 250 
AZ3 Conti. N/A 20 30 N/A 400 200 N/A 250 300 N/A 
AZ4 Conti. UBAI 20 15 10 400 200 200 350 350 350 
AZ5 Periodic UBAI 20 15 10 400 200 200 350 350 350 
 
All samples were analysed off-line using PXRD. Data were obtained using a Bruker D4 Endeavor 
equipped with monochromated Cu Kα radiation (λ=1.54056 Å) at 298 K. Samples were prepared on 
zero background silicon wafers by pressing approximately 2 mg of each sample over the wafer with 
a glass slide.  
 Results 
The products from each of these runs AZ1-AZ5 (Table 5.4) were analysed using PXRD (Figure 5.23,  
Figure 5.25-Figure 5.28) and, for AZ1 and AZ2, by SEM (Figure 5.22, Figure 5.24). 
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Table 5.5 Results and observations from UBA crystallisation experiments using continuous 
MSMPR with vacuum transfer. 
Expt. Purpose Observations Product 




Validation against  
LU set-up 




Test longer RT in Nuc. to 
prevent blocking 




Validation of cooling 
regime to obtain UBAI 
No blockage in transfer line 






operation with periodic 
operation 
System did not produce pure UBAI as in 
LU experiments 
Periodic transfer helped to alleviate the 




The results from these vacuum-line MSMPR runs at AZ are summarised briefly in Table 5.5 above, 
showing a mixture of UBAI and UBAIII, and can be contrasted with those achieved to date in the 
LU peristaltic pump driven MSMPR system. It should, however, be noted that a limited number of 
preliminary runs were carried out using the AZ MSMPR, and the parameters for its operation are 
unlikely yet to be optimised. 
 
Figure 5.22 SEM images of samples from Experiment AZ1 of UBA continuous crystallisation 
using vacuum transfer. 
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Figure 5.23 PXRD analysis of samples from Experiment AZ1 of UBA continuous crystallisation 
using vacuum transfer. 
 
Figure 5.24 SEM images of samples from Experiment AZ2 of UBA continuous crystallisation 
using vacuum transfer. 
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Figure 5.25 PXRD analysis of samples from Experiment AZ2 of UBA continuous crystallisation 
using vacuum transfer. 
 
PXRD analysis of experiments AZ1 and AZ2 showed that throughout the experiments a mixture of 
UBAI and UBAIII was obtained (Figure 5.23 and Figure 5.25). During these experiment the transfer 
lines were temporarily removed and flushed with methanol to clear. No UBAII was present in these 
samples. Initially samples obtained were a mixture of UBAI and UBAIII, however by RT5 PXRD 
analysis indicates that UBAI is dominant. In experiments AZ1 and AZ2 issues were encountered 
with blockages within the transfer line between the NUC and GV1, an indicator that there is still 
primary nucleation occurring in the transfer lines and GV1. 
 
In order to overcome the issues with transfer line blockages and encrustation, AZ3 was configured 
with only two vessels (NUC and GV1) the working volume of the NUC was doubled by altering the 
position of opening of the transfer line.  The total RT within the crystalliser remained the same (37.8 
minutes) but the RT within the NUC at 20 °C was doubled (from 12.6 minutes to 25.2 minutes) in an 
attempt to reduce the fouling in the transfer line to GV1. By increasing the RT the time allowed for 
nucleation at 20 °C was increased which restricted the nucleation process to the NUC vessel and 




Figure 5.26 PXRD analysis of samples from Experiment AZ3 of UBA continuous crystallisation 
using vacuum transfer. 
PXRD of samples from AZ3 initially show a mixture of UBAI and UBAIII, however by RT5 (after 
189 minutes) the sample has fully transformed to UBAI.  This may indicate the favourability of 
transformation from UBAIII to UBAI as was observed in most PMSMPR experiments at LU.  
 
In addition to the effect upon polymorph it may prove interesting to investigate the effect increasing 
the working volume of the nucleator on the RTD which could be measured by monitoring the PSD. 
One would expect that the RTD would be broader as the likelihood of the older crystals being 





Figure 5.27 PXRD analysis of samples from Experiment AZ4 of UBA continuous crystallisation 
using vacuum transfer. 
In experiment AZ4, UBAI seed was used and the temperature profile was reduced to mimic the 
profile used in experiment LU6 which obtained UBAI, however in this set up a mixture of UBAI 
and UBAIII was produced throughout the experiment. There are several possible reasons why solely 
UBAI was not produced in AZ4. Firstly, a lower concentration seed-loading (1%) was used, as was 
the case for AZ5, in contrast to the seeded runs at LU which used significantly higher seed loadings 
(10%). This step was taken to represent seed loadings used in industrial crystallisation ≤ 1%, which 
may not have been high enough for the level of supersaturation in the Nuc. Secondly, AZ4 utilised 
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continuous MSMPR operation, as opposed to the periodic operation implemented in LU6 and AZ5, 
although AZ5 also produced a mixture of UBAI and UBA III (Figure 5.28). While the periodic 
operation of AZ5 did not offer polymorph control it did reduce the propensity for build-up of solids 
in the Nuc. As the flow rates were much faster and the outlet of the transfer line could be positioned 
well below the surface of the solution. Further investigation of this will form part of the future work 
in developing the AZ MSMPR system.  
 
 
Figure 5.28 PXRD analysis of samples from Experiment AZ5 of UBA continuous crystallisation 
using vacuum transfer. 
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 Conclusions  
The MSMPR at AstraZeneca has been successfully commissioned and operated in a multi-
component continuous crystallisation. This has involved empirical investigation of mass transfer 
effects, and design of transfer protocols to minimise blockages to allow complete unit operation; 
 UBA has been crystallised successfully in the AZ MSMPR in five separate operational runs, 
with filtration and collection of the final solid products enabled; A mixture of UBAI and 
UBAIII was found to be produced in all experiments carried out. It has not as yet been 
possible to isolate individual polymorph in the MSMPR at AZ, but the process design has 
not been comprehensively explored as yet. One significant issue that has been identified for 
improvement is the loss of solvent during the vacuum transfer processes, which leads to 
variation in the supersaturation conditions during the process, and which should be 
investigated; 
 No metastable UBAII has been produced in these runs in the AZ MSMPR system; 
 The following difficulties were encountered using the vacuum transfer method: 
o Loss of volatile solvent to vacuum 
o Increased fouling on vessel walls at fill level 
o Reduced solids transfer due to surface position (coupled with mixing conditions) 
  The use of peristaltic pumps for transfer should be investigated for the system. On a 
practical note, the use of dual head pumps would save on space, which is at a premium in 
the current location of the device. 
 Transfer using pressure from nitrogen gas should also be studied as the system would be 
closed this should help to negate the loss of solvent which occurred when using vacuum 
transfer and has recently been adopted in the MSMPR set-up within CMAC at the University 
of Strathclyde. 
 
5.3 Conclusions - Scaling-up Batch Cooling Crystallisation of UBA and Transfer 
to MSMPR 
The initial conditions for batch cooling crystallisation production of the three UBA solid forms have 
been established by experiments in an STR at 500 ml scale. Access to UBAI and UBAIII has been 
shown to be dependent on the cooling rate, with slower cooling tending to favour production of 
UBAIII, while the more metastable UBAII proved more elusive, as might be expected. UBAII was 
in the end isolated in single phase form using a two-step cooling regime with linear cooling at 1 
°Cmin-1 to 35 °C followed by very slow linear cooling (0.05 °Cmin-1) to 10 °C; this was, however,  
not reproducible over several experiments as trace amounts of UBAI were found to be present in 
most of the samples. This may have been as a result of seeding from the more stable UBAI.  
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The order of addition of the starting materials into the crystallisation vessel was studied to investigate 
the effect of localised mixing conditions upon UBA polymorph selectivity in batch cooling 
crystallisation. It was demonstrated that by adding urea into a pre-prepared solution of BA it was 
possible to produce only UBAI in a reproducible way. The effect of component addition on the 
resulting solid product has been investigated further in the continuous MSMPR set up. 
 
The in-situ PAT used in these initial UBA cooling crystallisation experiments within the STR 
confirmed the presence of the various UBA solid forms, but their full interpretation was hampered 
by later findings that these measurements suffered from the effects of fouling on the Raman probe 
used; the full analysis of solid forms presented here (including selectivity of solid form production) 
was therefore based on subsequent off-line PXRD experiments. Further investigation is required to 
overcome fouling on the probes and to understand if it is possible to monitor polymorphic transitions 
in this system (or more widely) using in-situ Raman spectroscopy.  
 
The results from the work carried out in the MSMPR system at Loughborough University using 
peristaltic pump transfer provide evidence that the proposed PMSMPR (periodic) cascade system, 
with a suitably designed dissolution stage, can provide a platform for the production of the targeted 
polymorph (UBAI) of the model UBA co-crystal system. A range of MSMPR experiments explored 
the effects of various parameters on the polymorphic outcome of UBA crystallisation.  The 
parameters investigated included 
 variations in temperature profile across the MSMPR stages; 
 seeding, both with UBAI and UBAIII seeds; 
 periodic vs. continuous operation in the MSMPR; 
 combined vs. separate urea and BA feed sources; 
 the rate of addition of urea to BA when separate feed sources are employed. 
 
Through unseeded continuous operation of MSMPR using separate urea and BA feed sources it was 
found to be possible to isolate UBAI as targeted. However, there were significant issues with 
blockages in the transfer lines due to the lower flow rates that were required to achieve this 
selectivity. The same conditions were subsequently investigated using periodic transfer, which also 
resulted in strong selectivity for UBAI (although traces of UBAIII were observed using Raman 
spectroscopy but not PXRD). This helped to overcome blockage of the transfer lines and as a result 
periodic operation was adopted for all subsequent experiments. When a combined urea and BA feed 
source was used instead of the separate feed approach, mixtures of UBAI and the unwanted UBAIII 
were produced rather than UBAI selectively. The order and rate of addition of urea to BA may 
influence the polymorph of UBA produced as it may influence the initial mixing dynamics, the 




Experiments were also carried out using seed crystals of UBAI and of UBAIII. These experiments 
were successful using UBAI seed, selectively producing UBAI product crystals. However when 
UBAIII seeds were used UBAIII selectivity was not achieved; this approach again resulted in a 
mixture of UBAI and UBAIII rather than the targeted UBAIII polymorph.  
 
The successful isolation of pure UBAI during several of the MSMPR experiments at Loughborough 
using peristaltic pump transfer experiments, which in addition showed a significant reduction in 
product variability compared to batch operation (as discussed in sections 4.4 and 5.1), has 
highlighted the viability of MSMPR as a route to selective controlled continuous multi-component 
crystallisation. In particular the seeded experiments using periodic operation, whereby continuous 
operation is periodically interrupted by controlled hold periods, afforded the most control. This is 
most likely as a result of increased residence times for crystal growth which have helped to improve 
the product quality attributes and the overall yield. The periodic operation allowed the flow rate 
though the transfer lines to be increased and this proved particularly useful in alleviating blockage 
of the transfer lines which was observed in the more conventional continuous MSMPR experiments. 
 
Less time was able to be spent at AstraZeneca optimising the vacuum transfer MSMPR system for 
UBA production, but in the experiments that were carried out, mixtures of UBAI and UBAIII were 
always obtained; it was not possible to isolate UBAII. However, this early operation of this device 
with a multi-component, polymorphic system shows it to have significant promise. One significant 
problem with operating the vacuum transfer method in continuous mode is that there is constantly a 
flow of air drawn over the system which causes evaporation and hence affects the level of 
supersaturation maintained in the crystallising solution, making it more difficult to follow the desired 
desupersaturation profile as the crystallisation proceeds. In addition the level of the transfer tubes 
had a significant impact upon the ratio of solids to solvent in the suspension transferred between 
vessels. Periodic operation was explored in several experiments in this MSMPR set-up and helped 
to improve the yield of solids transferred. However, in this case the periodic operation of vacuum 
transfer was controlled by hand which is not ideal for a continuous process. Further investigations 
are planned within AstraZeneca for this MSMPR configuration using nitrogen to pressurise the 
system to drive the transfer of suspension between vessels, with the aim of overcoming the issues 
with solvent evaporation. In addition, exploration into automated cessation of the gas flow to enable 
the system to be operated in the periodic nature achieved with peristaltic pump transfer at 
Loughborough will be undertaken in the AstraZeneca system by future CMAC placement students. 
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6 Flow Crystallisation of UBA 
In recent years it has proved popular to scale chemical synthesis down to the micro-scale with 
numerous continuous reaction studies in microreactor devices (ID < 1000 μm) using either tubular 
or micro-well plate designs138-141. The key driver is process intensification142 owing to an increased 
surface to volume ratio delivering better heat and mass transfer and highly controlled mixing 
conditions. 
 
Microreactors have more commonly been used for chemical reaction processes rather than 
crystallisation due to size constraints introducing difficulties when processing solids. This has often 
been deemed the limiting factor for adopting continuous crystallisation using microreactor 
technologies although it will only cause problems if the crystals are larger than, or form agglomerates 
larger than, the dimensions of the tubes 138. With this in mind several studies have shown that it is 
possible to create nanocrystalline materials using microreactors 143-145 and of late there has been a 
switch to mesoreactor crystallisation (ID > 1000 μm). Jiang et al. investigated crystallisation of the 
amino acid L-asparagine in its monohydrated form using a tubular mesocrystalliser with an ID of 
2000 – 3100 μm146 under air-liquid segmentation. Using a biphasic flow systems it is possible to 




Figure 6.1 Segmented flow with internal vortex circulation as observed in segmented flow. 
Due to differences in the viscosity and surface tension of each phase and  the non-slip boundary 
between the solution and the carrier medium (either air or liquid),  is created (Figure 6.1) which 
provides good mixing conditions within each slug and helps to prevent back-mixing in the 
crystalliser142. Overall, this ensures that each slug experiences the same crystallisation conditions, 





6.1 KRAIC Tubular Flow Crystalliser 
The kinetically regulated automated input crystalliser (KRAIC) (Figure 6.2) is a small scale 
tubular flow crystalliser designed by Dr Karen Robertson and developed within the Wilson group 
at the University of Bath. It comprises one or more feed vessels (round bottomed flask, 3 L), 
temperature controlled using a DrySyn® holder(s) (Asynt) and hotplate with thermocouple and 
temperature feedback control. The feed vessel(s) feed into three coils of fluorinated ethylene 
propylene (FEP) tubing which are connected in series. The solution enters at the bottom of each 
coil and leaves from the top, with the inlet of the subsequent coil positioned higher than the outlet 
from the previous coil, in order to minimise disruption to established fluid dynamics. 
 
 
Figure 6.2 Initial set-up of KRAIC tubular flow crystalliser. 
Each of the three coils are housed within three separate cylindrical DrySyn® containers, each placed 
on a hotplate which affords individual temperature control to each coil. To aid heat transfer and 
facilitate efficient temperature control the containers are filled with graphite powder or sand which 
packs around the FEP coils. During development experiments a glass container was used to house 
the first coil to allow observations on segmentation and crystal formation to be made easily.  
 
Solution is pumped through the crystalliser using a dual channel head on a Watson Marlow 343U 
peristaltic pump fitted with 4.8 mm ID marprene tubing. Using a glass mixer piece (Figure 6.3), the 
flow from the feed vessel(s) is segmented using either a gas or liquid carrier medium to form discrete 




Figure 6.3 Photos of custom designed glass mixer pieces for KRAIC tubular crystalliser. a) K-
piece, b) acute angled cross piece, c) impinging mixer piece, d) T-piece, e) Y-piece and f) cross 
piece. 
 
When using liquid-liquid segmentation in crystallisation the wetting properties of the carrier fluid 
and solution must be considered, ensuring that the carrier fluid has higher surface wetting than the 
solution allowing the carrier fluid to coat the walls of the tube around the slug of solution. This helps 
to ensure that the crystallisation solution does not interact with the tube walls, reducing 
sedimentation and encrustation.  
 
It is possible to combine and segment two or more feeds using one of several glass mixer pieces 
(Figure 6.2). This is particularly useful in the case of multi-component crystallisation. Alternatively, 
as part of the re-configurability of the KRAIC platform, it is possible to fit two different mixer pieces 
in series. Although not investigated here, this may, for example, allow two flows to be first mixed, 
then to subsequently segment the resultant flow (Figure 6.30).  
 
One of the key difficulties faced in bridging the gap between small scale multi-component materials 
discovery and continuous crystallisation is the scale of the continuous crystallisation platforms 
available; for example, for the COBC experiments described later in section 6.2, the DN15 
crystalliser operates at 50 mL min-1 and above.  However, it is often not feasible to obtain such large 
quantities of a target material, especially when in the early stages of API development. The small 
scale mixing and the tubular nature of the KRAIC lends itself to the implementation of smaller scale 
continuous crystallisation. With a modular design it is possible to add more temperature points to 
access different temperature regimes and it is also easy to shorten or extend the residence time at 




The KRAIC is a custom designed crystalliser that is still in the development stages. This research 
aims to trial if this new apparatus is suitable for small-scale multi-component continuous 
crystallisation. There are two main aims of this investigation. First, to determine if co-crystallisation 
of UBA can be produced in the KRAIC, and if there is any influence or selectivity for the 
polymorphic form of UBA isolated. Secondly, the experiments carried out were among the earliest 
carried out on the KRAIC, and were expected to highlight operational difficulties and allow solutions 
to be proposed or developed to enhance the operation of this new crystallisation platform. 
6.1.2 Materials 
Urea (98% bio-reagent grade) was purchased from Sigma Life Science and BA (98% reagent grade) 
was purchased from Sigma Aldrich. All reagents were used without further purification. Laboratory 
reagent grade methanol purchased from Sigma Aldrich was used for all KRAIC experiments. 
 
Several different configurations of the KRAIC were used to investigate small scale continuous 
crystallisation of UBA with an aim to identify the polymorphic form of UBA produced. A summary 
of experimental conditions are detailed in Table 6.1 below which are expanded on in the subsequent 
sections 6.1.3 to 6.1.6. 
 















(mLmin-1) sol. A sol. B 
K1 23 55 
impinging 
Jet 
N/A N/A 4.8 17.9 
K2 23 55 
impinging 
Jet 
N/A N/A 4.8 17.9 
K3 55 N/A Y air N/A 3.2 18.4 
K4 55 55 K air and PFPE 











6.1.3 Non-segmented Dual Feed 
In experiment K1 two solutions of UBA were prepared using a 2:1 molar ratio (urea:BA), the first 
solution was prepared using urea and BA concentrations of  0.009 g/g MeOH and 0.010 g/g MeOH, 
respectively and held at 23 °C (sol. A). The second solution was prepared using urea and BA 
concentrations of 0.016 g/g MeOH and 0.018 g/g MeOH, respectively and held at 55 °C (sol. B). Sol. A 
was introduced to the hot sol. B using the impinging mixer piece (Figure 6.3 c and Figure 6.4) at a 
combined flow rate of 17.9 mLmin-1 (8.9 mLmin-1 for each solution) and the resulting crystalline 
suspension was pumped along the ambient coils of FEP tubing (4.6 mm ID) to allow the solution to 
cool naturally over a residence time (RT) of 13.9 minutes. Upon reaching the end of the third coil 
the suspension was pumped directly to a Buchner funnel where the solids were isolated using vacuum 
filtration and analysed off-line using PXRD. 
 
Figure 6.4 Configuration of in-put in non-segmented flow crystallisations of UBA in the KRAIC 
using impinging jet mixer piece.  
After three minutes of operation nucleation was apparent in the first coil of the KRAIC but after ten 
minutes there were signs of crystals settling in the tubing. The flow rate was increased to 
21.6 mLmin-1 (reducing RT to 11.5 minutes) in an attempt to mitigate this. The crystals were 
propagated through coil one and on into coils two and three. After 28 minutes significant 
sedimentation was observed in coil one (Figure 6.5) even at this higher flow rate. By temporarily 
increasing the flow rate to 25.5 mLmin-1 the crystals were readily moved confirming that this was 
an issue with sedimentation and not encrustation on the tubing walls. Segmentation is likely to help 
to keep the crystals suspended due to the improved mixing conditions within the segments (Figure 




Figure 6.5 Sedimentation of UBA crystals in coil one of the KRAIC (Non-segmented UBA  
co-crystallisation in methanol at t= 28 minutes) 
 
The experiment was repeated (K2) using the same crystallisation conditions including the increased 
flow rate (21.6 mLmin-1) and as before crystals were visible in coil one after 3 minutes of operation 
with sedimentation occurring especially in the tubing between coils after 57 minutes (Figure 6.6). 
 
 





Figure 6.7 PXRD analysis of UBA samples taken from the outlet of the KRAIC in experiments K1 
and K2.  
Samples were collected at the end of each experiment and PXRD analysis indicted that both non-
segmented UBA crystallisation experiments yielded predominantly UBAI which from previous 
work had been indicated to behave as the kinetic polymorph.  
6.1.4 Segmented Flow Using Air 
Initially the KRAIC was developed with gas segmentation to aid mixing and impart plug flow. This 
was trialled using an air cylinder and regulator fed into one entry of the Y-piece glass mixer whilst 
methanol was fed into the other entry point (Figure 6.8) and was later modified to use a peristaltic 
pump to input air from the atmosphere (due to irregularity of the air feed from the cylinder).  
 
Figure 6.8 Configuration of Y-mixer piece used in experiments involving air segmentation of 
methanol 
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The methanol was dyed with methyl orange indicator to aid visualisation of the segments. Air 
segmentation of methanol gave uniform segmentation with sufficient surface tension and wetting 
properties from the methanol to prevent Ostwald ripening of the slugs (Figure 6.9).  
 
 
Figure 6.9 Segmentation of methanol (stained with methyl orange indicator) using air. 
UBA crystallisation was also tested from methanol using air segmentation (experiment K3). A 2:1 
UBA solution was prepared at 55 °C (Urea: 0.014 g/g MeOH and BA:  0.015 g/g MeOH) and held at 
50 °C prior to transfer to the crystalliser. 4.6 mm ID FEP tubing was used throughout the crystalliser 
both in solution transfer and in the coil sections. The hot UBA solution and air entered the Y-piece 
mixer at a flow rate of 8.9 mLmin-1 and 9.5 mLmin-1, respectively (in the same configuration as 
before, Figure 6.8). The hot segmented solution passed through the coils at a net flow rate of 
18.4 mLmin−1, passively cooling under ambient conditions over a mean RT of 13.6 minutes. 
 
Crystallisation occurred in the first coil after 6 minutes and it was possible to observe visually 
tumbling of the UBA crystals within each slug, highlighting the vortex mixing. However, there were 
significant issues with encrustation both in the mixer piece and along the first part of coil one. The 
crystallisation had to be stopped after about 20 minutes due to blockage of the mixer piece due to 
fouling. The suspension was drained from the crystalliser and the solids were isolated using vacuum 
filtration and analysed using PXRD. 
 
During this experiment and experiments carried out on other materials in the KRAIC, it became clear 
that the use of air segmentation causes significant encrustation and fouling problems. This is due to 
the fact that when the air passes through the mixer piece and tubing it causes evaporation of residual 
solution on the walls leaving behind crystalline material which provides prime sites for secondary 
nucleation. These deposits build up over time and eventually result in blockage of the crystalliser. 
Investigation into air segmented UBA crystallisation was thus halted and alternative segmentation 
media were investigated. 
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6.1.5 Liquid-liquid Segmented Flow Using Perfluoropolyether (PFPE) 
Galden® SV fluid (SV70 b.p. 70 °C) is a low molecular weight perfluoropolyether (PFPE) fluid. It 
is immiscible with a large range of solvents, highly chemically inert and has good surface wetting 
with FEP which makes it a good candidate as a carrier fluid for use in the KRAIC (fitted with FEP 
tubing). It helps to overcome the fouling issues that occur when using air segmentation in readily 
precipitating systems such as crystallisation processes. Previous studies carried out in unpublished 
work by Robertson et al. showed that PFPE had very good segmentation capabilities when used in 
aqueous systems behaving as illustrated in Figure 6.10a.   
 
With segmentation established in aqueous systems, initial studies were therefore carried out to test 
the segmentation capabilities of PFPE on methanol solutions, since methanol is the solvent of choice 
for the proposed UBA continuous crystallisation experiments. A few milligrams of methylene blue 
dye were dissolved in 1 L methanol to create a coloured solution to allow the segmented methanol 
slugs to be distinguished from the segmentation fluid and allow insight to be gained about their size 
and uniformity. 
 
The KRAIC was fitted with the Y-piece mixer (Figure 6.3 e) with the methanol inlet in-line with the 
outlet and the segmenting PFPE fluid entering against the net methanol flow to induce the best 
mixing conditions to generate segmentation (Figure 6.10 b). 
 
Figure 6.10 Schematic of configuration of Y-mixer piece used in the investigation into a) water 
segmentation with PFPE and b) methanol segmentation with PFPE.  
                                                     
 Work referenced here is currently in preparation for publication by other members of the Wilson group. 
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Experiments to test the segmentation of methanol using PFPE showed that the distribution of the 
segments was not uniform (Figure 6.11), in contrast to the uniform slugs observed during air 
segmentation of methanol (Figure 6.9) and with PFPE segmentation of water. Within the Y-piece 
mixer the methanol layered over the PFPE as a result of the lower surface tension of methanol which 
led to segments were of a variety of sizes. The irregularity was exacerbated through Ostwald ripening 
of the larger segments causing the formation of very large slugs in which there is poor vortex mixing 
(Figure 6.11). Merging of methanol slugs was particularly significant when moving between each of 
the coils due to the additional gravitational influence and resulted in methanol exiting the crystalliser 
preferentially over the PFPE. These experiments were repeated using IPA and ethanol solvent 
systems which resulted in the same outcome again due to low surface tension.  
 
 
Figure 6.11 Photos of irregular segmentation of methanol (coloured with methylene blue) using 
PFPE as carrier fluid. The red ring highlights a large slug created by Ostwald ripening.  
The decision was thus taken to discontinue further investigations using PFPE segmentation alone for 
methanol feed solutions, as the non-uniformity of the segments would have a significant effect on 
the crystallisation environment leading to irregular crystals. In order to improve this segmentation a 
tri-segmented approach was investigated. 
6.1.6 Tri-segmented Flow Using Dual Segmentation Media: Air and PFPE 
In order to regulate the non-uniform segments and layering of methanol on PFPE observed 
previously using solely PFPE liquid-liquid segmentation, a combination of air and PFPE 
segmentation was used in a tri-segmented flow set up using a K-piece mixer (Figure 6.3a). The aim 
of this experiment was to combine the segmentation capabilities of air with the wetting properties of 
PFPE; it was hoped that the former would produce uniform segments while the latter would coat the 
walls of the crystalliser, helping prevent fouling and reduce the risk of secondary nucleation on the 
walls as the segments travel along the crystalliser. 
 
Two different configurations were investigated (experiments K4 and K5) to see whether the direction 
of flow and the order of segmentation with air and PFPE would (i) result in the desired improved 
segmented flow and (ii) have an effect upon the polymorphic outcome of UBA crystallisation. 
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(Figure 6.12). As for previous UBA experiments in the KRAIC, urea and BA were dissolved in 
methanol in a 2:1 ratio (Urea: 0.014 g/g MeOH and BA: 0.015 g/g MeOH) to form a UBA feed solution 
which was held at 55 °C in feed vessel 1 (FV1) prior to the start of the experiment. Meanwhile PFPE 
was heated to 55 °C in feed vessel 2 (FV2). The UBA methanol solution and PFPE were transferred 
to the mixer piece using a dual head peristaltic pump (with a four–roller head) with tubing of 4.6 mm 
ID and 3.2 mm ID, respectively. Air flow was added using a separate peristaltic pump (with a two–
roller head) fitted with 10 mm ID tubing. The UBA methanol solution entered at the straight  
(10.8 mLmin-1) followed by air (9.4 mLmin-1), which was aligned with the direction of UBA 
methanol flow and then the warm PFPE was introduced (5.5 mLmin-1), directed against the flow of 
methanol and air (Configuration a, Figure 6.12 a). A 3.2 mm ID FEP tube was used for the length of 
the crystalliser instead of 4.8 mm ID tubing as used for previous experiments as this was shown to 
improve the liquid-liquid segmentation in other similar systems such as PFPE with acetonitrile. The 
net flow rate was 25.8 mLmin-1 resulting in a 4.7 min RT. This experiment was then repeated with 
the order of air and PFPE addition reversed (Configuration b, Figure 6.12 b), while all other 
conditions were kept constant.  
 
 
Figure 6.12 Schematic of configuration of K-mixer piece used in the investigation into 
segmentation of methanol with air and PFPE in two different configurations; Configuration a) 
air then PFPE and Configuration b) PFPE then air. 
As the peristaltic pump used for air addition was fitted with a head with two pinch points large slugs 
of air were present periodically in the segmented flow (as shown in Figure 6.13); this could be 




Figure 6.13 Still from a video of coil one in segmentation of UBA in methanol with air and PFPE 
using a K-mixer in configuration a (Experiment K4) Sections of methanol layered on PFPE are 
circled in blue and air segments are circled in red.  
 
Initially there were problems encountered with back-mixing of the slugs up into the air and PFPE 
inlets which were alleviated by ensuring that the methanol inlet and outlet of the K-piece were 
horizontally level, after this adjustment the slugs appeared more regulated. Layering of methanol 
and PFPE were apparent in the mixer piece (Figure 6.14) and some merging of methanol segments 
was apparent when moving between coils, against gravity. These issues considered, it was still a 
significant improvement in comparison to the segmentation using air-segmentation or PFPE-
segmentation alone. 
 
Figure 6.14 Still from a video of K-mixer in UBA tri-segmented flow experiment showing 
layering of methanol and PFPE in experiment K4 which leads to poor segmentation. 
 
Crystals were first observed in coil one after 7.5 minutes and at 10.9 minutes it was possible to detect 
crystals exiting coil three of the crystalliser. Encrustation at the tip of the outlet of coil three was 
apparent after 10 minutes due to solvent evaporation. After 18 minutes fouling was present at the 
PFPE inlet into the K-piece. The filter paper was changed at 28 minutes (RT 1 – RT 6) and again at 
46.5 minutes (RT 7 – RT 10). At 34 minutes the end of the crystalliser tube became blocked due to 
the continued encrustation, but the solids were easily removed with a spatula. 
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40 minutes into operation encrustation was observed inside the K-mixer, upon further investigation 
it was noted that the water bath had dropped from 50 °C to 30 °C. Attempts were made to clear the 
blockage by increasing the temperature of the water bath and the PFPE fluid to 55 °C, however solids 
continues to build up within the mixer piece (Figure 6.15).  
 
 
Figure 6.15 Photo of solids build-up within the K-mixer during experiment K4 after 60 minutes 
of operation 
The samples of product from the tri-segmented experiments K4 and K5 were analysed using PXRD 
(Figure 6.16 and Figure 6.17).  This showed that throughout both experiments using dual segmented 




Figure 6.16 PXRD of samples from experiment K4 
using tri-segmented flow with air then PFPE 
(configuration a)  
Figure 6.17 PXRD of samples from experiment K5 
using tri-segmented flow with air then PFPE 
(configuration b) 
 
6.1.7 Crystalliser Developments and Modifications 
As UBA was one of the first systems crystallised using the custom designed KRAIC the finer details 
of the platform and its operation were still under development during these experiments. Several 
modifications were made to the KRAIC as a result of issues encountered during crystallisation of 
UBA and other systems.  
 
One of the key issues encountered was fouling within the glass mixer piece as described above. 
Initially the mixer piece was placed upon a hot plate which was subsequently upgraded to a heated 
water bath (Figure 6.19 a) comprising a glass petri dish heated by a hot plate with the mixer piece 
clamped into place. It proved difficult to manipulate and fix the tubing in place whilst ensuring that 
the mixer piece was fully submersed and also level to ensure the best flow into the mixer piece (as 
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discovered in experiments K4 and K5). A custom designed water bath was produced which allowed 
the mixer piece to be fixed in place easily whilst fully submersed and level (Figure 6.18 and Figure 
6.19 b) 
 
Figure 6.18 Schematic of custom water bath design to enable uniform heating of mixer piece. 
 
Figure 6.19 The basic water bath (a) was adapted to accommodate better the mixer piece (b). 
Whilst fouling in the mixer piece was mitigated by the improved water bath design (Figure 6.18), 
this caused the fouling issue to be transported to the ambient transfer lines that pump the heated feed 
solutions between the feed vessels and the mixer piece. Although only traversing a short distance the 
solution often reduced in temperature causing increased supersaturation in the transfer tubes which 
often caused issues with fouling and blockages. On several occasions the crystallisation had to be 
terminated due to complete blockage. A flexible tubing jacket has been developed that attaches to 
custom made glass adaptors (designed in the Wilson group in collaboration with Asynt) that allow 
the transfer tubes to pass through the jacket and seal at either end encasing the tube in fluid heated 
by a bath circulator (Figure 6.20). This has proved particularly successful in mitigating fouling en 
route to the mixer piece.  
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Figure 6.20 Flexible tubing jacket developed to prevent fouling in transfer lines between the 
feed vessels and mixer piece. 
 
6.2 Continuous Oscillatory Baffled Crystalliser (COBC)  
6.2.1 The COBC and Oscillatory Flow Mixing 
The COBC is much larger in scale than the KRAIC, operating at litres per hour rather than millilitres 
per hour. Described as a cross between an MSMPR crystalliser and a tubular net flow crystalliser, 
the COBC is a tubular crystalliser divided into numerous small cells by periodically spaced baffles 
which leave a small orifice between the cells. As liquid under oscillatory flow is passed between 
cells, interaction with the baffles generates eddy currents and vortex mixing is induced. 
 
 
Figure 6.21 Schematic of eddy currents generated in the COBC under oscillatory flow conditions 




Figure 6.22 Schematic of different types of flow that can be achieved in a tubular crystalliser147. 
 
The oscillatory mixing within the COBC can be characterised using three dimensionless numbers; 
the oscillatory Reynolds number (Reo), the net flow Reynolds number (Ren) and the Strouhal number 
(St) which quantify the intensity of oscillation, the oscillatory mixing under flow and the ratio of 
tube diameter to oscillation amplitude, respectively148, 149. The level of plug flow in the system can 
be quantified by the velocity ratio (Ψ) which is the ratio of Reo to Ren. It is desirable to operate at 
Reo greater than 300 to ensure a turbulent well mixed flow is achieved 150 and Ψ between 2 and 12 
should give suitable plug flow in the COBC 151.  
 
Plug flow, in which the velocity of the fluid within the crystalliser is uniform across the cross section 
of the tube (Figure 6.22), is desirable, particularly in a continuous system, as it helps to achieve a 
narrow residence time distribution (RTD), i.e. the time spent by each particle within the crystalliser, 
is uniform which aids control of the physical attributes of the particles including PSD and 
polymorphic form.  
 
The geometry of the COBC was designed in order to operate as close to plug flow conditions as 
possible and is based on the principle that plug flow conditions are preferential for control over 
crystallisation and particle attributes in a flow system; if this is achieved, the hydrodynamics ensure 
that the crystallisation conditions experienced by each particle is near to identical. This feature is key 
to overcoming the issue of batch to batch variation and problems with scale-up in batch industrial 
crystallisation processes; the motivation for development of the COBC 152.   
 
In the literature there is significant evidence of crystallisation under oscillatory mixing conditions 
but the majority of these studies are investigated in batch crystallisations. Two key papers document 
the establishment of continuous crystallisation under oscillatory flow using the COBC; 
crystallisation of an AstraZeneca API (collaboration with Lawton et al., AstraZeneca)152 and a multi-
component crystallisation of α-lipoic acid with nicotinic acid by Zhao et al153. The application of 
oscillatory flow reactors (OFRs), including the COBC, in continuous crystallisation for the 
 186 
manufacturing of pharmaceuticals and fine chemicals has also been reviewed recently by McGlone 
et al154. 
 
The continuous multi-component crystallisation study by Zhao et al.153 involved a crystal 
engineering investigation with an aim to enhance the thermal stability of α-lipoic acid. Though 
screening with several co-former candidates three new co-crystal systems were discovered; α-lipoic 
acid with either nicotinic acid, isonicotinic acid or trans-cinnamide. Of these three multi-component 
systems the 1:1 α-lipoic acid: nicotinic acid co-crystal was found to be the most thermally stable and 
chosen as the candidate for transfer to continuous crystallisation. Successful crystallisation of the 1:1 
α-lipoic acid: nicotinic acid co-crystal using the COBC was demonstrated under both seeded and 
non-seeded crystallisation conditions.  
 
Although studies on cooling crystallisation using the COBC have been carried out previously on 
both multi-component materials and polymorphic materials a polymorphic multi-component system 
has yet to be investigated. This study on UBA documents the first polymorphic multi-component 
system crystallised in the COBC and highlights how mixing conditions within the COBC can be 
used to produce UBAI selectively.  
 
6.2.2 Materials 
Urea (98% bio-reagent grade) was purchased from Sigma Life Science and BA (98% reagent grade) 
from Sigma Aldrich and these reagents were used without additional purification. For all UBA 
crystallisation experiments in the COBC laboratory reagent grade methanol purchased from Sigma 
Aldrich was used. 
 
6.2.3 Method 
The DN15 COBC at UoB (Figure 6.23 and Figure 6.24) has a total volume of 2.8 L and comprises 
20 jacketed glass straights and 10 unjacketed glass bends which total 16 m in length. The tubes have 
an ID of 15 mm and are divided into cells 27 mm in length by baffles with an orifice diameter of 7.9 
mm.  Prior to operation the solution flow rate was calibrated to 49 mLmin-1 giving a mean residence 




Figure 6.23 Schematic highlighting the four different temperature controlled zones of the DN15 
COBC set-up at UoB, for experiments C1 and C2 (each zone is controlled by a separate bath 
circulator).  
 
Figure 6.24 Schematic highlighting the four different temperature controlled zones of the DN15 
COBC set-up at UoB, for experiment C3 (each zone is controlled by a separate bath circulator).  
 
For each experiment 95.6 g urea and 101.4 g BA were added to 8.5 L methanol in a custom built 9 L 
jacketed feed vessel with an overhead four-pitched blade PTFE impeller (stirring speed 500 rpm) to 
form a 2:1 UBA solution. The solution was held at 55 °C until all solids were dissolved and then 
cooled to 50 °C. The COBC was prepared for operation by priming with the UBA methanol to purge 
unwanted air bubbles from the system in order to prevent oscillation dampening. The hot UBA 
solution was pumped from the feed vessel at 49 mLmin-1 using a peristaltic pump with marprene 
tubing of 10 mm ID. The motor was set to oscillate at an amplitude of 30 mm (peak to trough) at a 
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frequency of 1 Hz. The suspension of crystals produced was directed into a custom vacuum filtration 
unit (designed in collaboration with Asynt) where the solvent was removed and the crystalline solids 
isolated. The filter papers were changed at time = RT and 2 RT for experiments C1 and C2 (Figure 
6.23) and for experiment C3 (Figure 6.24) at time = RT, 1.5 RT, 2 RT, 2.5 RT and 3 RT.   
 
For all three experiments the COBC was divided into four temperature controlled zones (defined in 
Figure 6.23 and Figure 6.24 and with temperatures summarised in Table 6.2). 
 









Feed Zone 1 Zone 2 Zone 3 
Zone 
4 
C1 49 30 1 55 50 30 17 10 
C2 49 30 1 55 50 30 17 10 
C3 49 30 1 53 31 27 12 9 
 
The temperature controlled zones were configured in such a way to give the cooling profiles detailed 
in Table 6.3 (experiments C1 and C2) and Table 6.4 (experiment C3). The aim in experiments C1 
and C2 was to use all four heater-chillers to implement a controlled linear cooling profile around 
1 °Cmin-1 in order to mimic the cooling profile used to obtain UBAI in batch cooling crystallisation 
experiments.  
 
Table 6.3 Details required to calculate the cooling rate across each temperature zone for 















1 1.6 2 1 5.71 55 50 0.9 
2 6.4 8 4 22.84 50 30 0.9 
3 4.8 6 3 17.13 30 17 0.8 
4 3.2 4 2 11.42 17 10 0.6 
 
Experiment C3 was configured in preparation for future seeding experiments. Nucleation of UBA at 
these concentrations was observed in batch processes at around 28 °C. (Section 5.1). Seeds of UBAI 
would be introduced in zone 2 after rapid cooling to 31 °C during the slow cooled period between 
31 and 27 °C. The current COBC set-up at UoB is not configured to introduce a seed suspension. 
This experiment was carried out as a control to investigate which UBA polymorph would be 
produced using this profile without seeding. 
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1 4.6 6 2 16.42 53 31 1.3 
2 5.7 7 4 20.34 31 27 0.2 
3 4.8 6 3 17.13 27 12 0.9 
4 0.9 1 1 3.21 12 9 0.9 
 
6.2.4 Results and Discussion 
Experiments C1 and C2  
During experiments C1 and C2 crystals were first observed (visually) in straight 11 after 15 and 18 
minutes, respectively. Fouling occurred on the walls of the crystalliser after around 35 minutes and 
continues to build up throughout the length of the crystalliser with some masses of encrusted crystals 
dislodging from the walls and settling in the bends of the COBC. Experiment C1 ran for 165 minutes 
(approximately 2.5 residence times) before the feed solution was depleted. In experiment C2 after 
150 minutes of operation the crystals had propagated back to inlet and the bellows and the experiment 
was halted to protect the bellows.  
 
Experiment C3 
In experiment C3 crystals could be observed visually in straight nine after just five minutes. This 
short induction time is due to the fact that the system was purged with UBA methanol solution. 
Solids started to grow on the walls of straights nine to eleven after 15 minutes. After 20 minutes 
there was significant fouling in straights seven to eleven. The amplitude and frequency of the 
oscillation was increased to 35 mm and 2 Hz temporarily in an attempt to dislodge some of the 
deposited material. Some of the material was removed however a significant coating of crystals was 
still present. It was possible to observe some crystals in straight two after 25 minutes. These crystals 
must be present due to back propagation, where material from the deposits on the walls has travelled 
backwards and seeded the solution inducing nucleation at much higher temperatures and may have 
been induced through the increased intensity of oscillatory conditions. Due to the vertical 
configuration of the COBC in all three experiments there was significant sedimentation of crystalline 
solids present at each of the bends with the most sedimentation occurring in bends four to seven. 
PXRD analysis of each sample collected every 28.5 minutes (RT/2) over approximately three RTs 
shows that UBAI is consistently produced throughout the crystallisation process in the COBC 





Figure 6.25 PXRD analysis of samples from 
crystallisation of UBA in COBC experiment C1 
(sample 1 t=27 mins, sample 2 t =120 mins) 
 
Figure 6.26 PXRD analysis of samples from 
crystallisation of UBA in COBC experiment C3 
(sample 1 t=28.5 mins, sample 2 t =57 mins, 
sample 3 t= 85.5 mins, sample 4 t= 114 mins 
and sample 5 t= 169 mins)  
 
Figure 6.27 PXRD analysis of samples from 
crystallisation of UBA in COBC experiment C2 




The yield of UBA was between 12 and 15%. across all three experiments. This was calculated for 
the theoretical mass that could be achieved of U and BA in a 1:1 ratio which is the ratio of the UBA 
co-crystals. This is instead of using the mass of the 2:1 urea: BA ratio that is required in solution to 
ensure that urea is saturated enough to be available for co-crystallisation.  
 
Using the solubility of UBAI it is possible to calculate the equilibrium concentration of UBAI in the 
solution when it exits the COBC at a temperature of 10 °C (0.0088 g/mLMeOH). If this is taken into 
consideration then the yield of the crystallisation process is 25%.  
 
PXRD analysis of samples taken from each experiment (Figure 6.25 to Figure 6.27) show that UBA 
I was produced for experiments C1 to C3 using two different cooling profiles; this is a significant 
finding, representing the first example of selective production of a single solid form of a polymorphic 
multi-component molecular systems in a continuous crystallisation platform such as the COBC. 
 
6.3 Facilitating the Future Move to the Small Scale  
During the course of the present project, CMAC researchers at the University of Bath (UoB) have 
been developing and commissioning a range of continuous crystallisation platforms, optimised for 
the assembly and manufacturing of target molecular materials at relatively small scales. These 
developments, led by Dr Karen Robertson and in which the author has had significant involvement, 
have encompassed a range of novel concepts.  They have also benefitted from harnessing the best 
available technology solutions from both the upstream (flow chemistry) and downstream (flow 
processing) communities.  The platforms developed operate on a range of principles, from segmented 
tubular flow (the KRAIC, described in chapter 6), through small scale cascade stirred tank reactors 
(cSTRs), to membrane-mediated continuous evaporative approaches. The platforms are being 
developed and commissioned with a view to deployment on a range of appropriate target materials 
across the CMAC consortium, forming a part of a flexible approach to providing reconfigurable and 
fit-for-purpose platforms for continuous crystallisation. 
 
There is understandable focus within CMAC research on the requirement to develop continuous 
crystallisation processes that scale-up to larger volumes of product. For many applications, however, 
optimising small scale production of molecules, materials and particles – such as manufacturing of 
high value products – is an equally valuable challenge, and the work on new crystalliser development 
described here is addressing this. 
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6.3.1 Small Scale Cascade of Stirred Tank Reactors (cSTR) 
With the focus on optimising crystallisation processes at small scale, a continuous crystalliser has 
been designed and constructed based on a cascade of small-volume STRs, in collaboration with 
Cambridge Reactor Design.  Individual STR volumes are around 7-10 ml with an internal weir 
arrangement that harnesses gravity for transport between vessels negating the need for more pumps 
or a pressurised system. The UoB cSTR offers a fully reconfigurable platform with a flexible number 
of STRs in series, and full temperature control over each section of the device. 
 
 
Figure 6.28 Photo of a prototype of a custom STR for the small scale cSTR set-up 
6.3.2 Continuous Evaporative Crystalliser 
Building upon the most common technique used for multi-component crystallisation the continuous 
membrane-mediated evaporative crystalliser (CMEC) aims to translate batch evaporative processes 
into the continuous environment. Designed within the Wilson group at UoB in collaboration with 
(and constructed by) ChemTrix BV (Netherlands), this crystalliser offers a small scale solution in 
which solvent evaporation, rather than cooling, is used as the means to induce supersaturation and 
control nucleation and growth. By passing the sample solution through a pair of spiral paths within 
the device, and mediating evaporation across a double-sided membrane in two stacked layers within 
the crystalliser, there is potential to achieve a high level of process control within an extremely 
compact crystallisation platform. The crystalliser is approximately 14 cm3 in volume; the flow 
channels are 3 mm in diameter and 2 m in length, which are arranged to fit inside a compact device 
with a foot print of 20 cm2. The continuous evaporative device should find particular use in cases 
where control of solvent behaviour is critical, including the production of solvates and hydrates, and 
adds a further capability within the CMAC continuous crystalliser portfolio at UoB. 
 
The UBA system lends itself to use in the CMEC as it has been investigated using methanol solvent 
which has a low boiling point and as it is a small molecule system there will be good membrane 
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permeation. The morphology of the UBA co-crystals is block-like and there have been no issues in 
filtration processes during UBA experiments which indicates that it would allow solution to move 
freely at the membrane surface. However there have been significant issues with fouling on surfaces 
when investigating the UBA system and this may prove a key challenge when using UBA in the 
CMEC.  
 
6.4 Conclusions – Flow Crystallisation of UBA 
6.4.1 KRAIC Tubular Crystalliser 
Several different crystallisation methods were tested for UBA crystallisation using the KRAIC. It 
was possible to selectively produce UBAI using the non-segmented flow set-up with dual UBA feed 
(K1 and K2). However, when a single UBA feed was used in combination with segmented flow  
(K3-K5) using a range of different carrier media (air, PFPE and air with PFPE) a mixture of UBAI 
and UBAIII was produced. As with all previous continuous crystallisation of UBA, UBAII was not 
present in the end product. This difference in polymorphic outcome is most likely due to the different 
mixing conditions experienced with the non-segmented and segmented flows. The former has 
laminar flow with poor mixing and a large amount of back-mixing, whereas the latter has gentle 
mixing under bolus flow and in an ideal system there should be no back-mixing.  
 
In addition to this reasoning, owing to the dual UBA feed of the non-segmented flow set-up (K1 and 
K2) in comparison with the single feed used in segmented flow (K3-K5) the desupersaturation 
profiles followed are very different and are likely to have a significant effect upon the polymorphic 
outcome. Further investigation of crystallisation using a dual UBA feed combined with segmented 
flow may help to decouple the effect of the desupersaturation profile vs. mixing conditions. 
 
The main issue encountered with fouling in the KRAIC experiments was within the glass mixer 
piece. This could be as a result of choice of construction material and the difference in the contact 
with the glass and the fluorinated ethylene propylene (FEP) tubing. It would be useful to test FEP 
mixers or glass mixers coated in FEP and see if these helped to reduce or prevent fouling in the 
mixer.  
 
All KRAIC experiments on UBA detailed here were carried out using a peristaltic pump, however 
subsequent investigations on other materials have used a recently sourced gear pump. This has 
helped to achieve more uniform segmentation due to the nature of the constriction mode of a gear 
pump which reduces the amount of pulsation in comparison to a peristaltic pump. The only issue 
with switching to a gear pump is that the mechanism cannot function with solids present and 
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therefore it is imperative that the pumps are flushed out with warm solvent once the crystallisation 
is finished. Future experiments using UBA should be carried out using the new gear pump in order 
to investigate what effect this may have upon the size variation of segments, especially in the 
methanol system with air/PFPE segmentation.  
 
A new air/PFPE segmentation configuration that uses a cross piece mixer (Figure 6.3 f) was recently 
trialled (Robertson et al.) for a flow chemistry reaction in acetonitrile solvent, which has similar 
surface tension and wetting properties to methanol. Highly uniform segmentation was achieved in 
this experiment. This set-up will be trialled for UBA in methanol with an aim to achieve enhanced 
and more uniform segmentation (Figure 6.29, Figure 6.30). 
 
This work has focused upon the application of the KRAIC for crystallisation of UBA but further 
development of the crystalliser is required. Surface tension and zeta potential measurements for the 
different liquids used could prove useful for future systems as this may lead to the discovery of more 
suitable carrier fluids for different purposes, taking into account fluid properties such as density and 
viscosity. In addition, computational fluid dynamics (CFD) simulations are being undertaken in the 
Bath laboratory (P.-B. Flandrin, PhD project).  These are modelling a range of flow chemistry and 
flow crystallisation systems, including the KRAIC and the COBC (below).  Modern CFD 
simulations are increasingly sophisticated and allow both carrier fluid and sample properties to be 
included as parameters, thus allowing for optimisation of parameters and materials for future 
developments of crystallisation processes in the KRAIC and other continuous crystallisers deployed 
in the Bath laboratory.  
 
Figure 6.29 Proposed experimental set-up for UBA crystallisation using tri-segmented flow with 
a cross piece mixer. Note that the cross piece is viewed from a top down perspective.  
                                                     
 Work referenced here is currently in preparation for publication by other members of the Wilson group. 
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Figure 6.30 Future experiment using separate urea and BA feed through a Y-piece mixer 
followed by tri-segmented flow with a cross piece mixer. Note that the apparatus is drawn from 
a top down perspective 
 
6.4.2 Continuous Oscillatory Baffled Crystalliser 
The campaign in the COBC represents a breakthrough in establishing continuous crystallisation of 
multi-component molecular materials with a view to establishing a continuous platform for the 
production of such materials in a continuous manufacturing context. As has been noted above, the 
UBA system is a notable challenge for transfer to continuous. Not only is it multi-component, with 
introducing issues with potentially incompatible solubilities between the molecular components, etc, 
but it is also polymorphic in both the products (UBAI, UBAII and UBAIII) and in one of the starting 
constituents (BA, which can also readily form a dihydrate in addition to its polymorphism). The 
system was deliberately selected to pose these challenges, and it is in this context that the successes 
of this work can be noted. 
 
The very fact that UBA solids are produced represents one of the first examples of a systematic 
exploration of continuous crystallisation production of a multi-component molecular system. In 
order to achieve this, cooling routes to UBA needed to be established and, crucially, transferred into 
the parameters selected for the continuous COBC platform. 
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Moreover, it has been possible to control the continuous process in the COBC so as to deliver phase 
pure UBAI. This is the first example of such a process delivering polymorph selectivity in a multi-
component molecular system. Establishing this selectivity is particularly notable given that the 
thermodynamic stabilities of UBAI and UBAIII are, on all available evidence, very similar. This 
emphasises the high degree of control of kinetic factors that is possible in a continuous flow reactor 
such as the COBC. It has, however, proven challenging to obtain either UBAII or UBAIII selectively 
in the COBC. This is not unexpected for the highly metastable UBAII, but it should be possible to 
optimise the crystallisation conditions to allow the isolation of UBAIII, and work on this is ongoing. 
 
The UBA crystallisations involved operation of the COBC for three residence times (total run time 
of 180 minutes), allowing the harvesting of approximately 7 g/hr of UBAI from the continuous 
process. 
 
The COBC has shown selective crystallisation of UBAI of the target multi-component UBA system 
and represents a breakthrough in deployment of such a device and offers real potential for its 
exploitation in the production of multi-component solid forms. The first steps have been taken to 
deployed the COBC at UoB as a fully continuous crystalliser within this project, although for the 
process to be fully continuous much longer experimental runs are required which for the capacity of 
the set-up described here would require a much larger set of feed vessels. 
 
There are also some other issues that must be addressed in further developing its use in tackling the 
high value target materials typically developed in the multi-component materials area. There are 
some restrictions upon the efficiency of the mixing within the COBC due to the fact that it uses a 
single motor positioned at the very beginning of the crystalliser. It is plausible that the mixing 
efficiency falls off as a result of increasing distance from the motor, in which case (i.e. one with 
smaller working volume) the mixing should be fairly consistent throughout for a shorter crystalliser, 
while as the crystalliser increases in length mixing will become poor (due to the dampening effect 
of the liquid media). As the set-up used in the experiments described here uses 20 COBC straights 
with a total length of 16 m, the mixing towards the end of the COBC is inconsistent with the mixing 
at the start of the COBC. This could be addressed by reconfiguring the COBC into a more compact 
arrangement; this has recently been done in the Bath laboratory, with evidence of the successful 
crystallisation of both succinic acid (Klapwijk et al.) and paracetamol (Agnew et al.) from multi-
component environments. Shortening the COBC however, reduces the residence time within the 
crystalliser and the net flow rate needs to be kept high to maintain good mixing conditions therefore 
                                                     
 Work referenced here is currently in preparation for publication by other members of the Wilson group.   
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this may not be a suitable resolution particularly for systems with slow nucleation and growth 
kinetics. 
 
In both the UBA runs and these subsequent COBC experiments, a second issue has become apparent, 
which is the large amounts of sample required for operation of the large volume DN15 COBC. These 
typically require around 250-500 g of material per crystallisation run, which is a large quantity for 
many candidate materials.  Smaller diameter COBCs exist within CMAC, which may be better suited 
to deployment on many of the likely target materials; certainly in the earlier stages of their 
development where sample quantity may be limited but it is still vital to assess and develop their 
capacity for continuous production. Further developments of small scale crystallisers are also 
ongoing that help address this issue and are discussed below. 
 
This work is has shown that is possible to selectively crystallise UBAI using the COBC with the 
cooling profiles and mixing conditions detailed above, further investigations are required to 
systematically vary the temperature profile and mixing conditions to investigate if it is possible to 
crystallise UBAII and UBAIII as well as UBAI.  
 
The COBC will be modified to place feed inlet after a single heated straight to resolve issues with 
fouling in the unjacketed tube positioned near the bellows. This modification has been implemented 
in COBC configurations used within CMAC at the University of Strathclyde and has proved 
beneficial. 
 
In addition the COBC is to be reconfigured to install a dual feed and seeding port in order to repeat 
experiment C3 with varying concentrations of seed suspension using UBAI produced via mechano-
chemical methods (as discussed in section 4.3) and also to investigate separate addition of the urea 
and BA components as investigated with MSMPR experiments (section 5.2). 
 
It has been noted throughout crystallisation of UBA that it has a tendency to foul on surfaces over 
long periods of time. Investigations are underway within CMAC to trial the use of different coatings 
on a range of materials of construction, and the potential use of heat pulses, to prevent/reduce 
encrustation and the UBA system will be one of the materials trialled.  
 
6.4.3 Sample Analysis  
All analysis of materials produced through flow crystallisation were carried out using off-line 
measurements. As PXRD is the main technique used to identify the presence of each polymorph of 
the UBA system it would initially be beneficial to install sampling ports throughout the COBC and 
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the KRAIC so that samples cold be analysed over the length of the crystalliser rather than waiting 
until the product is eluted from the end of the crystalliser. An aspiration aim would be to implement 
in-line PXRD analysis using flow through PXRD.  
 
Figure 6.31 Schematic diagrams of non-commercial in-situ PXRD instruments as developed by 
Blagden et al.155, Hammond et al.156, and Coquerel et al.157 (from left to right). 
This has been partly achieved in the laboratory by various authors (Figure 6.31). In the most recent 
development by Coquerel157, a slurry flow cell has been constructed, based on an STR that can be 
mounted on a PXRD instrument. In the experimental arrangement, the incident X-ray beam is 
directed towards the base of the STR which contains a Kapton window to allow the beam to penetrate 
into the vessel, and the crystallisation is monitored through diffraction measurements in reflectance 
geometry. 
 
Building on this work on STRs, flow crystallisation systems such as the COBC or KRAIC are ideally 
suited to installation in an X-ray beam, and may particularly benefit from installation in more open 
XRD environments such as those on instruments at synchrotron radiation sources like the Diamond 
Light Source, Harwell, UK. The benefits here would be that, with the use of small diameter flow 
tubes, measurements may be possible more easily in transmission (“capillary”) geometry, and the 
tuneable radiation at the synchrotron would open up the possibility of both wide and small angle 
diffraction, as well as potential spectroscopic monitoring, using the intense beams from the 
synchrotron source. This would build on previous work carried out by Quayle et al. and Hammond 
et al. in designing continuous crystallisation flow cells for deployment on synchrotron beamlines156, 
158. 
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7 Multi-component Materials Discovery 
 
Running parallel to the investigations into the previously discovered multi-component system UBA, 
this project has also focused on new multi-component materials discovery with an aim to find 
candidates that may be suitable for transfer and scale up into continuous cooling crystallisation. 
Several new multi-component materials were discovered in a series of small scale evaporative multi-
component screening experiments. Some of the complexes have been transferred into cooling 
crystallisation in preparation for progression on to continuous crystallisation using some small scale 
technologies developed at UoB (chapter 6).  
 
7.1 Molecular Complexes of 3-deazauracil 
Following on from previous studies on nucleobase derivatives, 3-deazauracil (3DU), a uracil 
derivative with two hydrogen bond donor groups and one hydrogen bond acceptor would be 
predicted to co-crystallise with a range of other small molecules.  However, since the structure of 
this material was first determined by Low et al. in 1983159, it was studied by Wilson et al. for around 
20 years, with no polymorphism observed in the material nor any multi-component materials 




Figure 7.1 Tautomers of 3-deazauracil with potential to influence hydrogen bonding 
 
A screening experiment in search of multi-component materials of 3DU was carried out using a 
range of different co-former materials (listed below), these were selected for their hydrogen donating 
and/or accepting groups and the compatibility of their geometries with 3DU. Crystallisations were 
prepared using a range of solvents and solvent mixtures (50:50 v/v) and different ratios of 3DU to 













 2,5-dinitrobenzoic  
acid 
 2-nitrobenzoic acid 
 3,5-dinitrobenzoic  
acid 
 4,4’bipyridine (BP) 
 5-fluorocytosine 
 DMAN 
 Fumaric acid 
 Isonicotinic acid 
 L-glutamic acid 
 Maleic acid 
 
 Nicotinic acid 
 Oxalic acid 
 Oxamic acid  
(OXA) 
 Picolinic acid 
 Squaric aicd 
 Taurine 


















After evaporation, samples were screened for new multi-component materials using a combination 
of PXRD and SXRD.  
 
Preparation of 3-deazauracil molecular complexes 
As can be seen from Table 7.1 and 7.2, of the 19 co-formers tested, three of these formed molecular 
complexes with 3-deazauracil (3DU); these will be discussed here. 
 
Table 7.2 Evaporative crystallisation conditions by which three 3DU multi-component 
















TRIM 26 20 1:1 methanol/water 
4 
18 
OXA 30 17 1:1 water 18 
BP 30 20 1:1 methanol/water 4 
 
3DU (20.8 mg, 18.8 mMol) and trimesic acid (TRIM) (39.4 mg, 18.8 mMol) were dissolved 
separately, each in 2 mL methanol/water solution (50:50 by volume) at room temperature. The 
solutions were then combined forming a 1:1 ratio of 3DU to TRIM and left to evaporate under 
ambient conditions. Initially a mass of white hair-like needles formed and within this there were a 
few small colourless blocks. These were too small and coated in too many crystallites to be used for 
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SXRD. The alteration of the supersaturation of the mother liquor due to the removal of solids for 
analysis under optical microscope promoted dissolution of the needles and growth of the colourless 
blocks. A colourless block was then selected from the mother liquor for SXRD. 
 
3DU (20.8 mg, 18.8 mMol) and oxalic acid OXA (16.9 mg, 18.8 mMol) were dissolved separately 
in water (2 mL each) at room temperature. The solutions were combined to produce a 1:1 solution 
of 3DU to OXA. This was left to evaporate under ambient conditions for several days. A colourless 
block crystal was selected for SXRD.  
 
3DU (13.9 mg, 12.5 mMol) and 4,4’-bipyridyl (BP) (19.5 mg, 12.5 mMol) were dissolved separately, 
each in 2 mL methanol/water solution (50:50 by volume) under ambient conditions. After combining 
the solutions to form a single 1:1 solution of 3DU:BP the vial was placed in the fridge at 4°C. A 
mass of pale yellow needles crystallised after 5 days from which a needle suitable for SXRD was 
selected.  
7.1.1 Structural Analysis and Characterisation of 3-deazauracil Trimesic Acid (1:1) 
Monohydrate (3DU:TRIM:H2O) 
SXRD data were collected using a Rigaku R-axis/RAPID161 single crystal diffractometer at 100 K 
using Mo Kα radiation (λ = 0.71073 Å). The structure was solved by charge flipping using 
SUPERFLIP within the WinGX v2014.1162 package and was refined using SHELXL-2014163. 
 
 
Figure 7.2 Molecular structures of 3-deazauracil (3DU) and trimesic acid (TRIM) 
 
3DU-TRIM crystallises in the spacegroup P21/c with two molecules of 3DU, two molecules of TRIM 




Figure 7.3 Asymmetric unit of 3DU-TRIM comprising two molecules of TRIM, two molecules of 
3DU and two water molecules 
 
Figure 7.4 Labelling scheme of molecules within 3DU-TRIM asymmetric unit  
Both molecules of 3DU adopt tautomeric configuration c (Figure 7.1) with a secondary amine, a 
carbonyl group situated in the ortho position and an alcohol situated at the para position. 
 
TRIM A forms an O5-H5···O35 hydrogen bond interactions with 3DU B and 3DU B interacts with 
Water A an O33-H33···O41) (Figure 7.5 a and b, respectively) to create a trimer unit. Trimer units 
translate through the glide planes (running parallel to the a axis) to form a tape of trimer units joined 
through an O2-H2···O35 and an N36-H36···O3 hydrogen bond between TRIM A and 3DUB in 
neighbouring trimers (Figure 7.5 d and e, respectively). The TRIM A tape is further strengthened by 
an O-H···O hydrogen bond between TRIM A and Water A in adjacent trimers (Figure 7.5 c).  
 
Trimers are also formed through O-H···O hydrogen bonding (Figure 7.6 f and g) between TRIM B, 
3DU A and Water B and form extended TRIM B tapes which are isostructural with the TRIM A 
tapes except for the orientation of molecules of Water A which are oriented such as to facilitate 
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bifurcated C=O···HNHN hydrogen bonds between water A and TRIM B in a single tape and TRIM 
B tape and Water A in a neighbouring TRIM B tape (Figure 7.6 g and k). 
 
Alternating TRIM A tapes and TRIM B tapes form extended sheets through pairs of O-H···O 




Figure 7.5 Trimer unit within TRIM-BP structure comprising,  TRIM A, 3DU B and Water A (left), 
which interact with adjacent trimers through two O-H···O hydrogen bonds (c and d) and an N-




Figure 7.6 Trimer unit within TRIM-BP structure comprising,  TRIM B, 3DU A and Water B (left), 
which interact with adjacent trimers through two O-H···O hydrogen bonds (h and i) and an N-
H···O hydrogen bond (j) to form a TRIM A extended tape (right). Atom O23 forms an additional 




Figure 7.7  TRIM A trimer tapes (green and yellow) bond with adjacent TRIM B trimer tapes (red 
and blue) through pairs of O-H···O hydrogen bonds (l and m) to form an extended sheet.  
 
Extended sheets of alternating trimer tapes are aligned parallel to the (2 0 -1) plane and stack 
perpendicular to this interacting through bridging hydrogen bonded water molecules and - 




Figure 7.8 TRIM-BP structure viewed down the b-axis highlighting the layers of extended sheets 
aligned parallel to (2 0 -1) interacting through hydrogen bonding between channels of Water B 




Table 7.3 Hydrogen bond distances and angles within the 1:1 3DU-TRIM monohydrate co-crystal 
D-H···A   D-H (Å)          H···A (Å)          D···A (Å) <(DHA) (o) 
O2-H2···O35 #1            1.00(7) 1.59(7) 2.595(5) 175(5) 
O5-H5···O35 #2 0.91(6) 1.66(6) 2.566(5) 173(5) 
O8-H8···O29 #3            0.87(5) 1.81(5) 2.667(5) 168(4) 
O13-H13···O51            0.85(5) 1.84(5) 2.694(5) 179(5) 
N16-H16···O26 #1           0.94(5) 1.92(5) 2.820(5) 161(4) 
C14-H14···O22 #4             1.00(5) 2.63(5) 3.277(6) 122(3) 
C14-H14···O51 1.00(5) 2.48(5) 3.174(6) 127(3) 
O22-H22···O15 #5              1.08(7) 1.46(8) 2.533(4) 172(6) 
O25-H25···O15 #1              0.90(6) 1.72(6) 2.605(5) 165(5) 
O28-H28···O9 #6              0.86(4) 1.79(5) 2.640(5) 173(4) 
O33-H33···O41 #7              0.94(7) 1.80(7) 2.733(7) 167(6) 
N36-H36···O3 #1              0.91(5) 1.97(5) 2.854(6) 164(4) 
C34-H34···O41 #7              0.89(5) 2.63(5) 3.287(8) 131(4) 
O41-H22···O6              0.94(2) 1.86(3) 2.771(6) 164(8) 
O51-H51···O23 #8              0.937(19) 1.95(3) 2.830(5) 155(4) 
O51-H52···O23              0.942(18) 1.99(3) 2.899(5) 162(4) 
Symmetry transformations used to generate equivalent atoms: 
#1(-x+1, -y+1, -z), #2(x-1, -y+3/2, z-1/2), #3(-x+1, y+1/2, -z+1/2), #4(x, -y+1/2, z+1/2),   
#5(x, -y+1/2, z-1/2), #6(-x+1, y-1/2, -z+1/2), #7(-x+1, -y+2, -z), #8(-x+1, -y, -z) 
 
7.1.2 Structural Analysis and Characterisation of 3-deazauracil Oxalic Acid (1:1) 
(3DU:OXA) 
SXRD data were collected using an Agilent XCALIBUR single crystal diffractometer equipped with 
and Eos S2 CCD detector. The structure was solved by direct methods using SHELXS-2014163 within 
the WinGX v2014.1162 package and was refined using SHELXL-2014163. 
 
 
Figure 7.9 Molecular structures of 3-deazauracil (3DU) and oxalic acid (OXA) 
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3DU and OXA (Figure 7.9) crystallise in a 2:1 ratio to form a 3DU-OXA co-crystal where both 
molecular species remain neutral and the 3DU species, as in the 3DU-TRIM structure, adopts 
tautomeric configuration c (Figure 7.1). The asymmetric unit contains one molecule of 3DU and half 
a molecule of OXA which is situated on an inversion centre.  
 
 
Figure 7.10  Two 3DU-OXA-3DU units, each formed through two pairs of O-H···O (a) and C-H···O 
(b) hydrogen bonds and bonded together through a pair of N-H···O hydrogen bonds (c) 
 
 
Figure 7.11 Continuous tape formed of 3DU-OXA-3DU units 
A 3DU-OXA-3DU unit comprises one OXA molecule bonded to two 3DU molecules through two 
O2-H6···O3 hydrogen bonds between the OXA alcohol group and a carbonyl group on each 3DU 
molecule (Figure 7.10 a). These are stabilised by two weaker C4-H4···O4 hydrogen bonds to form 
two 𝑅 (8)2
2  motifs (which are identical due to the position on an inversion centre) (Figure 7.10 b). 
The 3DU-OXA-3DU units link to one another through pairs of moderate N1-H5···O2 hydrogen 
bonds (Figure 7.10 c) forming 𝑅 (8)2
2  motifs between 3DU molecules in neighbouring units which 
can extend to form a continuous tape. (Figure 7.11) (Hydrogen bond distances are given in  
Table 7.4). 
 
Along either edge of the tape there are exposed hydrogen donating alcohol groups (3DU molecules) 
alternating with hydrogen bond accepting carbonyl groups (OXA molecules) which form a 
moderately strong O1-H3···O4 hydrogen bond with a respective carbonyl group or alcohol group on 
another tape. (Figure 7.12 d). It is also possible to form weaker secondary O1-H3···O3 interactions, 
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whose strength within the bifurcated hydrogen bond thus formed will vary with any variation in the 
direction of the O1-H3 alcohol group (Figure 7.12 e). 
 
Table 7.4 Hydrogen bond distances and angles within the 2:1 3DU OXA co-crystal 
Hydrogen bond   D-H (Å)          H···A (Å)          D···A (Å) <(DHA) (o) 
N1-H5···O2 #1            0.90(2) 1.91(2) 2.803(1) 174(2) 
O1-H3···O4              0.89(2) 1.85(2) 2.729(1) 168(2) 
O1-H3···O3 #2            0.89(2) 2.50(2) 2.968(1) 114(2) 
O3-H6···O2 #3              1.08(2) 1.85(2) 2.440(1) 166(2) 
C4-H4···O4 #4 0.99(2) 2.50(2) 3.388(2) 149(1) 
Symmetry transformations used to generate equivalent atoms: 




Figure 7.12 Bifurcated O-H···OO hydrogen bonding between 3DU and OXA in five neighbouring 
chains and through (O1-H3···O4 (d) and O1-H3···O3 (e))  
 
As a result, each tape is bonded to four other tapes for every 3DU-OXA-3DU unit present in the 
tape. The extended tapes can adopt one of two orientations either parallel to the (1 1 -2) plane or 
parallel to the (1 -1 -2) plane (Figure 7.13). The four adjoining tapes adopt the same opposite 
orientation to the main tape (Figure 7.12), which is due to the conformational freedom inherent in 
the alcohol group of 3DU and the proximity of the 3DU molecules (3.615 Å , centroid to centroid) 




Figure 7.13 Two extended tapes in opposite orientations, parallel to either the (1 1 -2) plane or 
the (1 -1 -2) plane joined through bifurcated O-H···O hydrogen bonding 
 
Figure 7.14 π-π stacking between 3DU molecules of extended tapes stacked parallel to the 
a- axis when visualised down the b axis. 
 
7.1.3 Structural Analysis and Characterisation of 3-deazauracil 4,4’-bipyridine (2:1) 
Dihydrate (3DU:BP) 
SXRD was carried out using a Rigaku R-axis/RAPID161 single crystal diffractometer at 100 K using 
Mo Kα radiation (λ = 0.71073 Å). The structure was solved by direct methods using SHELXS-
2014163 within the WinGX v2014.1162 package and was refined using SHELXL-2014163. 
 
Figure 7.15 Molecular structures of 3-deazauracil (3DU) and 4,4’-bipyridine (BP) 
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3DU and BP (Figure 7.15) crystallise in a 2:1 ratio with an asymmetric unit comprising one molecule 
3DU, half a molecule of BP and two water molecules, one of which is 50:50 disordered. Within this 
2:1 dihydrated 3DU-BP co-crystal 3DU molecules related by a centre of inversion form homodimer 
units through two symmetry related N2-H8···O2 hydrogen bonds (2.782(4) Å). This leaves the 
hydroxyl groups within the 3DU homodimer available to interact with the nitrogen atoms within the 
BP molecule through O1-H6···N1 hydrogen bonds (2.622(5) Å) forming extended alternating chains 
(Figure 7.16).  
 
These chains adopt a non-planar “zig-zag” structure (Figure 7.17) which propagates parallel to the 
(0 1 0) plane in the a-b direction.  
 
 
Figure 7.16 An alternating chain of 3DU homodimers and BP molecules bonded through O-H···N 
hydrogen bonds 
 
Figure 7.17 Schematic showing zig-zag shape of the alternating chains 
 
The chains connect to form extended sheets through C1-H1···O1 hydrogen bonds and neighbouring 
sheets are held together through C1-H1···O1 hydrogen bonds where the atoms C1 and H1 exist in 
one layer and O1 resides in the adjacent layer this is possible due to the “zig-zag” nature of the chains 
the 3DU and BP molecules (Figure 7.18). The layers are also connected by channels of water 
molecules (omitted from Figure 7.18 for clarity) that run parallel to the b-axis (Figure 7.19) and π-π 
interactions (centroid to centroid distance of 3.779 Å) between 3DU-BP ribbons stacked parallel to 




Figure 7.18 The chains connect through C1-H1···O1 hydrogen bonds to form an extended sheet. 
Note the atoms circled in red are also C1, H1 and O1, however due to the zig-zag nature of the 
chains the 3DU and BP molecules are oriented such that they form C1-H1···O1 hydrogen bonds 
to chains in the neighbouring layers 
 
Figure 7.19 3DU-BP viewed down the c-axis showing a disordered hydrogen bonded water 
channel parallel to the b-axis which not only interconnects the 3DU-BP ribbons to form 
extended sheets but also links the neighbouring sheets together 
 
Figure 7.20 π-π interactions between 3DU-BP extended ribbons 
 211 
 
Table 7.5 Hydrogen bond distances and angles within the 2:1 3DU-BP dihydrated co-crystal 
Hydrogen bond   D-H (Å)          H···A (Å)          D···A (Å) <(DHA) (o) 
C4-H4···O3 #1 0.93 2.49 3.367(5) 157 
C1-H1···O1 #2 0.93 2.45 3.344(5) 162 
C5-H5···O4A #3 0.93 2.53 3.387(9) 154 
O3-H11···O2 #3 0.92(2) 1.91(3) 2.767(4) 154(4) 
O3-H12···O2 0.92(2) 1.92(3) 2.769(4) 152(4) 
O1-H6···N1 1.08(7) 1.55(3) 2.622(5) 177(5) 
O4A-H14···O3 #4 0.92(2) 1.89(3) 2.801(8) 167(10) 
O4B-H13···O3 #4 0.92(2) 1.94(5) 2.822(8) 160(12) 
O4B-H16···O4B #5 0.90(2) 1.98(8) 2.77(1) 146(13) 
N2-H8···O2 #6 0.90(8) 1.88(8) 2.782(4) 172(7) 
Symmetry transformations used to generate equivalent atoms: 
#1(x-1/2, y+1/2, z), #2(-x+1/2, y-1/2, -z+1/2), #3(x, y+1, z), #4 (x-1/2, y-1/2, z), #5 (-x, -y+1, -z),  
#6 (-x+1/2, -y+1/2, -z) 
 
 
Of the three structures discovered containing 3DU, 3DU-BP and 3DU-OXA are most similar, both 
containing moderate 3DU homodimer motifs creating alternating 3DU dimer – conformer ribbons 
and tapes, respectively. The 3DU homodimer is not present in the 3DU-TRIM structure probably 
owing to the three fold symmetry within the TRIM molecule rather than the two fold symmetry 
observed for BP and OXA molecules. The structure is additionally disrupted by the introduction of 
solvent water molecules.  
 
Further investigation into the crystallisation conditions of these systems is required to ascertain if it 




Table 7.6 Crystallographic data for co-crystals of 3DU with TRIM, OXA and BP 







Molecular weight  
(g mol-1) 
339.25 156.12 450.45 
Temperature (K) 100 101 100 








a (Å) 26.157(4) 3.6146(1) 22.557(9) 
b (Å) 15.930(2) 10.6233(3) 3.779(2) 
c (Å) 7.0089(8) 16.2437(4) 27.05(1) 
α (o) 90.0 90.0 90.0 
β (o) 93.921(7) 90.411(2) 110.580(8) 
γ (o) 90.0 90.0 90.0 
Volume (Å3) 2913.6(7) 623.73(3) 2158.5(15) 
Z 8 4 4 
θ range/˚ 2.996-27.485 4.036-28.985 3.116-27.480 
Completeness (%) 99.8 99.6 97.9 
Reflections 
Collected 
55909* 7116 9783 
Independent 6672 1524 2393 
Refln (obs.I> σ(I)) 2642 1289 1259 
Rint 0.2328* 0.0321 0.1052 
Parameters 521 124 181 
GooF on F2 0.956 1.061 1.136 
R1 (Observed) 0.0951 0.0374 0.0810 
R1 (all) 0.2322 0.0462 0.1386 
wR2 (all) 0.2701 0.0921 0.3443 
 
*Note that due to the needle morphology and poor quality of the 3DU-TRIM crystals it was difficult to obtain high quality 
data, hence the poor Rint of 23%. The large number of reflections collected is attributed to poor crystal quality which lead 
to an ambiguity in the value of the γ angle during unit cell screening and the decision was taken to collect a full sphere of 
data.  
7.2 Molecular Complexes of 5-hydroxyuracil 
Many uracil derivatives, including 5-fluorouracil164 and 5-hydroxyuracil165 (5OHU), have been 
identified and implemented as anti-cancer and antiviral agents. The uracil analogues either act as 
inhibitors or as substitutes for uracil in ribose nucleic acid (RNA), which disrupts the DNA 
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transcription process, inhibiting DNA replication and is particularly useful for cancer treatments as 
inhibits rapid cell division and can induce cell death166, 167. 
 
The structure of 5OHU (CSD ref: QARWAI) was first recorded by Copley et al. in 2005 in a study 
on crystal structure prediction of 5OHU along with 3-oxauracil, another uracil derivative used in 
cancer treatment.166 The study also identified a 5OHU DMSO solvate (CSD ref: QARWEM). These 
are the only two structures involving 5OHU deposited in the CSD at present. No known 
multicomponent crystal structures of 5OHU have been recorded and to date there isn’t any literature 
on co-crystal screening studies this coupled with status as a potential API target and favourable 
hydrogen bonding groups makes 5OHU a prime candidate for multi-component crystallisation.  
 
5OHU has the potential to tautomerise (Figure 7.21) and the tautomeric form adopted can 
significantly change the hydrogen bonding potential of the molecule, thus affecting its characteristics 
for potential molecular complex formation and the solid state packing these may adopt.  
 
 
Figure 7.21 Tautomers of 5-hydroxyuracil with potential to influence hydrogen bonding 
 
A range of different co-former materials (Table 7.7) were selected as candidates for screening for 
5OHU multi-component materials. Crystallisations were prepared using several solvents, solvent 
combinations (50:50 by vol.) and crystallisations temperatures. 
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 Succinic acid 
 riboflavin 
 pyridoxine 
 Pyrazine  
carboxamide 
 Oxamic acid 




 Malonic acid 
 Maleic acid 
 imidazole 
 Fumaric acid 
 cytosine 
 Caffeine 
 Benzoic acid 
 Benzimidazole 
 4,4’-bipyridyl 
 3,5-dinitrobenzoic  
acid 














Samples from the screening study were analysed using a combination of PXRD and SXRD which 
resulted in the discovery of a new 2:1 co-crystal of 5OHU with BP. From the 24 co-formers tested, 
molecular complex with 5-hydroxyuracil (5OHU) was obtained, with the co-former 4,4’-bipyridyl 
(BP). 
 
The 5OHU-BP complex was grown from a 1:1 solution of 5OHU:BP formed by combining a 
solution of 24 mg (18.8 mMol) of 5OHU in 2 mL of water and a solution of 29.3 mg (18.8 mMol) 
BP in 2 mL of water, both at 40°C. The solution was left to evaporate at 40°C for 5 days producing 
a mesh of off-white needle crystals formed from which a suitable single crystal was selected for 
SXRD.  
 
SXRD data was collected using a Rigaku R-axis/RAPID161 single crystal diffractometer at 100 K 
using Mo Kα radiation (λ = 0.71073 Å). The structure was solved by direct methods using SHELXS-
2014163 within the WinGX v2014.1162 package and was refined using SHELXL-2014163. 
7.2.1 Structural Analysis and Characterisation of 2:1 Co-crystal of 5-hydroxyuracil 
with 4,4’-bipyridine 
5OHU and BP (Figure 7.22) crystallise in a 2:1 ratio (5OHU:BP) which solves in the monoclinic 
space group C2/c with an asymmetric unit containing one molecule of 5OHU and half a molecule of 
BP. The 5OHU molecule exists as tautomer b (Figure 7.21) with two protonated nitrogen atoms, two 
carbonyl groups and an alcohol group. This is the same configuration adopted in the structure of 
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5OHU starting material166. Further structures would be required to determine if this was the most 
stable tautomer of 5OHU however the fact that the first structures discovered involving 5OHU are 
of this tautomeric configuration as are structures of other 5-substituted uracils indicates that it is a 
stable tautomer.  
 
Figure 7.22 Molecular structures of 5-hydroxyuracil (5OHU) and 4,4’-bipyridine (BP) 
Within the 5OHU-BP structure two molecules of 5OHU related through an inversion centre form a 
𝑅 (8)2
2  homodimer motif through two symmetry related N1-H1···O1 hydrogen bonds (2.8295 Å) 
(Figure 7.23 a). The O1 atom is acts as a bifurcated H-bond acceptor as it forms an O1···H2-N2 
hydrogen bond with a symmetry related neighbouring homodimer further stabilised by the second 
N2-H2···O1 (Figure 7.23 b). These moderately strong hydrogen bonding interactions form extended 
non-polar ribbon motifs (Figure 7.23 c) as observed in the crystal structure of the 5OHU starting 
material and in several other 5-substituted uracils including 5-ethyluracil and 5-chlorouracil168.  
 
 
Figure 7.23 Hydrogen bonding interactions between 5OHU in the 2:1 molecular complex of 
5OHU-BP. a) 𝑹 (𝟖)𝟐
𝟐  homodimer about an inversion centre, b) linking of dimers about inversion 
centre through another 𝑹 (𝟖)𝟐
𝟐  motif and c) a non-polar ribbon of 5OHU 
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The 5OHU ribbons are joined together through moderate O3-H4···N3 hydrogen bonds (2.785(2) Å) 
(supported by a weaker C5-H7···O2 hydrogen bonds) to BP linkers (Figure 7.24).  
 
 
Figure 7.24 O-H···N and C-H···O hydrogen bonding linking a 5OHU dimer within an extended 
ribbon (that would protrude from the page) to two twisted BP molecules  
 
The ribbons are slightly offset and staggered parallel to the b-axis with π-π interactions  
(3.394 – 3.632 Å) between the ribbons (Figure 7.25). The 5OHU homodimers within the ribbons 
alternate in orientation either parallel to the (-1 -1 6) plane or to the (-1 1 6) plane (Figure 7.26) with 
the BP linkers adopting an twisted configuration with the two six-membered rings positioned at 49 ° 
relative to one another (Figure 7.27). This results in the alternating 5OHU and BP structure observed 
in Figure 2.8.  
 
Figure 7.25 5OHU-BP and 5OHU-5OHU π-π stacking interactions between stepped layers within 
the 5OHU-BP crystal structure  
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Figure 7.26 Schematic highlighting the alternating alignment of the 5OHU ribbons. Depicted 
here are two ribbons parallel to the (-1 -1 6) plane interconnected through BP linkers to five 
5OHU ribbons orientated parallel to the (-1 1 6) plane running out of the page 
 
Figure 7.27 The mean planes drawn through both six-membered rings of the BP molecule 
(shown in red and blue) are at 49o to one another highlighting the twisted BP conformation  
 
Figure 7.28 The 5OHU-BP crystal structure viewed down the a-axis (a) and the b-axis (b)  
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Table 7.8 Hydrogen bond distances and angles within the 2:1 5OHU BP co-crystal 
D-H···A   D-H (Å)           H···A (Å)          D···A (Å) <(DHA) (o) 
N1-H1···O1 #1            0.88(2) 1.96(2) 2.830(2) 171(2) 
N2-H2···O1 #2 0.96(2) 1.84(2) 2.797(2) 174(2) 
O3-H4···N3 0.92(2) 1.91(2) 2.785(2) 159(2) 
C2-H3···O2 #3            1.06(2) 2.43(2) 3.419(2) 154(1) 
C6-H8···O3 #4            0.97(2) 2.51(2) 3.297(2) 139(1) 
C5-H7···O2              0.97(2) 2.25(2) 3.050(2) 139(1) 
Symmetry transformations used to generate equivalent atoms: 
 #1(-x+2, -y, -z+1), #2(-x+5/2, -y+1/2, -z+1), #3(x+1/2, y+1/2, z), #4(x-1/2,y-1/2,z) 
Table 7.9 Crystallographic data for 2:1 co-crystal of 5OHU and BP 
Compound 2:1 5OHU BP 
Formula 2C4H4N2O3· C10H8N2  
Molecular weight / gmol-1 412.37 
Temperature (K) 100 
Space Group (crystal system) C 2/c (monoclinic) 
a (Å) 12.4646(8) 
b (Å) 5.8255(5) 
c (Å) 23.976(2) 
α (o) 90.0 
β (o) 94.513(7) 
γ (o) 90.0 
Volume (Å3) 1753.6(2) 
Z 4 
θ range (˚) 3.28-27.48 
Completeness (%) 99.9 
Reflections Collected 10061 
Independent 1973 
Refln (obs.I> σ(I)) 1524 
Rint 0.0324 
Parameters 163 
GooF on F2 1.127 
R1 (Observed) 0.0370 
R1 (all) 0.0519 
wR2 (all) 0.1015 
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7.3  Molecular Complexes of 8-azaguanine 
8-azaguanine (8AG) is a particularly insoluble yet useful aza derivative of the nucleobase guanine, 
which has been involved in studies for the treatment of leukaemia due to its action as a cell 
poison169poorly soluble . The aim of this study is to alter the solubility of 8-azaguanine via multi-
component crystallisation and to transfer this process into the continuous flow environment. It was 
only possible to dissolve very small quantities of 8AG in water alone and only at high temperatures 
(90 °C). To aid dissolution of 8AG, alkaline additives were used such as sodium hydroxide and 
ammonium hydroxide.   
 
Several co-formers were chosen for their compatibility with the geometry of the hydrogen bond 
donor and acceptor sites of 8AG (Table 7.10). Other nucleobases were the first co-formers 
considered. As 8AG is a derivative of guanine which forms nucleobase paring with cytosine in DNA, 
cytosine was selected as a potentially successful co-former. Cytosine is highly soluble in water and 
through co-crystallisation it was hoped that the aqueous solubility of 8AG would be improved. 
Where solvents other than dilute ammonium hydroxide solution were required to dissolve the co-
former, the co-former and 8AG components were dissolved separately in their respective solvents 
and then combined in a single vial prior to evaporation at a set temperature. This ensured that the 
8AG was able to dissolve completely prior to evaporation. Of the 24 co-formers screened with 8AG 
a molecular complex was only discovered in crystallisations involving the cytosine co-former 
molecule.    
 






























 L-glutamic acid 
 L-histidine 
 Malic acid 
 Malonic acid 
 Nicotinic acid 
 Oxamic acid 
 Oxalic acid 
 Phthalic acid 
 Picolinic acid 


















Equimolar quantities of 8-azaguanine (8AG) and cytosine (Figure 7.29) were dissolved separately 
in water and a dilute ammonium hydroxide solution (2% ammonium hydroxide by volume), 
respectively, prior to mixing. Upon evaporation of the pale yellow solution at 60 °C, pale yellow 
crystals of block morphology were formed as well as yellow crystalline powder. 
 
A pale yellow block shaped single crystal was selected and data were collected using a Rigaku R-
axis/RAPID161 single crystal diffractometer at 100 K using Mo Kα radiation (λ = 0.71073 Å). The 
structure was solved by direct methods using SHELXS-97163 within the WinGX v1.8.05162 package 
and was refined using SHELXL-97163.  
 
7.3.1 Structural Analysis and Characterisation of 1:1 Monohydrated Molecular 
Complex of 8-azaguanine with Cytosine 
The components crystallise in the triclinic space group P1¯; the unit cell parameters and 
crystallographic data are given in Table 7.12 and the intermolecular hydrogen bonds involved in the 
structure are outlined in Table 7.11, below. 
 
 
Figure 7.29. Molecular structures of 8-azaguanine (8AG) and cytosine (CYT) 
 
A 1:1 molecular complex of 8AG and CYT (Figure 7.29) is formed with inclusion of one solvent 
water molecule per formula unit. Heterodimers (Figure 7.30) are formed through a pseudo Watson-
Crick hydrogen bonding interaction consisting of three moderately strong hydrogen bonds, N7-
H11···O2, N5-H4···N8 and N6-H6···O3 with D···A distances of 2.904(2) Å, 2.891(2) Å and 
2.819(2) Å, respectively (a, b and c of Figure 7.30). A Watson-Crick hydrogen bond interaction 
occurs readily between the complementary nucleobases guanine and cytosine in DNA; in spite of 
this, there is no recorded structure of a guanine cytosine complex in the CSD to date. However, it 
has been possible to form a 9-ethylguanine 1-methylcytosine complex (Figure 7.31) (CSD ref. 
EGMCYT10)170 in which the two components also form dimers through a pseudo Watson-Crick 
hydrogen bonded unit. The hydrogen bonding is similar to that found here in the 8AG-cytosine 
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dimer, hydrogen bond a* which, like a, is the longest of the three interactions (2.943(3) Å), c*, like 
c, is the shortest hydrogen bond (2.806(3) Å) and hydrogen bond b*, like b, is mid-length 
(2.924(3) Å).  
 
 
Figure 7.30. Pseudo Watson-Crick hydrogen bonding in heterodimer of 8-azaguanine and 
cytosine 
 
Figure 7.31. PseudoWatson-Crick hydrogen bonding in heterodimer of 9-ethylguanine 1-
methylcytosine complex170 
 
Figure 7.32. Tetramer unit formed using two equivalent N6-H5···O3 (d) hydrogen bonds in the 
molecular complex of 8-azaguanine cytosine monohydrate 
The heterodimers interlink through two equivalent moderately strong N6-H5···O3 hydrogen bonds 
(2.810(2) Å) to form a planar tetramer (Figure 7.32 d), where the dimers are related via an inversion 
centre at the centre of the R (8)4
2  bonding motif. Additional moderate N9-H7···O1 and O1-H2···N4 
hydrogen bonds occur between the tetramer and two solvent water molecules (Figure 7.33 e and f) 
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forming two 𝑅 (10)3
3  motifs converting this to a hexamer unit. Atom O1 does not lie in plane with 
the tetramer; it sits approximately 0.6 Å above or below it.  
 
Figure 7.33. . Hexamer unit formed through N9-H7···O1 (e) and O1-H2···N4 (f) hydrogen bonds 
in the molecular complex of 8-azaguanine cytosine monohydrate 
The hexamers arrange into an extended chain linked through moderately strong N7-H10···N1 
hydrogen bonds of distance 3.065(2) Å (g, Figure 7.34).  
 
Figure 7.34. Extended chain formed from hexamers interlinked through N7-H10···N1 (g) 
hydrogen bonds in the molecular complex of 8-azaguanine cytosine monohydrate 
 
Figure 7.35.Moderate (h) and weak (i) hydrogen bonding present in extended sheet structure in 
the molecular complex of 8-azaguanine cytosine monohydrate 
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Several extended chains hydrogen bond together to form an extended sheet. Moderately strong N3-
H3···O1 hydrogen bonds of 2.761(2) Å in length (h, Figure 7.35) occur between solvent water 
molecules from one chain and the aza ring of 8AG molecules in an adjacent chain. Additionally there 
are weak C7-H8···N2 hydrogen bonding interactions (3.260(2) Å) (i, Figure 7.35) present between 
the central nitrogen of the aza ring of one chain and a carbon in the six-membered ring of cytosine 
in the chain flanking this. In the structure of 8AG (CSD ref. AZGUAN01171) alone there is no 
hydrogen bonding present that involves the central nitrogen in the aza ring, but in the 8AG 
monohydrate structure (CSD ref. AZGUAN169) there is an O-H···N hydrogen bond of 2.927 Å 
between the central nitrogen in the aza ring and oxygen of the solvent water molecule. 
 
Figure 7.36. Moderate and weak hydrogen bond interactions present between adjacent 
extended chains in the molecular complex of 8-azaguanine cytosine monohydrate 
 
The extended sheets stack to form a layered structure linked through DHAA bifurcated hydrogen 
bonds (Figure 7.36) that are present between the non-planar O1 atom of a solvent water molecule 
(as discussed previously) and the atoms O2 and O2’ from two 8AG molecules within a neighbouring 
extended sheet. When three sheets are layered a 𝑅2
2(6) motif is formed, about an inversion centre, 
by two bifurcated hydrogen bonds (Figure 7.37). The bifurcated bonds are approximately 
symmetrical, D···A distances between O1 and O2 and O1 and O2’ are 2.996(2) Å and 3.010(2) Å, 
respectively.  
 
The 8AG molecules stack upon other 8AG molecules in neighbouring layers and are parallel to one 
another. They are inverted with respect to each other about an inversion centre located halfway 
between the planes of the rings. The same is true for cytosine molecules, i.e. like stacks onto like. π-
π stacking interactions are present between the layered 8AG molecules (Figure 7.38). Between the 
layers A and B there are π-π stacking interactions present between the overlapping six-membered 
rings in each 8AG molecule at an inter-plane distance of ~3.24 Å. The five-membered aza rings of 
8AG in layers B and A’ also overlap giving rise to π-π stacking at an inter-plane distance of ~3.15 Å.  
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In the adjoining layers (B and A’), there are also additional π-π stacking interactions at an inter-
planar distance of ~3.21 Å between the six-membered rings of cytosine molecules (Figure 7.39). 
 
Figure 7.37. The DHAA bifurcated hydrogen bonding to water molecules in neighbouring layers 
in the molecular complex of 8-azaguanine cytosine monohydrate 
 
Figure 7.38. π-π stacking interactions between 8AG molecules from sheets in different layers in 
the molecular complex of 8-azaguanine cytosine monohydrate 
 
Figure 7.39. π-π stacking between cytosine molecules in adjacent sheets about an inversion 
centre (shown in yellow) in the molecular complex of 8-azaguanine cytosine monohydrate 
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Figure 7.40 π-π stacking interactions 
between  cytosine molecules in 
extended layers in the molecular 
complex of 8-azaguanine cytosine 
monohydrate 
Figure 7.41 Lack of overlap between 
cytosine molecules in A and B (or A’ 
and B’) extended layers in the 
molecular complex of 8-azaguanine 
cytosine monohydrate 
There is alternation between π-π interactions between cytosine molecules in B and A’ and a lack of 
π-π interactions between cytosine molecules in A and B (or A’ and B’) (Figure 7.40). Although the 
inter-plane distance between cytosine molecules in A and B is 3.097 Å, which is conducive to 
π-π interactions, the molecules are severely offset so π overlap is poor (Figure 7.41) 
 
Table 7.11. Hydrogen bond distances within the 1:1 8-azaguanine cytosine monohydrate 
molecular complex 
D-H···A   D-H (Å)           H···A (Å)          D···A (Å) <(DHA) (o) 
O1-H1···O2 #1 0.86(2) 2.24(2) 3.010(2) 146(2) 
O1-H1···O2 #2 0.86(2) 2.31(2) 2.996(2) 135(1) 
O1-H2···N4 #3 0.93(2) 1.86(2) 2.782(2) 172(2) 
N5-H4…N8 0.94(2) 1.95(2) 2.891(2) 177(2) 
N7-H10···N1 #4 0.90(2) 2.18(2) 3.065(2) 169(2) 
N6-H6···O3 0.92(2) 1.90(2) 2.819(2) 175(2) 
N9-H7···O1 #5 0.87(2) 2.07(2) 2.934(2) 173(2) 
N3-H3···O1 0.90(2) 1.90(2) 2.761(2) 159(2) 
N6-H5···O3 #6 0.92(2) 1.97(2) 2.810(2) 151(2) 
N7-H11···O2 0.90(2) 2.00(2) 2.904(2) 178(2) 
Symmetry transformations used to generate equivalent atoms: 




Table 7.12. Crystallographic data for monohydrated 1:1 8-azaguanine cytosine molecular 
complex 
Compound  8AG cytosine monohydrate 
Formula C4H5N3O· C4H4N6O· H2O 
Crystallisation Conditions Water with NH3. 60 °C 
Molecular weight / gmol-1 281.26 
Temperature (K) 100 
Space Group P-1 
a (Å) 7.172(2) 
b (Å) 8.779(3) 
c (Å) 9.961(3) 
α (o) 78.334(6) 
β (o) 78.786(7) 
γ (o) 66.631(6) 
Volume (Å3) 559.3(3) 
Z 2 
θ range (˚) 3.07-27.48 
Completeness (%) 99.6 
Reflections Collected 14108 
Independent 2555 
Refln (obs.I> σ(I)) 2108 
Rint 0.0299 
Parameters 225 
GooF on F2 1.007 
R1 (Observed) 0.032 
R1 (all) 0.0408 






7.4 Molecular Complexes of 5-fluorocytosine: synthesis by co-crystallisation 
and development of cooling crystallisation routes 
7.4.1 Introduction 
A substantial co-crystal screen was carried out of fluorinated nucleotide bases with a range of 
different carboxylic derivatives in order to investigate the effect of co-crystallisation upon solubility 
of the fluorinated nucleotide bases for their potential use as APIs (J. King & K. E. Wittering; J. King 
MChem project, University of Bath, 2013). Nucleobases are precursors for a range of APIs, 
especially cytosine which forms the basis of several anticancer and retroviral drugs such as 
Lamivudine and Cytarabine172. 5-flurocytosine is an antimycotic API that displays anti-fungal 
properties and is often used for fungal infection treatment administered in combination with 
amphotericin B173. 
 
One of the other key aims of this research was to use the anticipated co-crystal systems as an initial 
vehicle for moving away from the more commonplace small scale evaporative crystallisation into 
small scale cooling crystallisation in preparation for scale up to continuous cooling crystallisation. 
Two new multi-component molecular complexes of cytosine (CYT) and 5-fluorocytosine (5FCYT) 
with 4-chloro-3,5-dinitrobenzoic acid (4Cl35DNBA) were discovered in this study, and were 
selected as potential candidates for transfer to continuous cooling crystallisation. The structural and 
physical characterization of the new materials and preliminary experiments to transfer these systems 
into controlled small scale cooling crystallisation are discussed here and have been published by 
Wittering et al.100 
  
In addition, a previously unreported polymorph of 4Cl35DNBA was identified through analysis of 
the starting material supplied by Sigma Aldrich, which emphasises the need to analyse the starting 
materials, as discussed for barbituric acid in section 4.1.  The structural comparison to 4Cl35DNBA 
Form I, reported by Rehman et al.174, is detailed in section 7.4.5.100  
7.4.2 Materials 
5-fluorocytosine, 98% pure was obtained from Fluorochem Ltd. (Hadfield, UK) and cytosine, 99% 
pure, and 4-chloro-3,5-dinitrobenzoic acid, 97% pure were both supplied by Sigma Aldrich 
(Gillingham, UK). All crystallisations were performed using either 99% acetone or 99.8% ethanol 




7.4.3 A 1:1 Molecular Complex of 5-fluorocytosine and 4-chloro-3,5-dinitrobenzoic 
Acid 
 Experimental 
5FC and 4Cl35DNBA (Figure 7.42) were co-crystallised in an ethanol and water solvent mix (1:1 
by volume). 5FC (13.2 mg) and 4Cl35DNBA (12.9 mg) were measured into a glass vial and 
dissolved in the solvent solution using a combination of sonication and gentle heating. The solution 
was added into a single glass vial, sealed with a perforated plastic lid and left at room temperature 
(18–22 °C) for slow evaporative crystallisation. 
 
Figure 7.42 Molecular structures of 5-fluorocytosine (5FC) and 4-chloro-3,5-dinitrobenzoic acid 
(4Cl35DNBA) 
 Structural Analysis and Characterisation 
The 1:1 molecular complex of 5-fluorocytosine and 4-chloro-3,5-dinitrobenzoic acid (5FC-
4Cl35DNBA) is a salt with proton transfer indicated from the carboxylic acid group of 4Cl35DNBA 
to the lone pair of the free N2 of 5FC.  Heterodimers are formed through two charge-assisted N-
H···O hydrogen bonds (N···O distances 2.722(1) Å and 2.803(1) Å) (Figure 7.43 a and b, 
respectively). Two heterodimers related by a centre of inversion combine to form a tetramer through 
an additional N-H···O hydrogen bond (N···O 2.871(1) Å) as well as a C-H···F weak hydrogen bond 
(C···F 3.091(1) Å). Each tetramer unit forms two further hydrogen bonds to neighbouring tetramers 
through atoms O6 (H-bond acceptor) and N1 (H-bond donor). These connected chains pack in a zig-





Figure 7.43 A tetramer unit of the 5FC-4Cl35DNBA molecular complex. (a) and (b) are the N-
H···O hydrogen bonds forming the dimer, (c) and (d) are the N-H···O and C-H···F hydrogen 
bonds, respectively, that connect the two dimers together into the tetramer 
 
Table 7.13 Hydrogen bond distances within the molecular complex of 5FC and 4Cl35DNBA 
D-H···A   D-H (Å)           H···A (Å)          D···A (Å) <(DHA) (o) 
C4-H2···F1 #1 0.95(2) 2.23(2) 3.091(1) 150(1) 
N1-H6···O6 #2 0.84(2) 2.07(2) 2.810(1) 147(2) 
N3-H4···O5 #3 0.85(2) 2.08(2) 2.871(1) 154(2) 
N3-H3···O5 #4 0.92(2) 1.88(2) 2.803(1) 177(2) 
N2-H7···O6 #4 0.95(2) 1.78(2) 2.722(1) 171(2) 
Symmetry transformations used to generate equivalent atoms: 
#1(x, y+1, z), #2(x-1/2, -y+5/2, z-1/2), #3(x, y-1, z), #4(-x+2, -y+3, -z) 
 
PXRD shows that when crystallisation is initiated from a solution of a 1:1 ratio or a 2:1 ratio of 
starting materials (5FC:4Cl35DNBA), the same 1:1 5FC-4Cl35DNBA complex is formed, which is 
indicated by the intense peaks at 24.4o 2θ and 27.3o 2θ in the PXRD (Figure 7.44). However, when 
crystallised using a 1:2 starting ratio of 5FC to 4Cl35DNBA a unique and intense PXRD peak can 
be seen at 26.4° 2θ. This does not correspond to the 5FC-4Cl35DNBA complex, nor is it 
representative of either 5FC or 4Cl35DNBA (including any known hydrates or solvates). This would 
infer that there is new material present, which could be a new polymorph, a new multi-component 
molecular complex or another solvate of the starting materials; further analysis is required to 




Figure 7.44 PXRD pattern generated from the single crystal determined structure of  5FC-
4Cl35DNBA for comparison with PXRD patterns of  (b) 4Cl35DNBA, (c) 5FC, and products of 
evaporative crystallisation of 5FC:4Cl35DNBA in ethanol:water (1:1 by volume) in various ratios: 
(d) 1:2 (e) 2:1 and (f) 1:1 
DSC of a pure sample of 5FC-4Cl35DNBA arising from 1:1 evaporative crystallisation (as 
characterised through PXRD) shows a single endothermic event at 196.1 °C prior to decomposition 
(Figure 7.45a). This does not correspond to the DSC traces of the 4Cl35DNBA and 5FC starting 
materials. 4Cl35DNBA displays an endothermic event at 162.2 °C (Figure 7.45 b), which 
corresponds to its literature melting point of 159-162 °C and 5FC displays an exothermic event at 
292.6 °C, which corresponds  to 5FC thermal decomposition (296 °C) (Figure 7.45 c). 
 
 
Figure 7.45 Differential scanning calorimetry of (a) 5FC-4Cl35DNBA (b) 4Cl35DNBA (c) 5FC  
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7.4.4 A 2:1 Monohydrated Molecular Complex of Cytosine and 4-chloro-3,5-
dinitrobenzoic Acid 
 Experimental 
CYT-4Cl35DNBA was formed from a saturated solution of the molecular components (Figure 7.46). 
20 ml of acetone and water solvent solution (1:1 ratio by volume) was added to a conical flask 
followed by a 4:1 ratio of CYT:4Cl35DNBA until a fully saturated solution was achieved for cooling 
crystallisation (111.5 mg 4Cl35DNBA and 236.5 mg CYT). However, this sample immediately 
formed a slurry which remained in suspension. A small aliquot was transferred into a separate vial 
where solvent was allowed to evaporate at a constant temperature of 30 °C. After approximately 24 
hours several single crystals formed. These were subsequently used for SXRD analysis. 
Interestingly, after 48 hours at 30 °C the rest of the slurry suspension began to re-dissolve. After 5-
7 days the solvent had completely evaporated and a mixture of small, yellow needle crystals and 
larger plate crystals were produced.  
 
Figure 7.46 Molecular structures of cytosine (CYT) and 4-chloro-3,5-dinitrobenzoic acid (4Cl35DNBA) 
 Structural Analysis and Characterisation 
In contrast to the 5FC-4Cl35DNBA molecular complex, CYT forms a monohydrated 2:1 complex 
with 4Cl35DNBA (CYT-4Cl35DNBA). The asymmetric unit contains a water molecule, a single 
4Cl35DNBA molecule and two cytosine molecules (Figure 7.47). Interestingly, only one cytosine 
molecule remains neutral while the other accepts a proton from the carboxylic acid group of the 
4Cl35DNBA molecule. De-protonation of the carboxylic acid group is indicated by the similarities 





Figure 7.47 Asymmetric unit of CYT-4Cl35DNBA displaying the hydrogen bonding interactions of 
the deprotonated 4Cl35DNBA carboxylic acid group with the cytosine homodimer 
 
Table 7.14 Hydrogen bond distances within the molecular complex of CYT and 4Cl35DNBA 
Hydrogen Bond D-H (Å) H···A (Å) D···A (Å) <DHA (°) 
N10-H3···O17 #1 0.91(3) 1.91(3) 2.806(3) 171(3) 
C26-H2···O3 #2 0.95(3) 2.08(3) 3.015(3) 169(2) 
C10-H8···O5 #3 0.94(3) 2.61(3) 3.527(3) 165(2) 
N15-H9···O13 #4 0.98(3) 1.83(3) 2.804(3) 178(3) 
N8-H5···O3 #5 0.96(3) 2.49(3) 3.186(3) 130(2) 
N8-H5···O4 #5 0.96(3) 1.85(3) 2.802(3) 170(3) 
N14-H12···O15 #6 0.90(3) 1.92(3) 2.793(3) 161(3) 
C20-H10···O8 #4 0.97(3) 2.53(3) 3.026(3) 112(2) 
N9-H4···N16 #7 0.91(3) 1.91(4) 2.820(3) 175(3) 
N8-H6···O17 #7 0.90(4) 1.91(4) 2.809(3) 174(3) 
N14-H13···O13 #8 0.90(4) 1.97(4) 2.865(3) 169(3) 
O15-H15···O6 #9 0.87(5) 2.46(4) 3.146(3) 136(4) 
O15-H15···O7 #10 0.87(5) 2.44(4) 3.055(3) 128(4) 
O15-H14···O4 0.85(5) 1.93(5) 2.743(3) 161(4) 
Symmetry transformations used to generate equivalent atoms: 
#1(x, -y+1/2, z-1/2), #2(-x+1, y-1/2, -z+1/2), #3(x, y-1, z), #4(x, -y+1/2, z+1/2), #5(-x+1, y+1/2, -z+1/2), 
#6(x, y+1, z), #7(x, -y+3/2, z-1/2),#8(x, -y+3/2, z+1/2),#9(-x, -y+1, -z),#10(-x, -y, -z) 
 
Variation in the protonation states of the two cytosine species facilitates formation of a cytosine 
homodimer bound through a pseudo Watson-Crick hydrogen bonding interaction consisting of three 
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moderately strong hydrogen bonds N8-H6···O17, N9-H4···N16 and N14-H13···O13 with D···A 
distances of 2.809 (3) Å, 2.820 (3) Å and 2.865 (3) Å, respectively (Figure 7.48). Three further 
prominent hydrogen bonds link the three components of the molecular complex. Atom H5 acts as a 
bifurcated hydrogen bond donor to the carboxylate ion of 4Cl35DNBA and the water molecule forms 
a moderate strength hydrogen bond with atom O4 of the carboxylate group. The cytosine and 
4Cl35DNBA molecules lie parallel to the (1 0 -1) plane with each inversion related layer hydrogen 
bonded to the other through a water molecule.   
 
Figure 7.48 A cytosine dimer with pseudo Watson-Crick hydrogen bonding arrangement within 
CYT-4Cl35DNBA 
The products of further evaporative crystallisations of cytosine with 4Cl35DNBA were analysed 
using a combination of SXRD and PXRD (Figure 7.49). This confirmed that when using a 2:1 ratio 
of cytosine to 4Cl35DNBA the initial stoichiometry was retained and the 2:1 molecular complex 
CYT-4Cl35DNBA was produced. However, when a 1:1 stoichiometry of starting materials was used 
a crystalline powder was formed and the resulting PXRD pattern does not correspond to any of the 
starting materials (including polymorphs or solvates) or to the 2:1 molecular complex; it may, 
therefore, represent an additional unknown complex which could be a 1:1 molecular complex of 





Figure 7.49 PXRD patterns of (a) cytosine, (b) 4Cl35DNBA and (c) a pattern calculated from the 
single crystal structure of CYT-4Cl35DNBA. These were compared with PXRD patterns of bulk 
products of evaporative crystallisation of cytosine and 4Cl35DNBA from different crystallisation 
conditions using (d) a 2:1 starting material ratio from ethanol and water, (e) a 1:1 starting 
material ratio from acetone and water, (f) a 2:1 starting material ratio in acetone and water and 
(g) supersaturated preparation from which the single crystal used for full SXRD data was 
obtained 
The DSC trace for this form is simpler than that observed for the 2:1 CYT-4Cl35DNBA with a single 
endothermic event at a similar onset temperature to the second event in the 2:1 molecular complex 
(1:1, 192.3 °C; 2:1 184.2 °C) (Figure 7.50). The DSC trace for the 2:1 complex has an initial broad 
endothermic event at 95 °C which may reflect a desolvation process or a transformation into a 




Figure 7.50 Differential scanning calorimetry of (a) 4Cl35DNBA and (b) cytosine, together with 
those for products of the evaporative crystallisation of cytosine and 4ClDNBA in: (c) a 2:1 
starting material ratio in ethanol and water; (d) a 2:1 starting material ratio in acetone and 
water; (e) a 1:1 starting material ratio in acetone and water 
7.4.5 A New Polymorph of 4-chloro-3,5-dinitrobenzoic Acid 
 Experimental 
Attempts at co-crystallisation with 5FCYT and 4Cl35DNBA from ethanol and water via small scale 
evaporative crystallisation yielded single crystals of 4Cl35DNBA Form II which was shown to be a 
previously unreported polymorphic form of the 4Cl35DNBA starting material (Figure 7.51), as 
supplied by Sigma Aldrich.  
 
Figure 7.51 Molecular structure 4-chloro-3,5-dinitrobenzoic acid (4Cl35DNBA) 
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 Structural Analysis and Characterisation 
Further to the discovery of the two new multi-component molecular complexes discussed above, an 
additional polymorphic form of the starting material 4Cl35DNBA (Form II) was also characterised. 
The known crystal structure of 4Cl35DNBA (Form I) (Cambridge Structural Database (CSD) 
Refcode TIBGIV174) contains one molecule in the asymmetric unit and crystallises in the triclinic 
crystal system with space group  P1̅. The PXRD pattern of the 4Cl35DNBA starting material taken 
as received from Sigma Aldrich does not match the PXRD pattern generated from SXRD data of 
Form I (Figure 7.52).   
 
Figure 7.52 PXRD patterns of (a) 4Cl35DNBA Form I (calculated from SXRD structure) (b) 
4Cl35DNBA Form II (calculated) (c) 4Cl35DNBA Form II (as supplied from Sigma Aldrich) 
 
The asymmetric unit of Form II consists of two independent 4Cl35DNBA molecules connected 
through two O-H···O hydrogen bonds between the carboxylic acid moieties creating a carboxylic 
acid dimer motif. Form I also contains similar 4Cl35DNBA homodimer motifs; however, the 
homodimeric motif in Form I is planar in contrast to the twisted, non-planar dimer of Form II 
 (Figure 7.53). In both polymorphs the homodimers pack through π-π stacking interactions to form 










Figure 7.54 4Cl35DNBA dimers packing into layered sheets through - stacking interactions in: 
(a) 4Cl35DNBA Form I (b) 4Cl35DNBA Form II 
 
 
Table 7.15 Hydrogen bond distances within the new polymorph of 4Cl35DNBA 
D-H···A D-H (Å) H···A (Å) D···A (Å) <(DHA) (o) 
O9-H6···O5 #1 0.84(2) 1.86(2) 2.695(1) 174(2) 
O6-H3···O10 #1 0.84(2) 1.78(2) 2.613(1) 171(2) 
Symmetry transformations used to generate equivalent atoms: 





Table 7.16 Crystallographic information on two new multi-component molecular complexes of 
4Cl35DNBA and a new polymorphic form of 4Cl35DNBA 
Molecular complex 
 








Molecular weight (g.mol-1) 375.7 486.8 246.6 
Temperature (K) 100 100 100  
Space group P21/n P21/c P21/n 
a (Å) 12.068(1) 14.383(3) 8.9032(4)  
 
b (Å) 6.0558(6) 8.399(2) 8.9201(6)  
c (Å) 18.857(2) 17.339(4) 22.697(2)  
 
α (o) 90.00 90.00 90.00 
β (o) 93.021(7) 110.478(8) 90.880(6) 
 
γ (o) 90.00 90.00 90.00 
Volume (Å3) 1376.2(3) 1962.1(7) 1802.3(2)  
Z 4 4 8 
ρ (calcd)/Mg m-3 1.813 1.648 1.817 
θ range/˚ 3.2-27.5 3.0-27.5 3.2-27.5 
Completeness (%) 99.9 99.9 99.8 
Reflections collected 17302 24995 20452  
No. of unique data [Rint] 3153 [0.031] 4495 [0.096] 4130 [0.029] 
No. of reflections with  
I>2σ(I) 
2918 2748 3532 
GooF on F2 1.063 1.004 1.017 
Final R1 (I>2 σ(I))  0.029 0.052 0.028 
Final wR2 (all data) 0.081 0.152 0.069 
CCDC No. 976509 976510 976508 
 
7.4.6 Solubility Analysis of 5FC-4Cl35DNBA 
To inform and help interpret the targeted cooling crystallisation experiments, and also as a key target 
property in crystal engineering approaches to new solid forms, solubility analysis of 5FC-
4Cl35DNBA was carried out using the Crystal16. This confirms that the molecular complex is 
significantly less soluble than both 5FC and 4Cl35DNBA starting materials (Figure 7.55). It proved 
difficult to collect a wide range of solubility data for 4Cl35DNBA using the Crystal16 due to its very 
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high solubility. The volume of solid required to saturate the solution at high temperatures was too 
great for the small 2 mL vials. Additionally, when using large volumes of solid, magnetic stirring 
within the vials was hindered. 
 
Figure 7.55 Comparison of solubility of 5FC-4Cl35DNBA co-crystal with 5FC and 4Cl35DNBA 
starting materials 
Solubility analysis showed 4Cl35DNBA to be approximately six times more soluble in ethanol than 
5FC. 5FC was more soluble in ethanol than in water and 4Cl35DNBA did not dissolve in water 
alone. In light of this a mixture of ethanol and water was used to help to reduce the solubility of 
4Cl35DNBA. Turbidity measurements showed a 7:3 mixture of ethanol to water (by volume) to be 
a suitable ratio of solvents for this system.  
7.4.7 Transfer to Cooling Crystallisation 
Each mixture of molecular components was added to 20 ml of hot solvent solution (50 °C) until 
saturated. After this, the solution was left to settle whilst held at 50 °C. The top aliquot was removed 
using a heated syringe with micro filter and was subsequently divided into several 2.5 ml glass vials, 
each sealed with a cap and plastic paraffin film to minimise any possibility of evaporative 
crystallisation. The glass vials were then placed into a Barnstead/Stem RS12 ReactArray Reaction 
Block (RB) with an RS12 power supply and subjected to one of two cooling profiles generated and 
controlled using ReactArray Solo software Version 0.9.0.0 © 2005 Anachem Ltd.  In cooling profile 
1, which was used for solutions prepared with acetone, the vials were held at 50 °C for an hour 
followed by cooling to -5 °C at 0.2 °Cmin-1. Cooling profile 2 held the vials at 65 °C for an hour 
prior to cooling at a rate of 0.5 °Cmin-1 to -5 °C. This was used for solutions prepared with ethanol. 





Four cooling crystallisations of 4Cl35DNBA with cytosine or 5FC were carried out with differing 
conditions (Table 7.17); all produced very fine, yellow needle crystals. SXRD analysis of each 
sample showed that several crystals in each preparation corresponded to the targeted molecular 
complex previously discovered through evaporative routes as described above.  
 
Table 7.17 Cooling crystallisation experiments of CYT with 4Cl35DNBA and 5FCYT with 
4Cl35DNBA using a ReactArray Reaction Block 
Sample Components Ratio  Solvent Cooling profile 
A CYT, 4Cl35DNBA 1:1 acetone and water 1 
B 5FC, 4Cl35DNBA 1:1 acetone and water 1 
C 5FC, 4Cl35DNBA 1:1 ethanol and water 2 
D 5FC, 4Cl35DNBA 1:2 ethanol and water 2 
 
PXRD analysis of sample A (Figure 7.56) confirmed that CYT-4Cl35DNBA was produced, though 
it is important to note that the peak intensities do vary due to preferred orientation. The bulk of 
samples B, C and D were confirmed to be 5FC-4Cl35DNBA (Figure 7.57). 
 
 
Figure 7.56 PXRD analysis of products of cooling crystallisation A (a) CYT (b) 4Cl35DNBA (c) CYT-




Figure 7.57 PXRD Analysis of cooling crystallisations B, C and D. (a) 5FC (b) 4Cl35DNBA (c) 5FC-
4Cl35DNBA (d) Product B (e) Product C (f) Product D 
The formation of 5FC-4CL35DNBA could be followed during the cooling crystallisation using 
turbidimetric methods using a Crystal16 apparatus (Figure 7.58). Initially the turbidity signal is noisy 
due to the particle size but ranges from 60% to 100% transmittance. As the temperature increases 
the solution becomes turbid and the transmittance drops to 0%. This increase in turbidity with an 
increase in temperature in the early stages of the process is perhaps counterintuitive and indicates 
the initial, rapid, formation of the less soluble multi-component complex (as shown by solubility 
measurements of the complex). As the temperature continues to increase, 5FC-4Cl35DNBA 
dissolves and the solution develops 100% transmittance. 5FC-4Cl35DNBA then recrystallises upon 
cooling and the transmittance returns to 0%. Importantly, repetition of the heating and cooling 
temperature ramps then follows the expected trend, showing cloud points and clear points at the 
same temperatures as before. 
 
It should be noted that there are very few previous examples of the crystallisation of multi-
component complexes by cooling at this scale. This relatively simple methodology thus acts as an 
exemplar for the intended transfer of such processes into the continuous environment, by establishing 
the initial cooling stage. It is also useful to note that these determinations illustrate that significant 
progress can be made in establishing such crystallisation processes using relatively simple analytical 
methods such as turbidity measurement (while acknowledging its inherent limitations), even in the 





Figure 7.58 Plot of turbidity data from cooling crystallisation of 5FC with 4Cl35DNBA (1:2) in 
ethanol and water (7:3 by volume).  The temperature regimes used are shown in red. 
PXRD analysis of a range of samples from Crystal16 experiments confirm the formation of 5FC-
4Cl35DNBA (Figure 7.59) as indicated by the initial precipitation shown in the turbidity data. It 
should be noted, however, that when a slower cooling rate of 0.5 °Cmin−1 was used, residual 
4Cl35DNBA form II was present in the product as shown by the additional peaks in the PXRD 
pattern at 15.6° 2θ and 28.2° 2θ (Figure 7.59 d). While such a slow cooling rate is unlikely to be 
industrially relevant, for example, this element of the study was undertaken to explore the effect of 
cooling rate on the crystallisation products. The melt at 154.3 °C observed in DSC analysis (Figure 
7.60 a) is much lower than those for the other samples, and is similar to the melting point of 
4Cl35DNBA form II (162.2 °C). The other samples show endothermic events at 197.9 °C and 
195.8 °C which are consistent with the 5FC-4Cl35DNBA sample produced from evaporative cooling 





Figure 7.59 PXRD analysis of cooling crystallisations carried out using the Crystal16 apparatus: 
(a) 5FC (b) 4Cl35DNBA form II (c) 5FC-4Cl35DNBA. Products from 5FC and 4Cl35DNBA 
crystallisation in ethanol:water (7:3 by volume) in a: (d) 1:2 starting material ratio  




Figure 7.60 Differential scanning calorimetry of cooling crystallisations using the Crystal 16 
involving 5FC-4Cl35DNBA.  5FC with 4Cl35DNBA in ethanol:water (3:7 by volume) in a:  
(a) 1:2 ratio (0.5 °Cmin-1), (b) 1:2 ratio (2 °Cmin-1) and (c) 1:1 ratio (2 °Cmin-1) (d) 4Cl35DNBA (e) 




The work presented here represents the initial attempts to develop control over cooling crystallisation 
of the 5FC-4Cl35DNBA multi-component system. The crystallisation products from evaporative 
experiments have been reproduced using small scale cooling crystallisation and attempts have been 
made to optimise the crystallisation conditions to enable full conversion to the co-crystal. This initial, 
empirical investigation has established crystallisation under cooling of the target complexes, and the 
dependence of yield of co-crystal as a function of cooling rate and is of immediate value to the aim 
of establishing a cooling regime for initial transfer into the cooling/continuous crystallisation 
environment.  
7.4.9 Future Work 
The initial empirical approach reported here should be augmented and supported by more 
comprehensive quantitative studies, for example using PAT exploiting different spectroscopic 
probes such as solution state Raman and Infrared spectroscopies, or by comprehensive dissolution 
studies. In particular further investigation is required to understand fully the initial association 
process visualised in this work by the simplest of these PAT methods, turbidity. 
 
The Crystal16 has been used previously to map out phases for multi-component systems175 and the 
overarching aim is to carry out full mapping of these systems to aid control of future crystallisation 
scale up for multi-component systems. This apparatus also shows potential for future insight into the 
crystallisation kinetics of the multi-component nucleation process through study of MSZW and 
crystallisation induction times176. Understanding, monitoring and control of the initial association 
step in crystallisation is a key theme within the CMAC collaboration. It provides fundamental 
underpinning preparation for future scale-up, in order to achieve a well-integrated and controlled 
cooling crystallisation process with uniform particle attributes in the continuous crystallisation 





7.5 Multi-component Crystallisation of Fenamic Acid Derivatives: 
transferability of crystallisation methods and physical property 
enhancement 
7.5.1 Introduction 
This work was initially developed in preparation for a research-led undergraduate chemistry course, 
Frontiers of Crystallography, an idea developed and first implemented by Wilson, Parkin and 
Thomas in the School of Chemistry at the University of Glasgow178. The complexes initially 
produced for the structural elements of that course were subsequently characterised extensively with 
respect to their physical properties, structure-property relationships and the transferability of their 
production across crystallisation methods. The findings are reported here and have been published 
by Wittering et al21. 
 
Fenamic acid (FEN) along with its derivatives mefenamic acid (MEF), tolfenamic acid (TOL) and 
flufenamic acid (FLU) were chosen as target materials for multi-component crystallisation screening 
studies as a highly topical class of non-steroidal anti-inflammatory APIs (NSAIDs) with a highly 
polymorphic nature due to the conformational freedom at the secondary amine, present in all four 
molecules. 
7.5.2 Materials 
MEF, FLU, FEN and BP were purchased from Sigma Aldrich Chemie Gmbh (Steinheim, Germany) 
and TOL was purchased from TCI UK Ltd (Oxford, UK). All reagents were used without further 
purification. Laboratory grade solvents purchased from Sigma Aldrich were used for all 
crystallisations.  
7.5.3 Evaporative Crystallisation 
Thorough co-crystal screening studies were conducted through evaporative crystallisation methods 
using several different GRAS co-former molecules, solvents, ratios of fenamic acid derivative 
(FAD) to co-former and crystallisation temperatures (ca. 200 crystallisations; see Table 7.18). 
 
The crystallisations were prepared using the minimal solvent required for dissolution with the aid of 
a sonic bath (30 °C). All combinations of API, co-former and ratio stated in Table 7.18 were tested 
with one or more of the solvents listed depending on solubility, so not all possible solvents were used 
for each combination. The maximum crystallisation temperature used was appropriate to the boiling 
point of the solvent used. Whilst co-crystals for all FADs with 4,4’-bipyridine have been reported 
246 
 
previously 179-181 these combinations have been included in this study but with a wider range of co-
former / ratio / crystallisation condition permutations than previously reported. Despite this extensive 
study only 4,4’-bipyridine yielded co-crystals, which were found to comprise the previously reported 
complexes. 
 






































§Classified as GRAS by the Select Committee on GRAS Substances (SCOGS)  
 
Powder X-ray diffraction was initially used to screen all samples for the presence of new co-crystals. 
This led to the identification of two initially unknown co-crystals which were structurally 
characterised using single crystal X-ray diffraction after single crystals of suitable quality were 
obtained through evaporative crystallisation methods; the previously reported structure of FLU-BP 
was also re-determined.  
 





Table 7.19 Evaporative crystallisation conditions used to obtain each FAD-BP co-crystal for 














FEN 26 20 1:1 ethanol 
2 
18 
FLU 30 17 1:1 methanol 18 
MEF 30 20 1:1 IPA 4 
TOL 30 18 1:1 acetone 18 
 
7.5.4 Cooling Crystallisation 
All co-crystals resulting from the evaporative screens were also produced using two different cooling 
procedures; a rapid cooling method and a controlled linear cooling route detailed below. The 
quantities of the co-crystal components were initially based on the solubility data obtained for the 
individual APIs in an IPA/H2O solvent system. Although this method was successful for FEN-BP, 
this proved unsuccessful for FLU-BP producing a physical mixture of the individual components 
and very low yields of the MEF-BP and TOL-BP co-crystals. The molar ratios were therefore 
adjusted until the desired co-crystals could be produced reproducibly. Furthermore, in order to 
maximise the yield obtained for MEF-BP and TOL-BP the solvent system was changed to IPA and 
ethanol respectively. 
 
Solutions of each FAD with BP were prepared using the conditions detailed in Table 7.20. After 
dissolution the solution was either rapidly cooled in an ice bath or subjected to a linear cooling profile 
of 50 °C to 5 °C at 0.05 °Cmin-1 using the Cambridge Reactor Design Polar Bear Plus crystalliser.  
 
7.5.5 Mechano-chemical Crystallisation 
All samples used for the solubility and stability measurements were prepared by kneading a 2:1 
molar ratio of the FAD to BP with a pestle and mortar for 15 minutes with drop-wise addition of 
ethanol and IPA for the FEN-BP and MEF-BP co-crystals, respectively, and methanol for the FLU-





Table 7.20 Experimental conditions used in rapid uncontrolled cooling crystallisation and 



















cooling in an ice 
bath 
FLU 50 14 
2:1 IPA/H2O 
(1:1 v/v) 
MEF 75 49 
1:1 
IPA 
TOL 150 60 
3:2 
Ethanol 




50 °C to 5 °C  
at 0.05 °Cmin-1 
(300 rpm 
stirring) 
FLU 50 14 
2:1 IPA/H2O 
(1:1 v/v) 
MEF 75 49 
1:1 
IPA 





 Single Crystal X-ray Diffraction 
X-ray diffraction data were recorded on an Agilent Technologies Gemini A Ultra CCD 
diffractometer, using monochromatic Mo-Kα radiation (λ = 0.71073 Å) at 150 K. The sample 
temperature was controlled using an Oxford Diffraction Cryojet apparatus and the data processed 
using CrysAlisPro version 1.171.36.21. The structures were solved by direct methods using 
SHELXS-97 and full matrix least-squares refinement was carried out using SHELXL-97. All non-
hydrogen atoms were refined anisotropically and the hydrogen atoms were placed based on the 
Fourier difference maps. Molecular parameters for all structures were computed using the program 
PLATON. Crystallographic data and refinement parameters confirmed the known structures of all 




Table 7.21 Crystal data and structural refinement parameters for MEF-BP, TOL-BP and FLU-BP 
FAD-BP complex MEF-BP TOL-BP FLU-BP 
Formula unit 2C15H15NO2· C10H8N2 2C14H12ClNO2· C10H8N2 2C14H10F3NO2· C10H8N2 
Mr 319.37 339.79 1077.97 
Crystal system Triclinic Monoclinic Triclinic 
Space group P1̅ P21/c P1̅ 
a (Å) 7.3086(3) 4.7081(2) 9.8293(4) 
b (Å) 8.6692(4) 45.220(1) 10.3830(6) 
c (Å) 13.6320(5) 7.9188(3) 24.991(1) 
α (°) 106.135(4) 90 84.684(4) 
β (°) 99.428(4) 106.896(5) 81.333(4) 
γ (°) 98.758(4) 90 71.773(4) 
Volume (Å3) 800.46(6) 1613.1(1) 2392.1(2) 
Z 1 2 3 
Crystal size (mm3) 0.20×0.15×0.10 0.20×0.18×0.08 0.13×0.11×0.08 
ρ (calcd) (M g m-3) 1.325 1.399 1.497 
F(000) 338 708 1110 
θ Range (°) 2.89 - 29.64 3.01 - 26.37 2.80 - 25.35 
Reflections collected 17917 11680 19891 
No. of unique data [Rint)] 4011 [0.0444] 3267 [0.0387] 8741 [0.0545] 
No. of data with I > 2σ(I) 2899 2460 4684 
Final R(I > 2σ(I)) 0.0485 0.0520 0.0692 
Final wR2 (all data) 0.1137 0.1053 0.2055 
 
 Powder X-ray Diffraction 
PXRD patterns were collected in flat plate mode on a Bruker D8 Advance equipped with 
monochromated Cu-Kα radiation (λ = 1.54056 Å) in reflection geometry at 298 K.   
 
 Thermal Analysis 
Differential scanning calorimetry (DSC) studies were carried out using a Thermal Advantage Q20 
DSC from TA Instruments, equipped with Thermal Advantage Cooling System 90 and operated with 
a dry nitrogen purge gas at a flow rate of 18 cm3min-1. The samples were placed in sealed Tzero 




Data were collected using the software Advantage for Qseries. Complementary visual 
characterisation of the thermal properties of the co-crystals was carried out using a Mettler Toledo 
FP82 hot stage equipped with a Leica DM1000 microscope. Each crystal was subjected to a 
programmed temperature regime using the FP90 Central Processor. The crystals were filmed using 
an Infinity 2 microscopy camera.  
 Relative Humidity Studies 
Samples of the BP co-crystals, prepared by liquid-assisted grinding, and their corresponding fenamic 
acid starting materials were stored under moderate (24 °C and 45% RH) and harsh (45 °C and 80% 
RH) humidity conditions for a four and two week period respectively. Samples were taken at regular 
intervals and analysed using PXRD to determine the stability of the materials under these conditions 
with time.   
 Infrared Spectroscopy 
The FTIR spectra were recorded at room temperature using a Perkin Elmer FTIR Spectrometer in 
the range 4000-500 cm-1 with an ATR sampling accessory.   
 Solubility Measurements 
Solubility studies were carried out in a mixed solvent system of IPA and water (1:1 v/v) using a 
CrystallinePV parallel crystalliser from Technobis Crystallization Systems BV (formerly Avantium 
Pharmatech BV). Comprised of eight individually controlled reactors each with a working volume 
of 3-8 cm3, the CrystallinePV couples turbidity measurements with in-line particle visualisation and 
was used to obtain the necessary solubility information. The combination of turbidimetric data and 
images from in-line cameras allows determination of clear points with improved accuracy over 
turbidity measurements alone. Vials were cycled through temperature ranges from 20 °C to 75 °C 
using a heating rate of 0.5 °Cmin-1 and stirring at 800 rpm using standard (4 mm) magnetic stirrer 
bars. Data were analysed using CrystalClear software. It should be noted that this solvent system is 
generally regarded as acceptable for deployment in crystallisation processes within the 
pharmaceutical. 
7.5.7 Results and Discussion 
 Solid state Structure 
The two initially unknown co-crystals produced in the evaporative crystallisations (TOL-BP & 
MEF-BP) were structurally characterised using single crystal X-ray diffraction on single crystals of 
suitable quality; the previously reported structure of FLU-BP was also re-determined, as the previous 
determination was of relatively low quality. It should be noted that while this work was in progress, 
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Surov et al.179 in parallel synthesised and determined the X-ray crystal structures of TOL-BP and 
MEF-BP co-crystals. The two recently reported co-crystals, as well as the previously reported 
complexes FEN-BP and FLU-BP, were prepared through evaporative methods) and also by cooling 
methods and by liquid-assisted grinding, see below). As noted above, a range of other GRAS co-
formers were explored; however no new pharmaceutically relevant co-crystals were prepared. The 
scarcity of co-crystals of FADs is due to both the strong carboxylic acid homodimer synthon that is 
dominant within the numerous polymorphs of the FADs, and the ability for the molecules to adopt 
several stable conformations of their own. The strength of these interactions within these systems 
results in the evident preferential formation of polymorphs over co-crystals. 
 
The crystal structures of MEF-BP and TOL-BP (both form as 2:1 API:BP complexes)179 contain the 
common acid-pyridine hydrogen bonded heterosynthon and intramolecular N-H···O hydrogen bond 
(Figure 7.61, Table 7.22) that has been seen previously in the other co-crystals of FADs with BP180, 
181.The contents of the asymmetric units of MEF-BP and TOL-BP, however, comprise one API 
molecule and half a BP molecule which is in contrast to the previously reported 2:1 co-crystals of 
FLU-BP and FEN-BP that have three and two API molecules in the asymmetric unit, respectively. 
The dihedral angles relating the mean planes of the phenyl rings for each API molecule in the FLU-
BP and FEN-BP structures are considerably different, ranging from 49 to 70° for FEN-BP and from 
41 to 47° for FLU-BP. The MEF-BP co-crystal displays the largest angle between the mean planes 
of the phenyl rings of 79.05(4)°. 
 
 
Figure 7.61 The inter- and intramolecular hydrogen bonds of TOL-BP as a representative 
diagram for the two crystal structures discussed here.  
Table 7.22 Geometrical parameters for the significant hydrogen bonds of MEF-BP and TOL-BP 
FAD-BP 
Co-crystal 
Hydrogen bond d(H···A)/Å d(D-H···A)/Å (D-H···A)/° 
MEF-BP O1-H1···N2a 1.72(2) 2.682(2) 178(2) 
 N10-H10···O2 1.94(2) 2.656(1) 137(2) 
TOL-BP O1-H1···N2b 1.75(4) 2.674(4) 176(3) 
 N10-H10···O2 1.99(2) 2.659(3) 138(2) 
 C14-H14···Cl18c 2.81(2) 3.634(2) 146(2) 
ax, 1+y, z; b1+x, y, z; c-1+x, ½-y, -1/2+z 
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The overall packing arrangements of MEF-BP and TOL-BP are significantly different from one 
another. The bipyridine molecule of MEF-BP lies co-planar with the benzoic acid group of 
mefenamic acid. These co-planar sections are positioned along the (2 -1 1) planes. The semi-
perpendicular dimethyl phenyl rings form π-π interactions with their inversion-related counterparts 
(Figure 7.62) and two weak C-H···O interactions further stabilise the co-crystal and lock the 
conformation of MEF. The 4,4’-bipyridine molecule of TOL-BP is not co-planar to the benzoic acid 
group of tolfenamic acid (27(2)° angle between the mean planes; Figure 7.63) which results in 
extended, twisted TOL-BP-TOL trimer units. The chlorine atoms form weak hydrogen bonds to a 
phenyl C-atom (C-H···Cl, 3.634(2) Å, 146(2)°). Further detailed structural descriptions and 
comparisons for MEF-BP, TOL-BP and other previously published fenamates with 4,4-bipyridine 
have been highlighted in the Surov et al. paper.  
 
 
Figure 7.62 The packing arrangement of the MEF-BP co-crystal as viewed along (0 1 1) 
 
Figure 7.63 A packing diagram of TOL-BP as viewed down the c-axis illustrating the non-planar 





Table 7.23 Melting points of the various polymorphs of mefenamic, tolfenamic and flufenamic 
acid as well as their co-crystals with 4,4’-bipyridine. All temperatures are reported in °C  
Polymorph Mefenamic acid Tolfenamic acid Flufenamic acid 
I -† 213.105 134.56 
II 2294 213.525 129.66 
III -‡ 214.095 127.46 
IV - 206.785 123.96 
V - 215.175 124.96 
VI - - 124.26 
VII - - 120.76 
FAD-BP Complex 163 156 128 
† Converts to form II upon heating 
‡Converts to form I at ambient temperature and form II upon heating 
 Cooling crystallisation 
All samples obtained from the rapid cooling and controlled cooling crystallisations were analysed 
using PXRD (Figure 7.64) and show that all four co-crystals can be reproducibly prepared on this 
scale. Interestingly, both the rapid cooling profile and the controlled cooling profile (0.05 °Cmin-1) 
give the same crystalline form. This may be an indication of the favourability and stability of these 
FAD-BP co-crystals. 
 
Figure 7.64 Comparison of PXRD patterns of products from cooling crystallisation of FADs with 
BP with patterns calculated from the respective FAD-BP single crystal data 
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 Mechano-chemical Crystallisation 
PXRD was used to confirm that the solid forms of the kneaded samples were also the same as those 
obtained from the slow evaporation method (Figure 7.65).  
 
Figure 7.65 PXRD analysis of FAD-BP co-crystals produced from LAG and small scale evaporative 
crystallisation for comparison with patterns calculated from SXRD data 
 Solubility Analysis 
The solubilities of all four co-crystals and their corresponding API starting materials have been 
determined and compared. When evaluating the solubility of the raw starting materials, FLU is found 
to be more soluble than the other FADs (5 mg g-1 at 25 °C) while MEF and TOL have very low 
solubilities in the IPA and water solvent system used. The new co-crystals of each FAD also follow 
this trend with the FLU-BP complex possessing the highest solubility.  
 
Figure 7.66 shows the determined solubilities for each of the four target materials, and the 
comparison with that for their corresponding BP co-crystal. These results show that the solubility of 
the co-crystals is comparable to that of the parent APIs. It is important to note that these values only 
take into account the mass of the API within the co-crystal, allowing direct comparison with the 
solubility of the pure API.  
 
As an additional contribution towards the full description of solubility trends amongst the fenamic 
acid series and their BP co-crystals, rapid cooling of a saturated solution of TOL was undertaken, 
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yielding yellow needles of TOL form II were produced in sufficient quantity to allow the solubility 




Figure 7.66 Comparison of solubility of the FAD-BP co-crystal with the solubility of the 
respective FAD. (Note all solubilities for FAD-BP take into account the mass of the FAD 
component only) 
 Thermal Analysis 
A heat-cool cycle was carried out using DSC for each of the co-crystals and their corresponding 
APIs (Figure 7.67). Hot-stage microscopy (HSM) was also used to visualise the thermal event of 
melting for the co-crystals and to observe any other obvious phase changes upon heating or cooling 
(Figure 7.67). 
 
The DSC trace of FEN shows a single endothermic peak at 186 °C upon heating and two exothermic 
peaks at 116 and 106 °C upon cooling. FLU also displays one endothermic peak at 135 °C which 
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corresponds to the melting point of the most stable polymorphic form of flufenamic acid. Both FEN 
and FLU decompose upon heating and thus the recrystallisation peaks seen for FEN could be 
assigned to decomposition products. The co-crystals of FEN and FLU with BP melt at lower 
temperatures (146 and 128 °C) than their free acids and recrystallise upon cooling at 116 and 107 °C 
respectively (Figure 7.67).  
 
The DSC trace of MEF shows an endothermic peak at 170 °C which corresponds to an enantiotropic 
phase transition of form I to form II182-184. This is followed by another endothermic peak at 231 °C 
which represents the melting point of MEF form II. Upon cooling an exothermic peak is observed at 
135 °C which could be attributed to the recrystallisation of form I, which is stable at lower 
temperatures.182 The DSC traces for TOL form I and form II both show a sharp endotherm at 213 °C 
which agrees with previously reported results.185 Upon cooling, an exothermic peak is observed at 
135 °C for form I and 150 °C for form II. 
 
 
Figure 7.67 Comparison of DSC of the FAD-BP co-crystals with DSC of the respective FAD 
The DSC profiles of MEF-BP and TOL-BP display endothermic peaks at 163 and 156 °C upon 
heating and exothermic recrystallisation peaks at 151 and 98 °C upon cooling (Figure 7.67). In 
contrast to the DSC profile for FEN-BP and FLU-BP, where it can convincingly be stated that the 
co-crystals recrystallise upon cooling (owing to similar enthalpy changes for the endotherm and 
exotherm); the asymmetric and smaller exotherms for the other two co-crystals suggests a more 




As many of the polymorphs of the FADs differ only in a slight conformational change they have 
very similar melting points; the MEF form I to form II enantiotropic transition is an exception to this 
statement. It is common for phase transitions to be seen in DSC traces of polymorphic 
pharmaceuticals and it is therefore significant that in the DSC traces of these co-crystals there are no 
additional endothermic or exothermic peaks prior to melting that can be associated with a typical 
phase transition.  
 
Furthermore, no polymorphs of the co-crystals were observed during the extensive co-crystal screen; 
this suggests locking of the conformational freedom on formation of the co-crystal structures has 
resulted in a reduction in the propensity for polymorphism in these FADs. 
 
The melting points of all of the co-crystals are significantly lower than those of their corresponding 
API, with the largest difference of ca. 66 °C between the melting point of the MEF-BP co-crystal 
and that of polymorphic form II of MEF (Table 7.23). 
 
 Relative Humidity Stability 
A number of APIs are known to interconvert between polymorphic forms as well as anhydrous and 
monohydrate forms under relatively mild humidity conditions. This can cause serious issues with 
production, storage and transport of pharmaceutical products, and it has been shown that co-crystal 
formation of APIs can reduce or eliminate the possibility of these undesirable transformations.70, 73, 
186, 187 The co-crystals of the FADs studied here, along with the API starting materials, were thus 
investigated under moderate humidity storage conditions (24 °C and 45% RH) and ‘stress’ humidity 
storage conditions (45 °C and 80% RH) over a period of four and two weeks, respectively.  
 
PXRD patterns were recorded at various intervals and remained unchanged showing no indication 
of either new products being formed (possible hydrates) or dissociation of the co-crystals into their 
individual components (Figure 7.68 and Figure 7.69). These types of transformations normally occur 
at the higher humidity conditions (>75% RH) and have been found to be dependent on the aqueous 





Figure 7.68 PXRD patterns showing the stability of FEN and the FADs, FLU and MEF and their 
respective FAD-BP co- crystals, FEN-BP, FLU-BP and MEF-BP under moderate humidity 




Figure 7.69 PXRD patterns showing the stability of the FAD TOL (Form I and Form II) and its 
respective TOL-BP co- crystal under moderate humidity conditions (24 °C and 45% RH) 
 
 IR spectroscopy 
Fourier Transform infrared spectroscopy was used to study the conformational and structural 
changes of the important functional groups involved in the hydrogen bonds. In the free acids, the 
carboxylic acid groups form standard R2
2(8) dimers (Figure 7.71 a). In contrast, the co-crystals 
contain pyridine-acid supramolecular synthons and thus the carbonyl groups are not directly 
involved in the intermolecular hydrogen bonds and instead form a stronger intramolecular hydrogen 




Figure 7.70 FTIR spectra of the starting materials and FAD-BP co-crystals 
 
Detailed FTIR studies have been conducted on MEF form I and form II. It has been shown that form 
I, which contains the intramolecular hydrogen bond has an N-H stretching mode that occurs at a 
lower frequency (3311-3312 cm-1) than form II (3346-3347 cm-1) in which the intramolecular 
hydrogen bond no longer exists.189 In all our results we see a redshift for the N-H stretching mode 
upon co-crystal formation indicating a strengthening of the intramolecular hydrogen bond. The C=O 
stretching mode undergoes a blueshift upon co-crystal formation, which is further supported by a 
decrease in the carbonyl bond length (Table 7.24). The dimeric hydrogen-bonded units that are 
commonly seen for the stable polymorphs of the FADs have carbonyl stretching modes that occur at 
marginally lower frequencies than the co-crystals due to the increased C=O bond length which is 
due to a slight pull from the hydrogen bond acceptor. The large shifts (between 10 and 53 cm-1) 





Figure 7.71 Hydrogen bonding synthons present in a) pure FADs and b) co-crystals  
 
Table 7.24 Comparison of stretching frequencies and bond lengths of key functional groups in 
the FAD starting materials and the respective FAD-BP co-crystals. 
Vibration 
frequency (cm-1) 
FEN FEN-BP FLU FLU-BP MEF MEF-BP TOL (I)/(II) TOL-BP 
N-H stretch 3334 3286 3320 3293 3308 3285 3339/3322 3286 
C=O stretch 1653 1666 1651 1671 1647 1670 1654/1659 1664 
C=O bond length 
(Å) 
1.233 1.214 1.234 1.220 1.232 1.219 1.234/1.241 1.221 
 
7.5.8 Conclusions 
This work reports the co-crystal screening of a series of FADs. A total of four co-crystals were 
discovered from these screens, two of which have been previously known and two discovered in 
parallel in this work and in a recent report.179 These four co-crystals of fenamic acid, flufenamic acid, 
mefenamic acid and tolfenamic acid with the co-former 4,4’-bipyridine have been crystallised 
reproducibly here by a range of methods and characterised in terms of their thermal behaviour along 
with the determination of their key physical properties. The determination of these solid-form 
molecular structures and their physicochemical analysis add to the library of previously reported co-
crystals discovered en route to enhancing important solid-state properties, such as thermal stability 




In the pharmaceutical industry it is vitally important for APIs to display long term solid form 
stability. This is of particular note for polymorphic APIs, such as the fenamate family studied here, 
where phase transitions can occur due to heat and pressure changes, especially during secondary 
processing. It has been shown in this study that co-crystallisation enables these polymorphic 
transformations to be minimised, which is illustrated through the thermal investigations on four of 
the FADs and their respective co-crystals. DSC measurements demonstrated that while the melting 
points of the co-crystals were lowered with respect to the APIs, the four fenamate co-crystals 
displayed no evidence of thermally induced phase transitions in contrast to the parent APIs. Although 
the APIs in this study are co-crystallised with the non-GRAS co-former 4,4’-bipyridine, it serves as 
a proof of concept model for future investigations into inhibition of polymorphism in APIs as solid 
form stability and selectivity has been achieved under the experimental conditions investigated here.   
 
The stability of the reported co-crystals provides a robustness with respect to the crystallisation 
method used for their production. A variety of crystallisation methods, including rapid and controlled 
cooling, evaporative and grinding crystallisations, have all produced the desired co-crystals, in a 
single polymorphic form and reproducibly. This is of the utmost importance for large-scale 
production where available techniques and environmental control can be variable.  
 
It is of particular value that co-crystallisation has been achieved through cooling methods as this is 
the most commonly used technique in industrial crystallisation at present. Additionally, co-
crystallisation through liquid-assisted grinding, which has been demonstrated in this investigation, 
can be translated to a screw extrusion process on an industrial scale.72 This offers environmental 
benefits through a significant or complete reduction in solvent use76 and thus minimises the risk of 
potentially toxic residual solvent remaining in the end product.75, 190  
 
Turbidimetric measurements have provided solubility data of the APIs and their 4,4’-bipyridine co-
crystals over a temperature range of 25-70 °C in an IPA/water solvent system. Characterising the 
solubility of starting materials and products is an early step in designing any cooling crystallisation 
process and is fundamental to the optimisation of scale-up to industrial crystallisation volumes. The 
data presented will be beneficial to the design and optimisation of future cooling crystallisation 




8 Conclusions and Future Work 
8.1 Conclusions 
This work has presented a range of studies relevant to the development of continuous crystallisation 
methods for the manufacture of multi-component molecular complexes. Traditionally, investigations 
of this class of materials has focused on structure, with the approach of crystal engineering being 
used to predict and generate new complexes based on an understanding of intermolecular 
interactions. There has also been increasing awareness of the importance of property determination, 
particularly in terms of physical properties that are potentially useful for applications, including 
solubility, melting point. In studies of new or recently discovered molecular complexes here, 
reported in Chapter 7, the importance and relevance of full property determination has been 
emphasised, most notably in the series of fenamic acid complexes, where a comprehensive 
characterisation programme has been carried out. Moreover, it has become increasingly apparent 
that the understanding of the relevant physical properties – most obviously solubility – is a critical 
factor in the design of potential crystallisation processes; this aspect is revisited in the future work 
section below (section 8.1). 
 
This point illustrates one of the conundrums in the design of crystallisation processes, in that it is 
vital to determine a range of physical properties, notably solubility, before a crystallisation regime 
can be set up that will lead to the production of the very material whose properties need to be 
determined. This is most pronounced in the present case for the elusive form of urea barbituric acid 
(see below), where significant effort was required to isolate sufficient quantities of UBAII even to 
allow a basic solubility profile to be obtained. Resolving this conundrum relies on iterative 
approaches to materials production, property measurement and process design. 
 
In order to put the potential for crystallisation for manufacture of fine chemical and pharmaceutical 
products at the core of the study, it is important to demonstrate that particular multi-component 
materials can be produced by a range of crystallisation methods, and to investigate the scalability of 
these. To this end, significant investigations have been reported on the robustness of formation of a 
particular molecular complex, including the selectivity for solid-form (polymorph) in a number of 
the complexes studied. The crystallisation methods investigated have ranged from evaporative 
crystallisation (the traditional way in which such materials are initially synthesised), through to 
cooling, slurrying and mechano-crystallisation (grinding) methods. A range of systems have been 
shown to be transferable across two or more of these techniques, vital in understanding the 




While some limited scale-up studies have been carried out here on new or recently discovered 
molecular complexes, the bulk of the thesis focuses on the previously known polymorphic multi-
component systems urea barbituric acid, in which the full range of translational studies towards full 
continuous crystallisation have been undertaken, from evaporative discovery, through cooling and 
scale-up, to delivery of products using a range of continuous crystallisation platforms. The findings 
of these investigations are summarised briefly below. 
 
The initial crystallisation and properties of the various UBA polymorphs (forms I, II and III, with 
UBAII being metastable) have been reported in Chapter 4. The systematic evaporative co-
crystallisations carried out on the UBA system have shown that it is possible to produce each of the 
UBA polymorphs; importantly, the work presented here has examined the products in bulk, rather 
than simply as single crystals extracted from the solid product. This is vital in assessing phase purity 
of the resulting products. It was found that the more stable pair of polymorphs (UBAI and UBAIII) 
are produced under a range of conditions, while the metastable polymorph UBAII is only produced 
in one of the trials carried out; this is in keeping with its metastable nature, and its known status as 
an elusive solid. UBAI and UBAIII are found frequently to co-exist, and in all cases PXRD analysis 
shows that the final product includes residual starting material. The mechano-crystallisation 
experiments give access exclusively to UBAI, and in liquid-assisted grinding experiments using 
stoichiometric quantities of urea and barbituric acid, and the solvents methanol, ethanol or water, 
UBAI is formed as the sole product; this selectivity was not obtained in evaporative approaches. This 
facile and selective method to isolate UBAI offers a route to UBAI seed production for further 
selective crystallisation experiments.  
 
A design of experiments (DOE) approach was used to investigate the effects of the various 
parameters on the product generated; these confirmed that in the experimental space investigated 
UBAI was the dominant polymorph, with UBAII clearly elusive  
 
The importance of the provenance of starting materials was also investigated with one supplier being 
shown to supply a different polymorphic form of barbituric acid to the others, a factor that can 
significantly affect the design and implementation of crystallisation processes. 
 
In Chapter 5, the initial conditions for cooling crystallisation production of the UBA solid forms 
were established, including their scaling to larger (500 mL) volumes. Access to UBAI and UBAIII 
are dependent on the cooling rate, with slower cooling tending to favour production of UBAIII, while 
the more metastable UBAII is once again more elusive and was only isolated in a single experiment 
using a two-step cooling profile (1 °Cmin-1 to 35 °C followed by 0.05 °Cmin-1 to 10 °C)  and was 
produced with traces of UBAI. The method of adding urea into a pre-prepared solution of BA was 
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shown to produce only UBAI solid product, offering a further route towards polymorph selectivity. 
The in-situ PAT used in these initial experiments within the STR confirmed the presence of the 
various UBA solid forms, but their full interpretation was hampered by the effects of fouling on the 
Raman probe used, and the conclusions were based on off-line PXRD experiments. 
 
These cooling conditions were then used to design a range of campaigns for UBA production in the 
mixed-suspension, mixed-product-removal (MSMPR) system at Loughborough University, in 
collaboration with the research groups of Professors C.D. Rielly and Z. Nagy. These experiments 
showed the potential of periodic operation of such an MSMPR system, with a suitably designed 
dissolution stage, to provide a platform for the consistent production of the desired polymorphic 
form of the model UBA co-crystal system, decreasing product variability significantly compared to 
batch operation. 
 
The MSMPR work was then taken to a related but distinct system at AstraZeneca, Macclesfield, with 
the system there differing most significantly in using vacuum transfer of material rather than the 
peristaltic pump arrangement at Loughborough. Although less time was spent on campaigns in the 
AZ MSMPR system, in the experiments that were carried out, mixtures of UBAI and UBAIII were 
always obtained, and it was not possible to isolate UBAII. This device clearly has promise, even in 
the challenging multi-component, polymorphic system examined here. If the significant problem that 
the continuous vacuum transfer process causes evaporation and makes it more difficult to follow the 
desired supersaturation curves as the crystallisation proceeds, can be overcome, then this system has 
much promise for the future. 
 
Continuous production runs on the UBA system were also carried out in a range of crystallisers in 
the Bath Continuous Crystallisation Laboratory (BCCL) at the University of Bath, and are described 
in Chapter 6. The platforms used were the KRAIC segmented flow device and the NiTech DN15 
Continuous Oscillatory Baffled Crystalliser (COBC). With the inherent reconfigurability of the 
KRAIC, in particular, a wide range of options for segmentation, flow rates, materials transport, etc, 
were investigated. 
 
In the KRAIC, it was found possible to produce UBAI selectively using the non-segmented flow set-
up with a dual UBA feed. However, when a single UBA feed was used in combination with 
segmented flow, using a range of different carrier media (air, PFPE and air with PFPE), a mixture of 
UBAI and UBAIII was produced. As with all previous continuous crystallisations of UBA, UBAII 
was not present in the end product. This difference in polymorphic outcome is most likely due to the 
different mixing conditions experienced with the non-segmented and segmented flows, together with 
the different de-supersaturation profiles followed in the two feed set-ups. Further investigation of 
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crystallisation using a dual UBA feed combined with segmented flow may help to decouple the effect 
of the de-supersaturation profile vs. the mixing conditions. 
 
For the COBC studies of UBA, a range of different operating parameter were used, producing 
consistently good quality single phase UBAI product throughout the crystallisation processes. This 
was achieved over relatively extended periods of operation (typically 180 minutes, three residence 
times). The campaign carried out in the COBC represents a key breakthrough in establishing 
continuous crystallisation of multi-component molecular materials with a view to establishing a 
continuous platform for the production of such materials in a continuous manufacturing context. 
Achieving this for a multi-component system with starting components of substantially different 
solubility characteristics, and being able to produce a single form selectivity even though UBAI and 
UBAIII appear to be very close energetically, is a significant result. This emphasises the high degree 
of control of kinetic factors that is possible in a continuous flow reactor such as the COBC, holding 
much promise for the use of continuous crystallisation in this context. 
 
It has, however, proven challenging to obtain either UBAII or UBAIII selectively in the COBC. This 
is not unexpected for the highly metastable UBAII, but it should be possible to optimise the 
crystallisation conditions to allow the isolation of UBAIII, and work on this is ongoing. 
 
The COBC has been shown to deliver selective crystallisation of UBAI of the target multi-
component UBA system and represents a breakthrough in deployment of such a device and offers 
real potential for its exploitation in the production of multi-component solid forms. The first steps 
have been taken to deploy the COBC at UoB as a fully continuous crystalliser within this project, 
although for the process to be fully continuous much longer experimental runs are required which 
for the capacity of the set-up described here would require a much larger set of feed vessels. 
 
The range of crystallisations carried out during this project has produced a range of information 
about the polymorphic nature of UBA and the relationship between polymorphs. It has been possible 
to isolate successfully all three polymorphs. UBAI, which is the most prevalent polymorph, can be 
crystallised reproducibly via cooling and can also be obtained from mechanical co-crystallisation. 
However, it has proved more challenging to isolate UBAIII reproducibly and it is still extremely 





8.2 Future Work 
In order to progress this initial establishment of the continuous crystallisation of multi-component 
molecular complexes, the following developments are clear next steps. 
 
It will be important to establish a full UBA multi-component phase diagram. While an obvious tool 
for designing effective processes to assemble multi-component systems and to control the production 
of particular solid forms, such full phase diagram investigations remain relatively rare. However, 
with advances in instrumentation, most phase diagrams should be accessible for relatively rapid 
determination. In carrying out this phase diagram determination, it will also be possible to identify 
appropriate anti-solvents that can be used to control precipitation of the product materials and 
enhance yield. The yield of the UBA cooling crystallisation process is currently very low by 
industrial standards (maximum of 60%) as the solubility in methanol does not vary significantly with 
temperature. Other solvent systems such as ethanol, IPA and mixtures with water should be 
investigated. It would also be interesting to explore anti-solvent addition as a final step to the 
crystallisation process. Current industrial processes frequently use a non-polar solvent such as 
hexane as anti-solvent in the final stages of a cooling crystallisation process, to enhance yield; this 
method could be investigated systematically. The use of an appropriate anti-solvent may also offer 
more access to the metastable UBA form II. 
 
The possible use of water as a solvent or co-solvent in UBA continuous crystallisation is severely 
hindered by the tendency of the barbituric acid starting material to form BA hydrate. It would be 
interesting to investigate if there is a threshold for the presence of water in the crystallisation solvent 
or can a temperature profile be developed that when adhered to would prevent formation of the BA 
hydrate. It would also be of interest to investigate the effect of impurities in the BA starting materials 
and how these affect the polymorph of UBA adopted. 
 
The periodic MSMPR system at Loughborough has been shown to be an effective platform for 
production of UBA solid forms, with some evidence of selectivity.  Use of this device with other 
polymorphic multi-component systems should be investigated. In addition, a more systematic 
investigation of the contrasting performance of peristaltic pump vs. vacuum transfer of materials in 
the Loughborough and AZ MSMPR systems should be undertaken, in order to develop the latter 
further towards operation with solid form selectivity. In addition, the option for both continuous and 
periodic operation of the small scale cSTR being developed in BCCL should be pursued in parallel, 
offering a different transfer mechanism (using gravity), together with the significant scaling involved 




This work is has shown that is possible to selectively crystallise UBAI using the COBC with the sets 
of cooling profiles and mixing conditions described in Chapter 6. Further investigations should target 
the crystallisation of UBAII and UBAIII in the COBC, by varying systematically the temperature 
profile and mixing conditions.  In terms of hardware, the COBC will be modified to place the feed 
inlet after a single heated straight to resolve issues with fouling in the unjacketed tube positioned 
near the bellows, a modification implemented in COBC configurations used within CMAC; the 
COBC will also be reconfigured to install a dual feed and seeding port in order to repeat experiment 
C3 with varying concentrations of seed suspension using mechano-chemically produced UBA I 
seeds, and to investigate separate addition of the urea and BA components as investigated with 
MSMPR experiments. 
 
All analyses of materials produced from the COBC were carried out using off-line measurements. 
As PXRD is the main technique used to identify the presence of each polymorph in the UBA system 
it would initially be beneficial to install sampling ports so that samples could be analysed over the 
length of the crystalliser in situ. An aspirational aim would be to implement in-line PXRD analysis 
using flow-through PXRD, either in the laboratory or at a synchrotron source such as Diamond Light 
Source. Routine use of full quantitative phase analysis using PXRD would be of real benefit in 
assessing selectivity and yield; the techniques for doing so are standard, and include the ability to 
analyse multi-phase samples. The methods adopted can be based either on comparison with rigorous 
internal standards, Rietveld refinement, or on a combination of these with cluster analysis programs 
such as PolySNAP. 
 
The main issue encountered with fouling in the KRAIC experiments was within the glass mixer 
piece; to resolve this FEP mixers or glass mixers coated in FEP should be tested. All KRAIC 
experiments on UBA were carried out using a peristaltic pump, however subsequent investigations 
on other materials have used a recently sourced gear pump. This has helped to achieve more uniform 
segmentation due to the nature of the constriction mode of a gear pump which reduces the amount 
of pulsation in comparison to a peristaltic pump. Future experiments using UBA should be carried 
out using the gear pump in order to investigate what effect this may have upon the size variation of 
segments, especially in the methanol system with air/PFPE segmentation. New air/PFPE 
segmentation configurations are also still under development in BCCL, which should be trialled for 
UBA in methanol with an aim to achieve enhanced and more uniform segmentation. More generally, 
further development of the novel KRAIC crystalliser should also be pursued, as outlined in section 
6.1.7, using both experimental and computational approaches. Work is being developed on CFD 
(Computational Fluid dynamics) within the Wilson group. Within CMAC significant efforts have 
been made in characterization of the COBC using CFD, but the Bath effort complements this by 
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focusing upon modelling the KRAIC in order to gain additional information to support the 
understanding gained through ex silico experimental work.  
 
The UBA system should also be examined in the continuous membrane-mediated evaporative 
crystalliser (CMEC) in BCCL. The conditions under which UBA continuous crystallisation has been 
realised are well suited to implementation in the CMEC as it uses methanol solvent which has a low 
boiling point and as a small molecule system will have good membrane permeation. Filtration during 
UBA experiments have caused no issues, indicating that it would allow solution to move freely at 
the membrane surface, though surface fouling seen in the UBA system could cause difficulties. 
 
In terms of the next targets for translation of multi-component systems into the continuous 
crystallisation environment, these might include thiobarbituric acid urea co-crystals, beginning with 
a systematic investigation of the polymorphic behaviour of this multi-component molecular complex 
system. It would also be relevant to look into the transfer into the KRAIC or other continuous 
platform of the 5FCYT-4Cl35DNBA co-crystal system, for which batch cooling crystallisation 
parameters have been obtained (Section 7.4). 
 
There has been evidence in the MSMPR studies on UBA that seeding may be used to preferentially 
produce UBA form I and UBA form III. The seed loading for this is crucial. High seed loading (10%) 
has been shown to direct the formation of UBA I and UBA III, however a seed loading more 
representative of those used in industry (around 1%) have shown little effect. UBA II is more elusive 
and there has not been enough material generated to use this as seed. Further investigation into 
seeding using each of the different polymorphs may prove useful. Seeding has yet to be implemented 
in the small scale continuous crystallisation apparatus at Bath and will form the basis of a future PhD 
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